Annex D DICOM Controlled Terminology Definitions (Normative)

This Annex specifies the meanings of codes defined in DICOM, either explicitly or by reference to another part of DICOM or an external reference document or standard.

DICOM Code Definitions (Coding Scheme Designator “DCM” Coding Scheme Version “01”)

Code Value Code Meaning Definition Notes
109001 Digital timecode (NOS) A signal transmitted for the purpose of interchange of the current time, not specific to any source or methodology.
109002 ECG-based gating signal, processed A signal which is generated for each detection of a heart beat
109003 IRIG-B timecode A signal transmitted by the Inter-Range Instrumentation Group for the purpose of synchronizing time clocks.
109004 X-Ray Fluoroscopy On Signal A signal which indicates that X-Ray source has been activated for fluoroscopy use.
109005 X-Ray On Trigger A signal that indicated that the X-Ray source has been activated for image recording.
109006 Differential signal An electrical signal derived from two electrodes
109007 His bundle electrogram An electrophysiological recording from the HIS nerve bundle
109008 Monopole signal An electrical signal from one electrode relative to an indifferent potential.
109009 Pacing (electrical) stimulus, voltage The voltage stimulus during cardiac pacing
109010 Radio frequency ablation, power The power injected during RF ablation procedure
109011 Voltage measurement by basket catheter Electrophysiological signals acquired using a multi-splined catheter each equipped with multiple electrodes.
109012 Voltage measurement by mapping catheter Electrophysiological signals acquired using a steerable catheter
109013 Voltage measurement, NOS A voltage measurement not otherwise specified
109014 35% of thermal CO A signal point which is 35% of the peak thermal cardiac output signal
109015 70% of thermal CO A signal point which is 70% of the peak thermal cardiac output signal
109016 A wave peak pressure The peak pressure of each heart beat in the atrium caused by the atrial contraction
109017 A wave pressure, average The average of several A wave pressure measurements
109018 Beat detected (accepted) An identified cardiac beat used in the determination of a measurement
109019 Beat detected (rejected) An identified cardiac beat not used in the determination of a measurement
109020 Diastolic pressure, average The average of several diastolic pressure measurements Retired. Replaced with (F-00E22, SRT, “Average diastolic blood pressure”)
109021 Diastolic pressure nadir The lowest pressure value excluding any undershoot artifact. Retired. Replaced with (F-00E1F, SRT, “Minimum diastolic blood pressure”)
109022 End diastole The moment at the end of the diastolic phase of the cardiac cycle. Retired. Replaced with (F-32011, SRT, “End diastole”)
109023 End of expiration The moment at the end of respiratory expiration
109024 End of inspiration The moment at the end of respiratory inspiration
109025 Max dp/dt The maximum positive rate of change of pressure.
109026 Max neg dp/dt The maximum negative rate of change of pressure.
109027 Mean blood pressure The average blood pressure value, generally over 2 or more seconds Retired. Replaced with (F-31150, SRT, “Mean blood pressure”)
109028 Peak of thermal cardiac output bolus The peak change in blood temperature during a thermal cardiac output measurement.
109029 Start of expiration The moment respiratory expiration begins
109030 Start of inspiration The moment of respiratory inspiration begins
109031 Start of thermal cardiac output bolus The first discernable blood temperature change following the injectate during a thermal cardiac output measurement
109032 Systolic pressure, average The average of several systolic blood pressure measurements. Retired. Replaced with (F-00E14, SRT, “Average systolic blood pressure”)
109033 Systolic peak pressure The highest systolic blood pressure value excluding any overshoot artifact Retired. Replaced with (F-00E11, SRT, “Maximum systolic blood pressure”)
109034 V wave peak pressure The peak pressure of each heart beat in the atrium caused by the filling of the atrium.
109035 V wave pressure, average The average of several V wave pressure measurements
109036 Valve close The moment at which a heart valve closes
109037 Valve open The moment at which a heart valve opens
109038 Ablation off The moment when RF ablation current is turned off.
109039 Ablation on The moment when RF ablation current is turned on
109040 HIS bundle wave The moment in the cardiac cycle when the HIS bundle nerves depolarize.
109041 P wave The surface electrocardiogram of the atrial contraction
109042 Q wave The first negative deflection of the electrocardiogram cause by ventricular depolarization
109043 R wave The first positive deflection the electrocardiogram cause by ventricular depolarization
109044 S wave The first negative deflection after the R wave.
109045 Start of atrial contraction The beginning of the atrial contraction
109046 Start of atrial contraction (subsequent) The beginning of the second atrial contraction of two consecutive beats.
109047 Stimulation at rate 1 interval The stimulation interval during cardiac stimulation first used in a pacing train
109048 Stimulation at rate 2 interval The stimulation interval different from the first stimulation interval used in a pacing train
109049 Stimulation at rate 3 interval A stimulation interval different from and subsequent to the second interval in a pacing train.
109050 Stimulation at rate 4 interval Describes a stimulation interval different from and subsequent to the third interval in a pacing train
109051 T wave The electrocardiogram deflection caused by ventricular repolarization.
109052 V wave The peak pressure of each heart beat monitored in the atrium caused by the filling of the atrium
109053 V wave of next beat The second V wave measurement of two consecutive beats.
109054 Patient State A description of the physiological condition of the patient
109055 Protocol Stage The exercise level during a progressive cardiac stress test.
109056 Stress Protocol A series of physiological challenges designed to progressively increase the work of the heart.
109057 Catheterization Procedure Phase A subpart of a cardiac catheterization procedure Retired. Replaced with (G 72BB, SRT, “Catheterization Procedure Phase”)
109058 Contrast Phase The subpart of a cardiac catheterization procedure in which a radio-opaque contrast medium is injected into the patient.
109059 Physiological challenges Physical changes administered to a patient in order to elicit an physiological response
109060 Procedure Step Number Enumeration of a subpart of a catheterization procedure
109061 EP Procedure Phase A subpart of en electrophysiological procedure
109063 Pulse train definition A means of defining a series of cardiac stimulation pulses
109070 End of systole Retired. Replaced with (R-FAB5B, SRT, “End systole”)
109071 Indicator mean transit time Time for a median particle to travel from point of injection to point of detection
109072 Tau The time constant of isovolumic pressure fall
109073 V max myocardial Maximum velocity of myocardial contractility
109091 Cardiac Stress State Imaging after injection of tracer during increased cardiac workload or increased myocardial blood flow, achieved by either exercise or pharmacologic means. Retired. Replaced with (F-05019, SRT, “Cardiac stress state”).
109092 Reinjection State Imaging after injection of additional tracer under resting conditions.
109093 Redistribution State Imaging after allowing a moderate amount of time for tracer to move from its initial sites of uptake. Example: For Thallium imaging this would correspond to imaging 2-6 hours after injection.
109094 Delayed Redistribution State Imaging after allowing an extended amount of time for tracer to move from its initial sites of uptake. Example: For Thallium imaging this would correspond to imaging more than 6 hours after injection.
109095 Peak stress state Peak Cardiac stress state Retired, replaced by (F-05028, SRT, “Peak stress state”)
109096 Recovery state Recovery from cardiac stress Retired, replaced by (F-05018, SRT, “Cardiac stress Recovery state”)
109101 Acquisition Equipment Equipment that originally acquired the data stored within composite instances. For example, a CT, MR or Ultrasound modality.
109102 Processing Equipment Equipment that has processed composite instances to create new composite instances. For example, a 3D Workstation.
109103 Modifying Equipment Equipment that has modified existing composite instances (without creating new composite instances). For example, a QA Station or Archive.
109104 De-identifying Equipment Equipment that has modified an existing composite instance to remove patient identifying information
109105 Frame Extracting Equipment Equipment that has processed composite instances to create new composite instances by extracting selected frames from the original instance.
109110 Voice The sound of a human’s speech, recorded during a procedure. May include the patient’s voice, or the voice of staff present in the room, or an operator’s voice (whether for the purpose of recording a narrative accompanying a procedure or not).
109111 Operator’s narrative The voice of a device operator, recorded during a procedure.
109112 Ambient room environment The ambient sound recorded during a procedure, which may or may not include voice and other types of sound.
109113 Doppler audio The Doppler waveform recorded as an audible signal.
109114 Phonocardiogram The sound of the human heart beating. Such as might be recorded from an electronic stethoscope.
109115 Physiological audio signal Any sound made by the human body. May include the sound of the heart, but also sound from other organs, such as bowel sounds or bruits from vessels, or sounds of respiration. Not intended to include voice.
109116 Arterial Pulse Waveform A digitized signal from the patient arterial system collected through pulse oximetry or other means
109117 Respiration Waveform A digitized signal from the patient respiratory system representing respiration
109120 On admission to unit The occasion on which a procedure was performed on admission to a specialist unit (e.g., intensive care).
109121 On discharge The occasion on which a procedure was performed on discharge from hospital as an in-patient.
109122 On discharge from unit The occasion on which a procedure was performed on discharge from a specialist unit (e.g., intensive care).
109123 Pre-intervention The occasion on which a procedure was performed immediately prior to non-surgical intervention (e.g, percutaneous angioplasty, biopsy).
109124 Post-intervention The occasion on which a procedure was performed immediately after to non-surgical intervention (e.g, percutaneous angioplasty, biopsy).
109125 At last appointment The occasion on which a procedure was performed at the most recent outpatient visit.
109132 Joint position method The active or passive joint positioning during acquisition
109133 Physical force A physical force applied during acquisition
109134 Prior to voiding Prior to voiding
109135 Post voiding Post voiding
109136 Neutral musculoskeletal position Neutral musculoskeletal position
109200 America Kennel Club America Kennel Club
109201 America’s Pet Registry Inc. America’s Pet Registry Inc.
109202 American Canine Association American Canine Association
109203 American Purebred Registry American Purebred Registry
109204 American Rare Breed Association American Rare Breed Association
109205 Animal Registry Unlimited Animal Registry Unlimited
109206 Animal Research Foundation Animal Research Foundation
109207 Canadian Border Collie Association Canadian Border Collie Association
109208 Canadian Kennel Club Canadian Kennel Club
109209 Canadian Livestock Records Association Canadian Livestock Records Association
109210 Canine Federation of Canada Canine Federation of Canada
109211 Continental Kennel Club Continental Kennel Club
109212 Dog Registry of America Dog Registry of America
109213 Federation of International Canines Federation of International Canines
109214 International Progressive Dog Breeders’ Alliance International Progressive Dog Breeders’ Alliance
109215 National Kennel Club National Kennel Club
109216 North American Purebred Dog Registry North American Purebred Dog Registry
109217 United All Breed Registry United All Breed Registry
109218 United Kennel Club United Kennel Club
109219 Universal Kennel Club International Universal Kennel Club International
109220 Working Canine Association of Canada Working Canine Association of Canada
109221 World Kennel Club World Kennel Club
109222 World Wide Kennel Club World Wide Kennel Club
110020 Sheet Film Digitized Digitization of Sheet Film
110021 Cine Film Digitized Digitization of Cine Film
110022 Video Tape Digitized Digitization of Video Tape
110023 Paper Digitized Digitization of pages of a paper document (Units may be specified as Pages, Documents)
110024 CD Imported Importation of CD
110025 DVD Imported Importation of DVD
110026 MOD Imported Importation of MOD
110027 Studies Imported Importation of DICOM Studies
110028 Instances Imported Importation of DICOM Composite Instances
110100 Application Activity Audit event: Application Activity has taken place
110101 Audit Log Used Audit event: Audit Log has been used
110102 Begin Transferring DICOM Instances Audit event: Storage of DICOM Instances has begun
110103 DICOM Instances Accessed Audit event: DICOM Instances have been created, read, updated, or deleted -audit event
110104 DICOM Instances Transferred Audit event: Storage of DICOM Instances has been completed
110105 DICOM Study Deleted Audit event: Entire Study has been deleted
110106 Export Audit event: Data has been exported out of the system
110107 Import Audit event: Data has been imported into the system
110108 Network Entry Audit event: System has joined or left network
110109 Order Record Audit event: Order has been created, read, updated or deleted
110110 Patient Record Audit event: Patient Record has been created, read, updated, or deleted
110111 Procedure Record Audit event: Procedure Record has been created, read, updated, or deleted
110112 Query Audit event: Query has been made
110113 Security Alert Audit event: Security Alert has been raised
110114 User Authentication Audit event: User Authentication has been attempted
110120 Application Start Audit event: Application Entity has started
110121 Application Stop Audit event: Application Entity has stopped
110122 Login Audit event: User login has been attempted
110123 Logout Audit event: User logout has been attempted
110124 Attach Audit event: Node has been attached
110125 Detach Audit event: Node has been detached
110126 Node Authentication Audit event: Node Authentication has been attempted
110127 Emergency Override Started Audit event: Emergency Override has started
110128 Network Configuration Audit event: Network configuration has been changed
110129 Security Configuration Audit event: Security configuration has been changed
110130 Hardware Configuration Audit event: Hardware configuration has been changed
110131 Software Configuration Audit event: Software configuration has been changed
110132 Use of Restricted Function Audit event: A use of a restricted function has been attempted
110133 Audit Recording Stopped Audit event: Audit recording has been stopped
110134 Audit Recording Started Audit event: Audit recording has been started
110135 Object Security Attributes Changed Audit event: Security attributes of an object have been changed
110136 Security Roles Changed Audit event: Security roles have been changed
110137 User security Attributes Changed Audit event: Security attributes of a user have been changed
110150 Application Audit participant role ID of software application
110151 Application Launcher Audit participant role ID of software application launcher, i.e., the entity that started or stopped an application.
110152 Destination Role ID Audit participant role ID of the receiver of data
110153 Source Role ID Audit participant role ID of the sender of data
110154 Destination Media Audit participant role ID of media receiving data during an export.
110155 Source Media Audit participant role ID of media providing data during an import.
110180 Study Instance UID ParticipantObjectID type: Study Instance UID
110181 SOP Class UID ParticipantObjectID type: SOP Class UID
110182 Node ID ID of a node that is a participant object of an audit message
110138 Emergency Override Stopped Audit event: Emergency Override has Stopped
110139 Remote Service Operation Started Audit event: Remote Service Operation has Begun
110140 Remote Service Operation Stopped Audit event: Remote Service Operation has Stopped
110141 Local Service Operation Started Audit event: Local Service Operation has Begun
110142 Local Service Operation Stopped Audit event: Local Service Operation Stopped
110030 USB Disk Emulation A device that connects using the USB hard drive interface. These may be USB-Sticks, portable hard drives, and other technologies.
110031 Email Email and email attachments used as a media for data transport.
110032 CD CD-R, CD-ROM, and CD-RW media used for data transport.
110033 DVD DVD, DVD-RAM, and other DVD formatted media used for data transport.
110034 Compact Flash Media that comply with the Compact Flash standard.
110035 Multi-media Card Media that comply with the Multi-media Card standard.
110036 Secure Digital Card Media that comply with the Secure Digital Card standard.
110037 URI URI Identifier for network or other resource, see RFC 3968
110038 Paper Document Any paper or similar document.
110190 Issuer of Identifier System, organization, agency, or department that has assigned an instance identifier (such as placer or filler number, patient or provider identifier, etc.)
110500 Doctor cancelled procedure Procedure order cancelled by requesting physician or other authorized physician
110501 Equipment failure Equipment failure prevented completion of procedure
110502 Incorrect procedure ordered Procedure discontinued due to incorrect procedure being ordered
110503 Patient allergic to media/contrast Procedure discontinued due to patient allergy to media/contrast (reported or reaction)
110504 Patient died Procedure discontinued due to death of Patient
110505 Patient refused to continue procedure Procedure discontinued due to patient refusal to continue procedure
110506 Patient taken for treatment or surgery Procedure discontinued due to patient being taken for treatment or surgery
110507 Patient did not arrive Patient did not arrive for procedure
110508 Patient pregnant Procedure discontinued due to patient pregnancy (reported or determined)
110509 Change of procedure for correct charging Procedure discontinued to restart with new procedure code for correct charging
110510 Duplicate order Procedure discontinued due to duplicate orders received for same procedure
110511 Nursing unit cancel Procedure order cancelled by nursing unit
110512 Incorrect side ordered Procedure discontinued due to incorrect side (laterality) being ordered
110513 Discontinued for unspecified reason Procedure discontinued for unspecified reason
110514 Incorrect worklist entry selected Procedure discontinued due to incorrect patient or procedure step selected from modality worklist
110515 Patient condition prevented continuing Patient condition prevented continuation of procedure
110516 Equipment change Procedure step is discontinued to change to other equipment or modality
110518 Patient Movement A movement of the patient affecting test quality
110519 Operator Error An error of the operator affecting test quality
110521 Objects incorrectly formatted One or more of the objects is malformed.
110522 Object Types not supported Receiving System is unable to accept the object type.
110523 Object Set incomplete One or more objects associated with the object set is missing.
110524 Media Failure The contents of the Media could not be accessed properly.
110526 Resource pre-empted Procedure discontinued due to necessary equipment, staff or other resource becoming (temporarily) unavailable to the procedure.
110527 Resource inadequate Procedure discontinued due to necessary equipment, staff or other resource being inadequate to complete the procedure.
110528 Discontinued Procedure Step rescheduled A new Procedure Step has been scheduled to replace the Discontinued Procedure Step.
110529 Discontinued Procedure Step rescheduling recommended It is recommended that a new Procedure Step be scheduled to replace the Discontinued Procedure Step.
110001 Image Processing Image processing work item
110002 Quality Control Quality control work item
110003 Computer Aided Diagnosis Computer aided diagnosis work item
110004 Computer Aided Detection Computer aided detection work item
110005 Interpretation Interpretation work item
110006 Transcription Transcription work item
110007 Report Verification Report verification work item
110008 Print Print work item
110009 No subsequent Workitems
110010 Film Film type of output
110011 Dictation Dictation type of output
110012 Transcription Transcription type of output
110013 Media Import The procedure to read DICOM instances from DICOM interchange media, coerce identifying attributes into the local namespace if necessary, and make the instances available.
110800 Spin Tagging Perfusion MR Signal Intensity Signal intensity of a Spin tagging Perfusion MR image. Spin tagging is a technique for the measurement of blood perfusion, based on magnetically labeled arterial blood water as an endogenous tracer.
110801 Contrast Agent Angio MR Signal Intensity Signal intensity of a Contrast Agent Angio MR image.
110802 Time Of Flight Angio MR Signal Intensity Signal intensity of a Time-of-flight (TOF) MR image. Time-of-flight (TOF) is based on the phenomenon of flow-related enhancement of spins entering into an imaging slice. As a result of being unsaturated, these spins give more signal that surrounding stationary spins.
110803 Proton Density Weighted MR Signal Intensity Signal intensity of a Proton Density Weighted MR image. All MR images have intensity proportional to proton density. Images with very little T1 or T2 weighting are called ‘PD-weighted’.
110804 T1 Weighted MR Signal Intensity Signal intensity of T1 Weighted MR image. A T1 Weighted MR image is created typically by using short TE and TR times.
110805 T2 Weighted MR Signal Intensity Signal intensity of a T2 Weighted MR image. T2 Weighted image contrast state is approached by imaging with a TR long compared to tissue T1 (to reduce T1 contribution to image contrast) and a TE between the longest and shortest tissue T2s of interest.
110806 T2* Weighted MR Signal Intensity Signal intensity of a T2* Weighted MR image. The T2* phenomenon results from molecular interactions (spin spin relaxation) and local magnetic field non-uniformities, which cause the protons to precess at slightly different frequencies.
110807 Field Map MR Signal Intensity Signal intensity of a Field Map MR image. A Field Map MR image provides a direct measure of the B0 inhomogeneity at each point in the image.
110808 Fractional Anisotropy Coefficient reflecting the fractional anisotropy of the tissues, derived from a diffusion weighted MR image. Fractional anisotropy is proportional to the square root of the variance of the Eigen values divided by the square root of the sum of the squares of the Eigen values.
110809 Relative Anisotropy Coefficient reflecting the relative anisotropy of the tissues, derived from a diffusion weighted MR image.
110810 Volumetric Diffusion Dxx Component Dxx Component of the diffusion tensor, quantifying the molecular mobility along the X axis.
110811 Volumetric Diffusion Dxy Component Dxy Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Y directions.
110812 Volumetric Diffusion Dxz Component Dxz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Z directions.
110813 Volumetric Diffusion Dyy Component Dyy Component of the diffusion tensor, quantifying the molecular mobility along the Y axis.
110814 Volumetric Diffusion Dyz Component Dyz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the Y and Z directions.
110815 Volumetric Diffusion Dzz Component Dzz Component of the diffusion tensor, quantifying the molecular mobility along the Z axis.
110816 T1 Weighted Dynamic Contrast Enhanced MR Signal Intensity Signal intensity of a T1 Weighted Dynamic Contrast Enhanced MR image. A T1 Weighted Dynamic Contrast Enhanced MR image reflects the dynamics of diffusion of the exogenous contrast media from the blood pool into the extra vascular extracellular space (EES) of the brain at a rate determined by the blood flow to the tissue, the permeability of the Brain Blood Barrier (BBB), and the surface area of the perfusing vessels.
110817 T2 Weighted Dynamic Contrast Enhanced MR Signal Intensity Signal intensity of a T2 Weighted Dynamic Contrast Enhanced MR image. A T2 Weighted Dynamic Contrast Enhanced MR image reflects the T2 of tissue decrease as the Gd contrast agent bolus passes through the brain.
110818 T2* Weighted Dynamic Contrast Enhanced MR Signal Intensity Signal intensity of a T2* Weighted Dynamic Contrast Enhanced MR image. A T2* Weighted Dynamic Contrast Enhanced MR image reflects the T2* of tissue decrease as the Gd contrast agent bolus passes through the brain.
110819 Blood Oxygenation Level Signal intensity of a Blood Oxygenation Level image. BOLD imaging is sensitive to blood oxygenation (but also to cerebral blood flow and volume). This modality is essentially used for detecting brain activation (functional MR).
110820 Nuclear Medicine Projection Activity Accumulated decay event counts in a nuclear medicine projection image.
110821 Nuclear Medicine Tomographic Activity Accumulated decay event counts in a Nuclear Medicine Tomographic image (including PET).
110822 Spatial Displacement X Component Spatial Displacement along axis X of a non linear deformable spatial registration image. The X axis is defined in reference to the patient’s orientation, and is increasing to the left hand side of the patient.
110823 Spatial Displacement Y Component Spatial Displacement along axis Y of a non linear deformable spatial registration image. The Y axis is defined in reference to the patient’s orientation, and is increasing to the posterior side of the patient.
110824 Spatial Displacement Z Component Spatial Displacement along axis Z of a Non linear deformable spatial registration image. The Z axis is defined in reference to the patient’s orientation, and is increasing toward the head of the patient.
110825 Hemodynamic Resistance Measured resistance to the flow of blood, e.g. through the vasculature or through a heart value.
110826 Indexed Hemodynamic Resistance Measured resistance to the flow of blood, e.g. through the vasculature or through a heart value, normalized to a particular indexed scale.
110827 Tissue Velocity Velocity of tissue based on Doppler measurements.
110828 Flow Velocity Velocity of blood flow based on Doppler measurements.
110829 Flow Variance Statistical variance of blood velocity relative to mean.
110830 Elasticity Scalar value related to the elastic properties of the tissue.
110831 Perfusion Scalar value related to the volume of blood perfusing into tissue.
110832 Speed of sound Speed of sound in tissue.
110833 Ultrasound Attenuation Reduction in strength of ultrasound signal as the wave.
110834 RGB R Component Red component of a true color image (RGB).
110835 RGB G Component Green component of a true color image (RGB).
110836 RGB B Component Blue component of a true color image (RGB).
110837 YBR FULL Y Component Y (Luminance) component of a YBR FULL image, as defined in JPEG 2000.
110838 YBR FULL CB Component CB (Blue chrominance) component of a YBR FULL image, as defined in JPEG 2000.
110839 YBR FULL CR Component CR (Red chrominance) component of a YBR FULL image, as defined in JPEG 2000.
110840 YBR PARTIAL Y Component Y (Luminance) component of a YBR PARTIAL image, as defined in JPEG 2000.
110841 YBR PARTIAL CB Component CB (Blue chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000.
110842 YBR PARTIAL CR Component CR (Red chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000.
110843 YBR ICT Y Component Y (Luminance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000.
110844 YBR ICT CB Component CB (Blue chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000.
110845 YBR ICT CR Component CR (Red chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000.
110846 YBR RCT Y Component Y (Luminance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000.
110847 YBR RCT CB Component CB (Blue chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000.
110848 YBR RCT CR Component CR (Red chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000.
110849 Echogenicity The ability of a material to create an ultrasound return echo.
110850 X-Ray Attenuation Decrease in the number of photons in an X-Ray beam due to interactions with the atoms of a material substance. Attenuation is due primarily to two processes, absorption and scattering.
110851 X-Ray Attenuation Coefficient Coefficient which describes the fraction of a beam of X-Rays or gamma rays that is absorbed or scattered per unit thickness of the absorber. This value basically accounts for the number of atoms in a cubic cm volume of material and the probability of a photon being scattered or absorbed from the nucleus or an electron of one of these atoms.
110852 MR signal intensity Signal intensity of an MR image, not otherwise specified.
110853 Binary Segmentation Binary value denoting that the segmented property is present.
110854 Fractional Probabilistic Segmentation Probability, defined as a percentage, that the segmented property occupies the spatial area defined by the voxel.
110855 Fractional Occupancy Segmentation Percentage of the voxel area occupied by the segmented property.
110856 Linear Displacement Spatial dimension, denoting a linear displacement.
110857 Photon Energy Dimension denoting the energy (frequency or wavelength) of photons.
110858 Time Dimension used to sequence events, to compare the duration of events and the intervals between events.
110859 Angle Spatial dimension, denoting an angle.
110860 Left-Right Axis A spatial dimension axis running along a line between the patient’s left and right side.
110861 Head-Foot Axis A spatial dimension axis running along a line between the patient’s head and foot.
110862 Anterior-Posterior Axis A spatial dimension axis running along a line between the patient’s anterior and posterior sides.
110863 Apex-Base Axis A spatial dimension axis running along a line between the apex and base of an organ, object, or chamber.
110864 Anterior-Inferior Axis A spatial dimension axis running along a line between the anterior and inferior sides of an organ, object, or chamber.
110865 Septum-Wall Axis A spatial dimension axis running along a line between the septum and wall of a chamber.
110866 Right To Left Orientation of a spatial dimension where increasing values run from the right to the left side of the patient.
110867 Left To Right Orientation of a spatial dimension where increasing values run from the left to the right side of the patient.
110868 Head To Foot Orientation of a spatial dimension where increasing values run from the head to the foot of the patient.
110869 Foot To Head Orientation of a spatial dimension where increasing values run from the foot to the head of the patient.
110870 Anterior To Posterior Orientation of a spatial dimension where increasing values run from the anterior to the posterior side of the patient.
110871 Posterior To Anterior Orientation of a spatial dimension where increasing values run from the posterior to the anterior side of the patient.
110872 Apex To Base Orientation of a spatial dimension where increasing values run from the apex to the base.
110873 Base To Apex Orientation of a spatial dimension where increasing values run from the base to the apex.
110874 Anterior To Inferior Orientation of a spatial dimension where increasing values run from the anterior to the inferior.
110875 Inferior To Anterior Orientation of a spatial dimension where increasing values run from the inferior to the anterior.
110876 Septum To Wall Orientation of a spatial dimension where increasing values run from the septum of a chamber to the opposite wall.
110877 Wall To Septum Orientation of a spatial dimension where increasing values run from the opposite wall to the septum of a chamber.
111001 Algorithm Name The name assigned by a manufacturer to a specific software algorithm
111002 Algorithm Parameters The input parameters used by a manufacturer to configure the behavior of a specific software algorithm
111003 Algorithm Version The software version identifier assigned by a manufacturer to a specific software algorithm
111004 Analysis Performed The type of correlation applied to detection results (e.g., temporal, spatial)
111005 Assessment Category Assignment of intermediate or overall interpretation results to a general category
111006 Breast composition Assessment of annotating tissues in breast; generally including fatty, mixed or dense Retired. Replaced with (F-01710, SRT 1.1, “Breast composition”).
111007 Breast Outline including Pectoral Muscle Tissue Purpose of reference for an SCOORD content item that is an outline of the breast that includes the pectoral muscle tissue Purpose of Reference for content item of value type COMPOSITE or SCOORD
111008 Calcification Distribution The type of distribution associated with detected calcifications
111009 Calcification Type Identification of the morphology of detected calcifications
111010 Center Purpose of reference for an SCOORD content item that identifies the central point of a finding or feature Purpose of Reference for content item of value type COMPOSITE or SCOORD
111011 Certainty of Feature The likelihood that the feature analyzed is in fact the type of feature identified.
111012 Certainty of Finding The likelihood that the finding detected is in fact the type of finding identified.
111013 Certainty of Impression The certainty that a device places on an impression, where 0 equals no certainty and 100 equals certainty.
111014 Clockface or region A location identifier based on clockface numbering or anatomic subregion
111015 Composite Feature An item that is an inferred correlation relating two or more individual findings or features
111016 Composite type The inferred relationship between the findings or features making up a composite feature
111017 CAD Processing and Findings Summary General assessment of whether or not CAD processing was successful, and whether any findings resulted
111018 Content Date The date the data creation started
111019 Content Time The time the data creation started
111020 Depth A location identifier based on a feature’s inferred distance from the surface of the associated anatomy
111021 Description of Change A textual description of the change that occurred over time in a qualitative characteristic of a feature
111022 Detection Performed The type of finding sought after by a specific algorithm applied to one image
111023 Differential Diagnosis/Impression A general change that occurred within an imaged area between a prior imaging procedure and the current imaging procedure
111024 Failed Analyses A group of analysis algorithms that were attempted, but failed
111025 Failed Detections A group of detection algorithms that were attempted, but failed
111026 Horizontal Pixel Spacing For projection radiography, the horizontal physical distance measured at the front plane of an Image Receptor housing between the center of each pixel. For tomographic images, the horizontal physical distance in the patient between the center of each pixel.
111027 Image Laterality Laterality of (possibly paired) body part contained in an image
111028 Image Library A container that references all image data used as evidence to produce a report
111029 Image Quality Rating A numeric value in the range 0 to 100, inclusive, where 0 is worst quality and 100 is best quality.
111030 Image Region Purpose of reference for an SCOORD content item that identifies a specific region of interest within an image Purpose of Reference for content item of value type COMPOSITE or SCOORD
111031 Image View The projection of the anatomic region of interest on an image receptor.
111032 Image View Modifier Modifier for Image View
111033 Impression Description Free-form text describing the overall or an individual impression
111034 Individual Impression/Recommendation A container for a group of related results from interpretation of one or more images and associated clinical information
111035 Lesion Density The X-Ray attenuation of a lesion relative to the expected attenuation of an equal volume of fibroglandular breast tissue
111036 Mammography CAD Report A structured report containing the results of computer-aided detection or diagnosis applied to breast imaging and associated clinical information
111037 Margins The characteristic of the boundary, edges or border of a detected lesion
111038 Number of calcifications The quantity of calcifications detected within an identified group or cluster
111039 Object type A non-lesion object identified within one or more images
111040 Original Source Purpose of reference for a COMPOSITE content item that identifies it as the original source of evidence for another content item in the report Purpose of Reference for content item of value type COMPOSITE or SCOORD
111041 Outline Purpose of reference for an SCOORD content item that identifies the outline or bounding region of a finding or feature Purpose of Reference for content item of value type COMPOSITE or SCOORD
111042 Pathology The inferred type of disease associated with an identified feature
111043 Patient Orientation Column The patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive column axis (top to bottom)
111044 Patient Orientation Row The patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive row axis (left to right)
111045 Pectoral Muscle Outline Purpose of reference for an SCOORD content item that is an outline of the pectoral muscle tissue only Purpose of Reference for content item of value type COMPOSITE or SCOORD
111046 Percent Fibroglandular Tissue Percent of breast area that is mammographically dense, excluding pectoralis muscle.
111047 Probability of cancer The likelihood that an identified finding or feature is cancerous
111048 Quadrant location A location identifier based on the division of an area into four regions
111049 Qualitative Difference A qualitative characteristic of a feature that has changed over time
111050 Quality Assessment The effect of the quality of an image on its usability
111051 Quality Control Standard The quality control standard used to make a quality assessment
111052 Quality Finding A specific quality related deficiency detected within an image
111053 Recommended Follow-up Recommended type of follow-up to an imaging procedure, based on interpreted results
111054 Recommended Follow-up Date Recommended follow-up date to an imaging procedure, based on interpreted results
111055 Recommended Follow-up Interval Recommended follow-up interval to an imaging procedure, based on interpreted results
111056 Rendering Intent The recommendation of the producer of a content item regarding presentation of the content item by recipients of the report
111057 Scope of Feature An indication of how widespread the detection of a feature is within the analyzed image data set
111058 Selected Region Description A textual description of the contents of a selected region identified within an image
111059 Single Image Finding An item that was detected on one image
111060 Study Date Date on which the acquisition of the study information was started
111061 Study Time Time at which the acquisition of the study information was started
111062 Successful Analyses A group of analysis algorithms that were attempted and completed successfully
111063 Successful Detections A group of detection algorithms that were attempted and completed successfully
111064 Summary of Detections An overall indication of whether the CAD detection algorithms applied were completed successfully
111065 Summary of Analyses An overall indication of whether the CAD analysis algorithms applied were completed successfully
111066 Vertical Pixel Spacing For projection radiography, the vertical physical distance measured at the front plane of an Image Receptor housing between the center of each pixel. For tomographic images, the vertical physical distance in the patient between the center of each pixel.
111069 Crosstable
111071 CAD Operating Point One of a number of discrete points on the Receiver-Operator Characteristics (ROC) curve that reflects the expected sensitivity and specificity of a CAD algorithm, where zero indicates the highest specificity, lowest sensitivity operating point. The value should not exceed the Maximum CAD Operating Point.
111072 Maximum CAD Operating Point The maximum value of CAD Operating Point for the specific CAD algorithm used.
111081 CAD Operating Point Description The intended interpretation of a CAD Operating Point.
111086 False Markers per Image The number of false CAD markers per image. Correlates to inverse of Image Specificity.
111087 False Markers per Case The number of false markers per collection of images that are CAD processed as a group. Correlates to inverse of Case Specificity.
111088 Case Sensitivity The percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in at least one view.
111089 Lesion Sensitivity The percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in each view.
111090 Case Specificity The percentage of cases (collections of images CAD processed as a group) without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Case.
111091 Image Specificity The percentage of images without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Image.
111092 Recommended CAD Operating Point The CAD operating point that is recommended for initial display by the creator of the structured report.
111093 CAD Operating Point Table A list of CAD operating points including their corresponding characteristics.
111099 Selected region A specific area of interest noted within an image
111100 Breast geometry The surface shape of all or a portion of breast related anatomy
111101 Image Quality Image quality incorporates the following clinical image evaluation parameters: assessment of positioning, compression, artifacts, exposure, contrast, sharpness, and labeling
111102 Non-lesion A finding or feature that is identified as a non-anatomic foreign object
111103 Density A space-occupying lesion identified in a single image or projection Retired. Replaced with (F-01796, SRT 1.1, “Mammography breast density”).
111104 Individual Calcification A single identified calcification Retired. Replaced with (F-01776, SRT 1.1, “Individual Calcification”).
111105 Calcification Cluster Multiple calcifications identified as occupying a small area of tissue (less than 2 cc) Retired. Replaced with (F-01775, SRT 1.1, “Calcification Cluster”).
111111 Cooper’s ligament changes Straightening or thickening of Cooper’s ligaments
111112 Mass in the skin An abnormality noted at imaging within the dermis of the breast
111113 Mass on the skin An abnormality noted at imaging on the epidermis of the breast
111120 Post Procedure Mammograms for Marker Placement An assessment category to indicate that images have been acquired to assess marker placement following a breast interventional procedure
111121 Follow-up post biopsy as directed by clinician An indication that the patient should seek post procedural follow-up directives from a clinical health care provider.
111122 Known biopsy proven malignancy – take appropriate action A recommendation on a patient with known cancer to take steps appropriate to the diagnosis.
111123 Marker placement Positioning of a radiopaque marker.
111124 Personal history of breast cancer with mastectomy Patient has previous diagnosis of breast cancer resulting in mastectomy.
111125 Known biopsy proven malignancy Patient has had biopsy containing proven malignancy.
111126 Image detected mass Patient has a finding of mass reported on a prior imaging exam.
111127 Targeted A breast imaging procedure performed on a specific area of the breast.
111128 Survey A breast imaging procedure performed on the entire breast.
111129 Clustered microcysts A cluster of tiny anechoic foci each smaller than 2-3 mm in diameter with thin (less than 0.5 mm) intervening septations and no discrete solid components
111130 Complicated cyst A fluid filled mass most commonly characterized by homogeneous low-level internal echoes on ultrasound
111135 Additional projections Views not inclusive of MLO and CC (BI-RADS® )
111136 Spot magnification view(s) A spot or coned down compression of the breast providing a reduction in the thickness and a magnification of the localized area of interest and improved separation of breast tissue
111137 Ultrasound Retired. Replaced with (P5-B0099, SRT 1.1, “Ultrasound procedure”).
111138 Old films for comparison Obtain previous mammography studies to compare to present study
111139 Ductography A medical procedure used for the sampling of mammary duct tissue Retired. Replaced with (P5-40060, SRT 1.1, “Mammary ductogram”).
111140 Normal interval follow-up Follow up study at 12 months for women ≥ 40 years of age having a prior negative study and no mitigating risk factors for breast cancer
111141 Any decision to biopsy should be based on clinical assessment Any decision to perform tissue acquisition should be based on clinical assessment
111142 Follow-up at short interval (1-11 months) Follow-up at short interval (1-11 months)
111143 Biopsy should be considered Tissue acquisition should be considered
111144 Needle localization and biopsy Breast tissue acquisition following the identification of an area of concern with the placement of a needle or needle-wire assembly
111145 Histology using core biopsy Pathologic analysis of breast tissue and lesions using core tissue samples
111146 Suggestive of malignancy – take appropriate action Lesions that do not have the characteristic morphologies of breast cancer but have a definite probability of being malignant. There is a sufficient concern to urge a biopsy.
111147 Cytologic analysis Cellular analysis of specimen
111148 Biopsy should be strongly considered Tissue acquisition should be strongly considered
111149 Highly suggestive of malignancy – take appropriate action Lesions have a high probability of being cancer, which require additional action.
111150 Presentation Required: Rendering device is expected to present The producer of a report intends for a recipient of the report to present or display the associated content item
111151 Presentation Optional: Rendering device may present The producer of a report considers the presentation or display of the associated content item by a recipient to be optional
111152 Not for Presentation: Rendering device expected not to present The producer of a report intends for a recipient of the report NOT to present or display the associated content item
111153 Target content items are related temporally The associated content items are identfied as being the same finding or feature at different points in time
111154 Target content items are related spatially The associated content items are identified as being the same finding or feature on different projections taken at the same point in time
111155 Target content items are related contra-laterally The associated content items are identified as being related side-to-side
111156 Feature detected on the only image There is one image in the interpreted data set
111157 Feature detected on only one of the images There is more than one image of the same modality in the interpreted data set
111158 Feature detected on multiple images There is more than one image of the same modality in the interpreted data set
111159 Feature detected on images from multiple modalities The interpreted data set contains images from multiple modalities
111168 Scar tissue The fibrous tissue replacing normal tissues destroyed by disease or injury Retired. Replaced with (M-78060, SRT, “Scar tissue”).
111170 J Wire A medical appliance used for localization of non palpable breast lesions to insure that the proper area is removed in a surgical biopsy Retired. Replaced with (A-1016B, SRT, “J Wire”).
111171 Pacemaker A medical appliance used for regulating cardiac rhythms Retired. Replaced with (A-11101, SRT, “Cardiac Pacemaker”).
111172 Paddle A compression device used for obtaining mammographic images Retired. Replaced with (A-10042, SRT, “Compression paddle”).
111173 Collimator A device used for restricting an X-Ray beam Retired. Replaced with (A-10044, SRT, “Collimator”).
111174 ID Plate An area designated on a radiographic film for facility and patient ID information Retired. Replaced with (A-16016, SRT, “ID Plate”).
111175 Other Marker Site specific markers
111176 Unspecified The value of the concept is not specified
111177 View and Laterality Marker is missing Image quality deficiency according to MQSA
111178 View and Laterality Marker does not have both view and laterality Image quality deficiency according to MQCM
111179 View and Laterality Marker does not have approved codes Image quality deficiency according to MQCM
111180 View and Laterality Marker is not near the axilla Image quality deficiency according to MQCM
111181 View and Laterality Marker overlaps breast tissue Image quality deficiency according to MQCM
111182 View and Laterality Marker is partially obscured Image quality deficiency according to MQCM
111183 View and Laterality Marker is incorrect Image quality deficiency
111184 View and Laterality Marker is off image Image quality deficiency
111185 Flash is not near edge of film Image quality deficiency according to MQCM
111186 Flash is illegible, does not fit, or is lopsided Image quality deficiency according to MQSA
111187 Flash doesn’t include patient name and additional patient id Image quality deficiency according to MQCM
111188 Flash doesn’t include date of examination Image quality deficiency according to MQCM
111189 Flash doesn’t include facility name and location Image quality deficiency according to MQSA
111190 Flash doesn’t include technologist identification Image quality deficiency according to MQCM
111191 Flash doesn’t include cassette/screen/detector identification Image quality deficiency according to MQCM
111192 Flash doesn’t include mammography unit identification Image quality deficiency according to MQCM
111193 Date sticker is missing Image quality deficiency according to MQCM
111194 Technical factors missing Image quality deficiency according to MQCM
111195 Collimation too close to breast Image quality deficiency according to MQCM
111196 Inadequate compression Image quality deficiency according to MQCM
111197 MLO Insufficient pectoral muscle Image quality deficiency according to MQCM
111198 MLO No fat is visualized posterior to fibroglandular tissues Image quality deficiency according to MQCM
111199 MLO Poor separation of deep and superficial breast tissues Image quality deficiency according to MQCM
111200 MLO Evidence of motion blur Image quality deficiency according to MQCM
111201 MLO Inframammary fold is not open Image quality deficiency according to MQCM
111202 CC Not all medial tissue visualized Image quality deficiency according to MQCM
111203 CC Nipple not centered on image Image quality deficiency according to MQCM
111204 CC Posterior nipple line does not measure within 1 cm of MLO Image quality deficiency according to MQCM
111205 Nipple not in profile Image quality deficiency
111206 Insufficient implant displacement incorrect Image quality deficiency according to MQCM
111208 Grid artifact(s) Feature(s) arising from the acquisition unit's anti-scatter grid mechanism. For two-dimensional systems, such features include those of mechanically damaged or incorrectly positioned grids. For moving or Bucky grids, artifacts may result from intentional grid motion that is inadequate in duration or velocity uniformity.
111209 Positioning Inadequate arrangement of the anatomy of interest with respect to the X-Ray field and image detector sensitive area. Examples: 1) positioning is "cutoff" when the projection of anatomy of interest falls outside the sensitive area of the detector; 2) "cone cut", in which the X-Ray field does not adequately cover the anatomy of interest; 3) detector’s sensitive surface is too small to cover the projection of the anatomy of interest; 4) improper angular orientation or "rotation" of anatomy of interest with respect to the X-Ray source, or detector; 5) projection of other anatomy or clothing over the anatomy of interest in the image.
111210 Motion blur Unacceptable image blur resulting from motion of the anatomy of interest during exposure or the inadequately compensated motion of X-Ray source with respect to the image detector during exposure.
111211 Under exposed Inadequate number of quanta reached the detector during exposure. Reasons for under exposed images include low kVp, low mAs product, excess Source Image Distance. Under exposed images have inadequate signal and higher noise in the areas of interest.
111212 Over exposed An excess number of quanta reached the detector during exposure. Reasons for over exposed images include high kVp, high mAs product, short Source Image Distance. Over exposed images have high signal and lower noise in the areas of interest. Over exposed area may demonstrate lack of contrast from over saturation of the detector.
111213 No image No evidence of a patient exposure.
111214 Detector artifact(s) Superposed features or flaws of the detector.
111215 Artifact(s) other than grid or detector artifact Features or discontinuities arising from causes other than the anti-scatter grid and image detector.
111216 Mechanical failure Failure of the device to operate according to mechanical design specifications.
111217 Electrical failure Failure of a device to operate according to electrical design specifications
111218 Software failure Attributable to software used in generation or handling of image
111219 Inappropriate image processing Images processed inappropriately, not following appropriate protocol
111220 Other failure Failure that is not mechanical or electrical or otherwise described
111221 Unknown failure Unidentified or unknown cause of failure
111222 Succeeded The attempted process was completely successful
111223 Partially Succeeded The attempted process succeeded in some ways, but failed in others
111224 Failed The attempted process completely failed
111225 Not Attempted No process was performed
111233 Individual Impression / Recommendation Analysis Analysis of a related group of findings or features detected during image data inspection, to produce a summary impression and/or recommendation
111234 Overall Impression / Recommendation Analysis Analysis of all groups of findings or features, to produce a single impression and/or recommendation
111235 Unusable ( Quality renders image unusable The usability of an image for diagnostic interpretation or CAD, based on a quality control standard
111236 Usable ( Does not meet the quality control standard The usability of an image for diagnostic interpretation or CAD, based on a quality control standard
111237 Usable ( Meets the quality control standard The usability of an image for diagnostic interpretation or CAD, based on a quality control standard
111238 Mammography Quality Control Manual 1999, ACR An image quality control standard specified by the American College of Radiology
111239 Title 21 CFR Section 900, Subpart B An image quality control standard in the US Code of Federal Regulations
111240 Institutionally defined quality control standard An image quality control standard specified or adopted by the institution responsible for the document
111241 All algorithms succeeded; without findings No findings resulted upon successful completion of all attempted computer-aided detection and/or analysis
111242 All algorithms succeeded; with findings One or more findings resulted upon successful completion of all attempted computer-aided detection and/or analysis
111243 Not all algorithms succeeded; without findings No findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process
111244 Not all algorithms succeeded; with findings One or more findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process
111245 No algorithms succeeded; without findings All of the attempted computer-aided detection and/or analysis failed, so there could be no findings
111248 Adenolipoma A benign tumor having glandular characteristics but composed of fat, with the presence of normal mammary ducts Retired. Replaced with (M-83240, SRT, “Adenolipoma”).
111249 Ductal hyperplasia Retired. Replaced with (M-72170, SRT, “Ductal hyperplasia, Usual”).
111250 Adenomyoepithelioma Neoplasms composed of myoepithelial cells Retired. Replaced with (M-89830, SRT, “Adenomyoepithelioma”).
111251 Normal axillary node Axillary node that is normal in appearance with no associated pathology
111252 Axillary node with calcifications Axillary node containing calcifications
111253 Axillary node hyperplasia Excessive proliferation of normal tissue arrangement of the axillary node
111254 Asynchronous involution Retired. Replaced with (F-8A063, SRT, “Asynchronous involution of breast”).
111255 Benign cyst with blood Cyst with benign morphology containing blood
111256 Benign Calcifications Calcifications having typically benign morphology. They are not of intermediate or high probability of concern for malignancy.
111257 Intracystic papilloma Growing within a cystic adenoma, filling the cavity with a mass of branching epithelial processes Retired. Replaced with (M-85040, SRT, “Intracystic papilloma”).
111258 Ductal adenoma Adenoma located in mammary duct, present as discrete sclerotic nodules, solitary or mulitple
111259 Diabetic fibrous mastopathy The occurrence of fibrous tumor-forming stromal proliferation in patients with diabetes mellitus
111260 Extra abdomenal desmoid A deep seated firm tumor frequently occurring on the chest consisting of collagenous tissue that infiltrates surround muscle; frequently recurs but does not metastasize Retired. Replaced with (M-88211, SRT, “Extra abdominal desmoid”).
111262 Epidermal inclusion cyst A cyst formed of a mass of epithelial cells, as a result of trauma has been pushed beneath the epidermis. The cyst is lined with squamous epithelium and contains concentric layers or keratin Retired. Replaced with (M-33410, SRT, “Epidermal inclusion cyst”).
111263 Fibroadenomatoid hyperplasia Excessive proliferation of fibroadenoma tissue
111264 Fibroadenolipoma A lipoma with an abundant stroma of fibrous tissue
111265 Foreign body (reaction) Retired. Replaced with (M-44140, SRT, “Foreign body (reaction)”).
111269 Galactocele Retention cyst caused by occlusion of a lactiferous duct Retired. Replaced with (D7-90364, SRT, “Galactocele”).
111271 Hemangioma – nonparenchymal, subcutaneous A congenital anomaly that leads to a proliferation of blood vessels leading to a mass that resembles a neoplasm, not located in parenchymal areas but subcutaneous Retired. Replaced with (D3-F0620, SRT, “Hemangioma of subcutaneous tissue”).
111273 Hyperplasia, usual Retired. Replaced with (M-72000, SRT, “Hyperplasia, usual”).
111277 Juvenile papillomatosis A form of fibrocystic disease in young woman with florid and sclerosing adenosis that microscopically may suggest carcinoma
111278 Lactating adenoma Enlarging masses during lactation. A circumscribed benign tumor composed primarily of glandular structures with scanty stroma, with prominent secretory changes in the duct Retired. Replaced with (M-82040, SRT, “Lactating adenoma”).
111279 Lactational change Changes related to the process of lactation
111281 Large duct papilloma A papilloma pertaining to large mammary duct
111283 Myofibroblastoma Solitary or multiple tumors of muscles and fibrous tissues, or tumors composed of myofibroblasts Retired. Replaced with (M-88250, SRT, “Myofibroblastoma”).
111284 Microglandular adenosis Irregular clusters of small tubules are present in adipose or fibrous tissue, resembling tubular carcinoma but lacking stromal fibroblastic proliferation
111285 Multiple Intraductal Papillomas Papilloma typically involving an aggregate of adjacent ducts in the periphery of the breast, likely representing involvement of several foci of one or two duct systems
111286 No abnormality No abnormality
111287 Normal breast tissue Normal breast tissue
111288 Neurofibromatosis Condition in which there are tumors of various sizes on peripheral nerves. They may be neuromas or fibromas Retired. Replaced with (M-95401, SRT, “Neurofibromatosis”).
111290 Oil cyst (fat necrosis cyst) A cyst resulting from the loss of the epithelial lining of a sebaceous dermoid or lacteal cyst
111291 Post reduction mammoplasty Breast tissue with characteristics of a benign nature, following breast reduction surgery
111292 Pseudoangiomatous stromal hyperplasia A benign stromal lesion composed of intermixed stromal and epithial elements. The lobular and duct structures of the breast parenchyma are separated by an increased amount of stroma, non specific proliferative epithelial changes include hyperplasia of duct and lobular epithelium often with accentuation of myoepithelial cells and aprocine metaplasia with or without cyst formation
111293 Radial scar An nonencapsulated stellate lesion consisting of a fibroelastic core and radiating bands of fibrous connective tissue containing lobules manifesting adenosis and ducts with papillary or diffuse intraductal hyperplasia Retired. Replaced with (M-78731, SRT, “Radial scar”).
111294 Sclerosing adenosis Prominent interductal fibrosis of the terminal ductules Retired. Replaced with (M-74220, SRT, “Sclerosing adenosis”).
111296 Silicone granuloma Nodular inflammatory lesions due to the presence of silicone in the breast tissue
111297 Nipple Characteristic The morphologic status of the nipple
111298 Virginal hyperplasia Spontaneous excessive proliferation of breast tissue, usually found in younger women
111299 Peripheral duct papillomas Papilloma(s) pertaining the peripheral ducts
111300 Axillary node with lymphoma Axillary node with lymphoid tissue neoplasm
111301 Axillary nodal metastases Metastatic disease to the axillary node
111302 Angiosarcoma A malignant neoplasm occurring most often in breast and skin, believed to originate from endothelial cells of blood vessels, microscopically composed of closely packed round or spindle shaped cells, some of which line small spaces resembling vascular clefts Retired. Replaced with (M-91203, SRT, “Angiosarcoma”).
111303 Blood vessel (vascular) invasion Histological changes to the vascular system related to an invasive process
111304 Carcinoma in children Carcinoma of the breast found in patients less than 20 years of age
111305 Carcinoma in ectopic breast A carcinoma found in supernumerary breasts and aberrant breast tissue
111306 Carcinoma with endocrine differentiation A carcinoma that synthesizes substances, including hormones, not considered to be normal products of the breast
111307 Basal cell carcinoma of nipple A basal cell carcinoma that arises in the nipple of the breast
111308 Carcinoma with metaplasia Retired. Replaced with (M-85733, SRT, “Carcinoma with metaplasia”).
111309 Cartilaginous and osseous change Tissue changes to bones and cartilage
111310 Carcinoma in pregnancy and lactation Carcinoma of the breast presenting during pregnancy or lactation
111311 Carcinosarcoma A malignant neopalsm that contains elements of carcinoma and sarcoma, so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue Retired. Replaced with (M-89803, SRT, “Carcinosarcoma”).
111312 Intraductal comedocarcinoma with necrosis Comedocarcinoma of a duct with areas of necrotic tissue
111313 Intraductal carcinoma, low grade A non-invasive carcinoma restricted to the glandular lumen characterized by less aggressive malignant cytologic features and behavior
111314 Intraductal carcinoma micro-papillary Retired. Replaced with (M-85072, SRT, “Intraductal carcinoma micro-papillary”).
111315 Intracystic papillary carcinoma A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells found in a cyst
111316 Invasive and in-situ carcinoma Carcinoma with both characteristics of localized and spreading disease
111317 Invasive lobular carcinoma Retired. Replaced with (M-85203, SRT, “Invasive lobular carcinoma”).
111318 Leukemic infiltration Mammary infiltrates as a secondary manifestation in patients with established leukemia
111320 Lympathic vessel invasion Histological changes to the lymphatic system related to an invasive process
111321 Lymphoma A heterogenous group of neoplasms arising in the reticuloendoethelial and lymphatic systems Retired. Replaced with (M-95903, SRT, “Lymphoma”).
111322 Occult carcinoma presenting with axillary lymph node metastases A small carcinoma, either asymptomatic or giving rise to metastases without symptoms due to the primary carcinoma presenting with metastatic disease in the axillary lymph nodes
111323 Metastatic cancer to the breast A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a non-mammary malignant neoplasm
111324 Metastatic cancer to the breast from the colon A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the colon
111325 Metastatic cancer to the breast from the lung A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the lung
111326 Metastatic melanoma to the breast A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a melanoma
111327 Metastatic cancer to the breast from the ovary A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the ovary
111328 Metastatic sarcoma to the breast A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a sarcoma
111329 Multifocal intraductal carcinoma Multiple foci of non-invasive carcinoma restricted to the glandular lumen
111330 Metastatic disease to axillary node A malignant lesion in an axillary node arising from a non-axillary neoplasm
111331 Malignant fibrous histiocytoma Retired. Replaced with (M-88303, SRT, “Malignant fibrous histiocytoma”).
111332 Multifocal invasive ductal carcinoma Multiple sites of ductal carcinoma
111333 Metastasis to an intramammary lymph node A malignant lesion in a intramammary lymph node arising from a non-intramammary lymph node neoplasm
111334 Malignant melanoma of nipple A malignant melanoma of the skin that arises in the nipple of the breast
111335 Neoplasm of the mammary skin Retired. Replaced with (D0-F035F, SRT, “Neoplasm of the mammary skin”).
111336 Papillary carcinoma in-situ Retired. Replaced with (M-80502, SRT, “Papillary carcinoma in-situ”).
111338 Recurrent malignancy Recurrent malignancy
111340 Squamous cell carcinoma of the nipple Squamous cell carcinoma to the terminal portion of the alveolar
111341 Intraductal carcinoma, high grade A non-invasive carcinoma restricted to the glandular lumen characterized by more aggressive malignant cytologic features and behavior
111342 Invasive cribriform carcinoma Retired. Replaced with (M-82013, SRT, “Invasive cribriform carcinoma”).
111343 Angular margins An indication that some or all of the margin of a lesion has sharp corners, often forming acute angles.
111344 Fine pleomorphic calcification Calcifications that vary in sizes and shapes and are usually smaller than 0.5 mm in diameter.
111345 Macrocalcifications Coarse calcifications that are 0.5 mm or greater in size.
111346 Calcifications within a mass An indicator that calcifications are imbedded within a mass
111347 Calcifications outside of a mass An indicator that calcifications are imaged outside of a mass finding
111350 Breast background echotexture Tissue composition of the breast noted on sonography.
111351 Homogeneous fat echotexture Fat lobules and uniformly echogenic bands of supporting structures comprise the bulk of breast tissue.
111352 Homogeneous fibroglandular echotexture A uniformly echogenic layer of fibroglandular tissue is seen beneath a thin layer of subcutaneous fat.
111353 Heterogeneous echotexture The breast texture is characterized by multiple small areas of increased and decreased echogenicity.
111354 Orientation Referential relationship of the finding to the imaging device as noted on sonography.
111355 Parallel The long axis of a lesion parallels the skin line (“wider-than-tall” or in a horizontal orientation).
111356 Not parallel The anterior-posterior or vertical dimension is greater than the transverse or horizontal dimension.
111357 Lesion boundary The lesion boundary describes the transition zone between the mass and the surrounding tissue.
111358 Abrupt interface The sharp demarcation between the lesion and surrounding tissue can be imperceptible or a distinct well-defined echogenic rim of any thickness.
111359 Echogenic halo There is no sharp demarcation between the mass and the surrounding tissue which is bridged by an echogenic transition zone.
111360 Echo pattern An imaging characteristic of resonance noted during sonography
111361 Anechoic Without internal echoes
111362 Hyperechoic Having increased echogenicity relative to fat or equal to fibroglandular tissue
111363 Complex Mass contains both anechoic and echogenic components
111364 Hypoechoic Defined relative to fat; masses are characterized by low-level echoes throughout (e.g. appearance of a complicated cyst or fibroadenoma)
111365 Isoechoic Having the same echogenicity as fat (a complicated cyst or fibroadenoma may be isoechoic or hypoechoic)
111366 Posterior acoustic features The attenuation characteristics of a mass with respect to its acoustic transmission.
111367 No posterior acoustic features No posterior shadowing or enhancement
111368 Posterior enhancement Increased posterior echoes
111369 Posterior shadowing Decreased posterior echoes; edge shadows are excluded
111370 Combined posterior enhancement and shadowing More than one pattern of posterior attenuation, both shadowing and enhancement
111371 Identifiable effect on surrounding tissues Sonographic appearance of adjacent structures relative to a mass finding
111372 Vascularity Characterization of vascularization in region of interest.
111373 Vascularity not present Vascularity not evident, such as on ultrasound
111374 Vascularity not assessed Vascularity not evaluated
111375 Vascularity present in lesion Vascularity on imaging is seen within a lesion
111376 Vascularity present immediately adjacent to lesion Vascularity on imaging is seen immediately adjacent to a lesion
111377 Diffusely increased vascularity in surrounding tissue Vascularity on imaging is considered diffusely elevated within the surrounding breast tissue
111380 Correlation to other Findings Relationship of the new anomaly to other clinical or imaging anomalies
111381 Correlates to physical exam findings An indication that the current imaging finding relates to a finding from a clinical breast exam
111382 Correlates to mammography findings An indication that the current imaging finding relates to a finding from a mammography exam
111383 Correlates to MRI findings An indication that the current imaging finding relates to a finding from a breast MRI exam
111384 Correlates to ultrasound findings An indication that the current imaging finding relates to a finding from a breast ultrasound exam
111385 Correlates to other imaging findings An indication that the current imaging finding relates to a finding from an imaging exam
111386 No correlation to other imaging findings An indication that the current imaging finding has no relation to findings from any other imaging exam
111387 No correlation to clinical findings An indication that the current imaging finding has no relation to any other clinical findings
111388 Malignancy Type Classification of the cancer as invasive, DCIS, or other
111389 Invasive breast carcinoma A malignancy that has spread beyond an area of focus.
111390 Other malignancy type A breast cancer with malignant pathology findings that are not classified as invasive or in situ.
111391 Menstrual Cycle Phase A specific timeframe during menses
111392 1st week In the first week of the menstrual cycle phase, that is, one week following menses.
111393 2nd week In the second week of the menstrual cycle phase, that is, two weeks following menses.
111394 3rd week In the third week of the menstrual cycle phase, that is, three weeks following menses.
111395 Estimated Timeframe An estimated period of time
111396 < 3 months ago An event occurred less than 3 months ago.
111397 4 months to 1 year ago An event occurred between 4 months and 1 year ago.
111398 > 1 year ago An event occurred longer than 1 year ago.
111399 Timeframe uncertain The timing of an event is not recalled.
111400 Breast Imaging Report Report title for the diagnostic report for one or more breast imaging or intervention procedures.
111401 Reason for procedure Concept name for the description of why a procedure has been performed.
111402 Clinical Finding A finding during clinical examination (i.e., history and physical examination) such as pain, palpable mass or discharge.
111403 Baseline screening mammogram First screening mammogram taken for patient that is used as a comparison baseline for further examinations.
111404 First mammogram ever First mammogram taken for a patient without regard to whether it was for screening or a diagnostic procedure.
111405 Implant type Concept name for the material of which a breast prosthetic device is constructed.
111406 Number of similar findings A numeric count of findings classified as similar in nature.
111407 Implant finding Concept name for the status of a breast prosthetic device as noted by imaging.
111408 Film Screen Mammography Mammogram using traditional X-Ray film.
111409 Digital Mammography Mammogram using a digital image acquisition system.
111410 Surgical consult Referred for evaluation by a surgeon.
111411 Mammography CAD Computer aided detection and/or computer aided diagnosis for mammography.
111412 Narrative Summary Concept name for a text-based section of a report.
111413 Overall Assessment A title for a report section that summarizes all interpretation results for a report with one overriding assessment (e.g., benign or negative).
111414 Supplementary Data Concept name for a collection of supporting evidence for a report.
111415 Additional evaluation requested from prior study Prior study indicates that additional imaging be performed to further evaluate a suspicous or questionable anatomic region.
111416 Follow-up at short interval from prior study The prior study recommended a follow-up breast imaging exam in 1 to 11 months (generally in 6 months).
111417 History of breast augmentation, asymptomatic Prior breast augmentation (breast enlargement) and is not presenting with any symptoms.
111418 Review of an outside study Review or second opinion made on an image performed outside of the facility.
111419 Additional evaluation requested from abnormal screening exam Additional breast imaging perfomed at the time of the patient’s screening mammogram.
111420 History of benign breast biopsy Patient has had previous benign breast biopsies.
111421 Personal history of breast cancer with breast conservation therapy Patient has had a prior surgery such as a lumpectomy or quadrantectomy to remove malignant breast tissue, but breast tissue remains.
111423 Physical Examination Results The results of a physical examination performed on the patient, possibly including the results of inspection, palpation, auscultation, or percussion.
111424 Comparison to previous findings The result of assessing the current imaging exam in comparison to previous imaging exams.
111425 Intraluminal filling defect An abnormality observed during ductography where the ductal system within the breast fills in an abnormal pattern. Ductography is an imaging exam in which a radio opaque contrast media is introduced into the ductal system of the breast through the nipple and images of the ductal system are obtained.
111426 Multiple filling defect During ductography an observation of more than one filling abnormality within the breast ductal system.
111427 Abrupt duct termination An abnormality observed during ductography where the ductal system within the breast terminates in an unusual fashion.
111428 Extravasation Abnormal flowage of contrast media within the breast noted on ductography.
111429 Duct narrowing An abnormality observed during ductography where the ductal system within the breast appears narrow.
111430 Cyst fill During ductography an observation of the contrast media filling a cyst within the breast.
111431 Instrument Approach The area and line within the anatomy through which a needle or instrument passes during an interventional procedure.
111432 Inferolateral to superomedial The line within the anatomy from the lower outer to the upper inner aspect, for example, through which a needle or instrument passes in an interventional procedure.
111433 Inferomedial to superolateral The line within the anatomy from the lower inner to the upper outer aspect, for example, through which a needle or instrument passes in an interventional procedure.
111434 Superolateral to inferomedial The line within the anatomy from the upper outer to the lower inner aspect, for example, through which a needle or instrument passes in an interventional procedure.
111435 Superomedial to inferolateral The line within the anatomy from the upper inner to the lower outer aspect, for example, through which a needle or instrument passes in an interventional procedure.
111436 Number of passes The number of times a biopsy instrument is passed through an area of interest.
111437 Number of specimens The number of biopsy specimens obtained from an interventional procedure.
111438 Needle in target An indicator of whether or not a biopsy or localizing needle in an interventional procedure is seen to be in the area of interest.
111439 Number of needles around target The number of localizing needles placed around the area of interest in an interventional procedure.
111440 Incision made An indicator of whether or not an incision was made in the anatomy during an interventional procedure.
111441 Microclip placed An indicator of whether or not a radio opaque microclip was placed in the anatomy during an interventional procedure. Retired. Replaced with (111123, DCM, “Marker placement”)
111442 Confirmation of target An indicator of the degree of success of an interventional procedure.
111443 Target completely contained in the specimen An indicator that during an interventional procedure the area of interest was fully excised and is noted in the resultant biopsy specimen.
111444 Target partially obtained in the specimen An indicator that during an interventional procedure the area of interest was partially excised and is noted in the resultant biopsy specimen.
111445 Target not in the specimen An indicator that following an interventional procedure the area of interest is not seen in the resultant biopsy specimen.
111446 Calcifications seen in the core An indicator that following an interventional procedure the targeted calcifications are noted in the resultant biopsy specimen.
111447 Lesion completely removed An indicator that during an interventional procedure the area of interest was fully excised and is noted in the resultant biopsy specimen.
111448 Lesion partially removed An indicator that during an interventional procedure the area of interest was partially excised and is noted in the resultant biopsy specimen.
111449 Fluid obtained An indicator that during an interventional procedure fluid was successfully aspirated.
111450 Light brown color Color that is a light shade of brown.
111451 Dark red color Color that is a dark shade of red.
111452 Dark brown color Color that is a dark shade of brown.
111453 Bright red color Color that is a bright shade of red.
111454 Blood tinged color Color that is tinged with the color of blood.
111455 Occult blood test result An indicator of whether or not the fluid obtained during an interventional procedure contains red blood cells.
111456 Action on fluid An indicator of whether or not fluid during an interventional procedure was sent for cytological analysis or simply discarded.
111457 Sent for analysis An indicator that fluid obtained during an interventional procedure was sent to a laboratory for analysis.
111458 Discarded An indicator that fluid obtained during an interventional procedure was discarded.
111459 Mass with calcifications A radiopaque density noted during diagnostic imaging which has associated calcific densities.
111460 Complex cyst A fluid-filled sac with greater than normal characteristics.
111461 Intracystic lesion A tumor within a cyst.
111462 Solid mass A tumor or lesion.
111463 Supplementary Data for Intervention Supporting evidence for interpretation results of an interventional procedure.
111464 Procedure Modifier A descriptor that further qualifies or characterizes a type of procedure.
111465 Needle Gauge Needle size (diameter) characterization, for example, of a biopsy needle.
111466 Severity of Complication An indicator of the gravity of a problem experienced by a patient, related to a procedure that was performed.
111467 Needle Length Distance from the hub or bushing to the tip of the needle.
111468 Pathology Results The collection of observations and findings from pathologic analysis.
111469 Sampling DateTime The date and time that the sample was collected from the patient.
111470 Uninvolved Indicates that the margin of the biopsy specimen was not involved with the tumor.
111471 Involved Indicates that the margin of the biopsy specimen was involved with the tumor.
111472 Nipple involved Indicates whether the nipple was involved in an interventional procedure or pathologic analysis.
111473 Number of nodes removed Indicates the number of lymph nodes removed.
111474 Number of nodes positive Indicates the number of lymph nodes removed that contain cancer cells.
111475 Estrogen receptor The result of a test for the presence of a protein that binds with estrogen.
111476 Progesterone receptor The result of a test for the presence of a protein that binds with progesterone.
111477 S Phase Indicates the percentage of cells in S phase. Cell division is defined by phases; the S phase is the stage during which DNA replicates.
111478 Non-bloody discharge (from nipple) The visible emission of non-bloody fluid from the nipple.
111479 Difficult physical/clinical examination The inability to discern normal versus abnormal breast tissue during palpation.
111480 Cancer elsewhere An indication that a patient has or had a malignant occurrence in an area of the body other than the breast.
111481 Saline implant A salt water filled prosthetic device implanted in the breast.
111482 Polyurethane implant A polymer based (plastic) prosthetic device implanted in the breast.
111483 Percutaneous silicone injection The introduction of polymeric organic silicon based material through the skin, as for breast augmentation or reconstruction.
111484 Combination implant A prosthetic device that contains more than one material implanted in the breast.
111485 Pre-pectoral implant A breast implant placed in front of the pectoralis major muscle.
111486 Retro-pectoral implant A breast implant placed behind the pectoralis major muscle.
111487 Mammographic (crosshair) Using X-Ray technique and a superimposed set of crossed lines for detection or placement.
111488 Mammographic (grid) Using X-Ray technique and a superimposed aperture for detection or placement.
111489 Palpation guided Using physical touch for detection or placement.
111490 Vacuum assisted The performance of a biopsy procedure using a vacuum device attached to the biopsy needle.
111491 Abnormal discharge Unusual or unexpected emission of fluid.
111492 No complications Having experienced no adverse medical conditions related to or resulting from an interventional procedure.
111494 Stage 0 TNM grouping of tumor stage, from AJCC, where primary tumor is Tis, regional lymph node is N0, and distant metastasis is M0.
111495 Stage I TNM grouping of tumor stage, from AJCC, where primary tumor is T1, regional lymph node is N0, and distant metastasis is M0.
111496 Stage IIA TNM grouping of tumor stage, from AJCC, where primary tumor is T0 or T1, with regional lymph node N1 and distant metastasis is M0, or T2 with N0 and M0.
111497 Stage IIB TNM grouping of tumor stage, from AJCC, where primary tumor is T2, with regional lymph node N1 and distant metastasis is M0, or T3 with N0 and M0.
111498 Stage IIIA TNM grouping of tumor stage, from AJCC, where primary tumor is T0, T1 or T2, with regional lymph node N2 and distant metastasis is M0, or T3 with N1 or N2 and M0.
111499 Stage IIIB TNM grouping of tumor stage, from AJCC, where primary tumor is T4, regional lymph node is N0, N1 or N2, and distant metastasis is M0.
111500 Stage IIIC TNM grouping of tumor stage, from AJCC, where primary tumor is any T value, regional lymph node is N3, and distant metastasis is M0.
111501 Stage IV TNM grouping of tumor stage, from AJCC, where primary tumor is any T value, regional lymph node is any N value, and distant metastasis is M1.
111502 Bloom-Richardson Grade Histologic tumor grade (sometimes called Scarff-Bloom-Richardson grade) is based on the arrangement of the cells in relation to each other -- whether they form tubules, how closely they resemble normal breast cells (nuclear grade) and how many of the cancer cells are in the process of dividing (mitotic count).
111503 Normal implants Breast prosthetic devices are intact, not leaking, and are in a normal shape and form.
111504 Asymmetric implants Breast prosthetic devices are not symmetric, equal, corresponding in form, or are in one breast (unilateral).
111505 Calcified implant Fibrous or calcific contracture of the tissue capsule that forms around a breast prosthetic device.
111506 Distorted implant Breast prosthetic device is twisted out of normal shape or form.
111507 Silicone-laden lymph nodes Silicone from breast prosthetic device found in lymphatic tissue.
111508 Free silicone Silicone found in breast tissue outside of the prosthetic capsule or implant membrane.
111509 Herniated implant Protrusion of part of the structure normally encapsulating the content of the breast prosthetic device.
111510 Explantation Evidence of removal of a breast prosthetic device.
111511 Relevant Patient Information for Breast Imaging Historical patient health information of interest to the breast health clinician.
111512 Medication History Information regarding usage by the patient of certain medications, such as hormones. Retired, Replaced with (10160-2, LN, “History Of Medication Use”)
111513 Relevant Previous Procedures Interventional or non-interventional procedures previously performed on the patient, such as breast biopsies.
111514 Relevant Indicated Problems Abnormal conditions experienced by the patient which serve as the reason for performing a procedure, such as a breast exam. Retired, Replaced with (11450-4, LN, “Problem List”)
111515 Relevant Risk Factors Personal, familial, and other health factors that may indicate an increase in the patient's chances of developing a health condition or disease, such as breast cancer.
111516 Medication Type A classification of a medicinal substance, such as hormonal contraceptive or antibiotic.
111517 Relevant Patient Information Historical patient health information for general purpose use.
111518 Age when first menstrual period occurred The age of the patient at the first occurrence of menses.
111519 Age at First Full Term Pregnancy The age of the patient at the time of her first full term pregnancy.
111520 Age at Menopause The age of the patient at the cessation of menses.
111521 Age when hysterectomy performed The age of the patient at the time her uterus was removed.
111522 Age when left ovary removed The age of the patient at the time she had her left ovary removed.
111523 Age when right ovary removed The age of the patient at the time she had her right ovary removed.
111524 Age Started The age of a patient on the first occurrence of an event, such as the first use of a medication.
111525 Age Ended The age of a patient on the last occurrence of an event, such as the last use of a medication.
111526 DateTime Started The date and time of the first occurrence of an event, such as the first use of a medication.
111527 DateTime Ended The date and time of the last occurrence of an event, such as the last use of a medication.
111528 Ongoing An indicator of whether an event is still in progress, such as the use of a medication or substance, or environmental exposure.
111529 Brand Name Product name of a device or substance, such as medication, to identify it as the product of a single firm or manufacturer.
111530 Risk Factor modifier A descriptor that further qualifies or characterizes a risk factor.
111531 Previous Procedure A prior non-interventional exam or interventional procedure performed on a patient.
111532 Pregnancy Status Describes the pregnancy state of a referenced subject.
111533 Indicated Problem A symptom experienced by a patient that is used as the reason for performing an exam or procedure.
111534 Role of person reporting The function of the individual who is reporting information on a patient, which could be a specific health care related profession, the patient him/herself, or a relative or friend.
111535 DateTime problem observed The date and time that a symptom was noted.
111536 DateTime of last evaluation The date and time of the most recent evaluation of an indicated problem.
111537 Family Member with Risk Factor A patient’s biological relative who exhibits a health factor that may indicate an increase in the patient's chances of developing a particular disease or medical problem.
111538 Age at Occurrence The age at which an individual experienced a specific event, such as breast cancer.
111539 Menopausal phase The current stage of an individual in her gynecological development.
111540 Side of Family An indicator of paternal or maternal relationship.
111541 Maternal Relating to biological female parentage.
111542 Unspecified gynecological hormone A gynecological hormone (e.g., contraceptive, estrogen, Tamoxifen) for which the specific type is not specified.
111543 Breast feeding history An indicator of whether or not a patient ever provided breast milk to her offspring.
111544 Average breast feeding period The average length of time that a patient provided breast milk to her offspring.
111545 Substance Use History Information regarding usage by the patient of certain legal or illicit substances.
111546 Used Substance Type A classification of a substance, such as alcohol or a legal or illicit drug.
111547 Environmental Exposure History Information regarding exposure of the patient to potentially harmful environmental factors.
111548 Environmental Factor A classification of a potentially harmful substance or gas in a subject’s environment, such as asbestos, lead, or carcinogens.
111549 Previous Reports Previous Structured Reports that could have relevant information for a current imaging service request.
111550 Personal breast cancer history An indication that a patient has had a previous malignancy of the breast.
111551 History of endometrial cancer Indicates a previous occurrence of cancer of the lining of the uterus.
111552 History of ovarian cancer Indicates a previous occurrence of cancer of the lining of the ovary.
111553 History of high risk lesion on previous biopsy Indicates a prior diagnosis of pre-cancerous cells or tissue removed for pathologic evaluation.
111554 Post menopausal patient A female patient whose menstrual periods have ceased.
111555 Late child bearing (after 30) A female patient whose first child was born after the patient was 30 years old.
111556 BRCA1 breast cancer gene The first level genetic marker indicating risk for breast cancer.
111557 BRCA2 breast cancer gene The second level genetic marker indicating risk for breast cancer.
111558 BRCA3 breast cancer gene The third level genetic marker indicating risk for breast cancer.
111559 Weak family history of breast cancer A patient’s biological aunt, grandmother, or female cousin was diagnosed with breast cancer. Definition from BI-RADS®.
111560 Intermediate family history of breast cancer A patient’s biological mother or sister was diagnosed with breast cancer after they had gone through menopause. Definition from BI-RADS®.
111561 Very strong family history of breast cancer A patient’s biological mother or sister was diagnosed with breast cancer before they had gone through menopause, or more than one of the patient’s first-degree relatives (biological mother or sister) were diagnosed with breast cancer after they had gone through menopause. Definition from BI-RADS®.
111562 Family history of prostate cancer Previous diagnosis of a malignancy of the prostate gland in a biological relative.
111563 Family history unknown The health record of a patient’s biological relatives is not known.
111564 Nipple discharge cytology The study of cells obtained from fluid emitted from the breast.
111565 Uterine malformations A developmental abnormality resulting in an abnormal shape of the uterus.
111566 Spontaneous Abortion A naturally occurring premature expulsion from the uterus of the products of conception – the embryo or a nonviable fetus.
111567 Gynecologic condition An ailment/abnormality or state of the female reproductive tract.
111568 Gynecologic surgery A surgical operation performed on any portion of the female reproductive tract.
111569 Previous LBW or IUGR birth Prior pregnancy with a low birth weight baby or a fetus with Intrauterine Growth Restriction or Retardation.
111570 Previous fetal malformation/syndrome History of at least one prior pregnancy with fetal anatomic abnormality(s).
111571 Previous RH negative or blood dyscrasia at birth History of delivering a Rhesis Isoimmunization affected child(ren) or a child(ren) with another blood disorder.
111572 History of multiple fetuses History of at least one pregnancy that contained more than one fetus (e.g., twins, triplets, etc.)
111573 Current pregnancy, known or suspected malformations/syndromes At least one fetus of this pregnancy has an anatomic abnormality(s) that is known to exist, or a “marker” is present that suggests the abnormality(s) may be present.
111574 Family history, fetal malformation/syndrome Biological relatives have previously conceived a fetus with an anatomic abnormality(s).
111575 High A subjective descriptor for an elevated amount of exposure, use, or dosage, incurring high risk of adverse effects.
111576 Medium A subjective descriptor for a moderate amount of exposure, use, or dosage, incurring medium risk of adverse effects.
111577 Low A subjective descriptor for a limited amount of exposure, use, or dosage, incurring low risk of adverse effects.
111578 Dose frequency A measurement of the rate of occurrence of which a patient takes a certain medication.
111579 Rate of exposure The quantity per unit of time that a patient was or is being exposed to an environmental irritant.
111580 Volume of use The quantity per unit of time that a medication or substance was or is being used.
111581 Relative dose amount A qualitative descriptor for the amount of a medication that was or is being taken.
111582 Relative amount of exposure A qualitative descriptor for the amount of present or past exposure to an environmental irritant.
111583 Relative amount of use A qualitative descriptor for the amount of a medication or substance that was or is being used.
111584 Relative dose frequency A qualitative descriptor for the frequency with which a medication was or is being taken.
111585 Relatve frequency of exposure A qualitative descriptor for the frequency of present or past exposure to an environmental irritant.
111586 Relative frequence of use A qualitative descriptor for the frequency with which a medication or substance was or is being used.
111590 Recall for technical reasons Patient returns for additional images to improve the quality of the most recent exam.
111591 Recall for imaging findings Patient returns for additional images to clarify findings from the most recent exam.
111592 Recall for patient symptoms/ clinical findings Patient returns for additional images to clarify symptoms or signs reported by the patient or a healthcare professional at the time of the most recent exam.
111601 Green filter Filter that transmits green light while blocking the other colors, typically centered at 510-540 nm Retired. Replaced with (A-010E2, SRT, “Green optical filter”)
111602 Red filter Filter that transmits red light while blocking the other colors, typically centered at 630-680 nm Retired. Replaced with (A-010DF, SRT, “Red optical filter”)
111603 Blue filter Filter that transmits blue while blocking the other colors, typically centered at 460-480 nm Retired. Replaced with (A-010DA, SRT, “Blue optical filter”)
111604 Yellow-green filter A filter of 560nm that is used for retinal imaging and can provide good contrast and good visibility of the retinal vasculature Retired. Replaced with (A-010E0, SRT, “Yellow-green optical filter”)
111605 Blue-green filter A filter of 490nm that is used for retinal imaging because of excessive scattering of some retinal structures at very short wavelengths Retired. Replaced with (A-010D8, SRT, “Blue-green optical filter”)
111606 Infrared filter Filter that transmits the infrared spectrum, which is light that lies outside of the visible spectrum, with wavelengths longer than those of red light, while blocking visible light Retired. Replaced with (A-010DC, SRT, “Infrared optical filter”)
111607 Polarizing filter A filter that reduces reflections from non-metallic surfaces such as glass or water by blocking light waves that are vibrating at selected angles to the filter. Retired. Replaced with (A-010E1, SRT, “Polarizing optical filter”)
111609 No filter No filter used
111621 Field 1 for Joslin 3 field Joslin NM-1 is a 45 degree field focused centrally between the temporal margin of optic disc and the center of the macula: Center the camera on the papillomacular bundle midway between the temporal margin of the optic disc and the center of the macula. The horizontal centerline of the image should pass directly through the center of the disc
111622 Field 2 for Joslin 3 field Joslin NM-2 is a 45 degree field focused superior temporal to the optic disc: Center the camera laterally approximately one-half disc diameter temporal to the center of the macula. The lower edge of the field is tangent to a horizontal line passing through the upper edge of the optic disc. The image is taken temporal to the macula but includes more retinal nasal and superior to the macula than standard field 2.
111623 Field 3 for Joslin 3 field Joslin NM-3 is a 45 degree field focused nasal to the optic disc: This field is nasal to the optic disc and may include part of the optic disc. The horizontal centerline of the image should pass tangent to the lower edge of the optic disc.
111625 Diffuse direct illumination A broad or “soft” light supplied from a single source.
111626 Scheimpflug Camera A slit reflected light microscope, which has the ability to form an image of the back scattered light from the eye in a sagittal plane. Scheimpflug cameras are able to achieve a wide depth of focus by employing the “Sheimpflug principle” where the lens and image planes are not parallel with each other. Rotating Sheimplug cameras are able to generate three-dimensional images and calculate measurements of the anterior chamber of the eye.
111627 Scotopic light Lighting condition approximately 0.04 lux
111628 Mesopic light Lighting condition approximately 4 lux
111629 Photopic light Lighting condition approximately 40 lux
111630 Dynamic light Acquisition preceded by intense light
111631 Average Glandular Dose Calculated from values of entrance eposure in air, the X-Ray beam quality (half-value layer), and compressed breast thickness, is the energy deposited per unit mass of glandular tissue averaged over all the glandular tissue in the breast.
111632 Anode Target Material The primary material in the anode of an X-Ray source.
111633 Compression Thickness The average thickness of the body part examined when compressed, if compression has been applied during X-Ray exposure.
111634 Half Value Layer Thickness of Aluminum required to reduce the X-Ray output at the patient entrance surface by a factor of two.
111635 X-Ray Grid An anti-scatter device based on radiation absorbing strips above the detector, for example in the patient support.
111636 Entrance Exposure at RP Exposure measurement in air at the reference point that does not include back scatter, according to MQCM 1999.
111637 Accumulated Average Glandular Dose Average Glandular Dose to a single breast accumulated over multiple images.
111641 Fixed grid An X-Ray Grid that does not move during exposure.
111642 Focused grid An X-Ray Grid with radiation absorbing strips that are focused toward the focal spot, to eliminate grid cutoff.
111643 Reciprocating grid An X-Ray Grid that is designed to move during exposure, to eliminate the appearance of grid lines on the image.
111644 Parallel grid An X-Ray Grid with radiation absorbing strips that are parallel to each other and that is used only with long source to image distances.
111645 Crossed grid An X-Ray Grid with crossed radation absorbing strips used for more complete cleanup of scatter radiation.
111646 No grid No X-Ray Grid was used due to low scatter conditions.
111671 Spectacle Prescription Report The spectacle prescription for a patient.
111672 Add Near Refractive measurements of the eye to correct for inability to focus at near while wearing the distance prescription.
111673 Add Intermediate Refractive measurements of the eye to correct for inability to focus at intermediate distance while wearing the distance prescription.
111674 Add Other Refractive measurements of the eye to correct for inability to focus at the specified distance while wearing the distance prescription.
111675 Horizontal Prism Power The power of a prism to bend light in the horizontal direction, in prism diopters
111676 Horizontal Prism Base Direction of the base of a horizontal prism -- either in (toward the nose), or out (away from the nose)
111677 Vertical Prism Power The power of a prism to bend light in the vertical direction, in prism diopters.
111678 Vertical Prism Base Direction of the base of a vertical prism -- either up, or down.
111679 Distance Pupillary Distance Distance in mm between the pupils when the patient’s object of regard is in the distance.
111680 Near Pupillary Distance Distance in mm between the pupils when the patient’s object of regard is at near.
111685 Autorefraction Visual Acuity A patient’s vision with the correction measured by an autorefractor in place.
111686 Habitual Visual Acuity A patient’s vision with whichever vision correction the patient customarily wears
111687 Prescription Visual Acuity A patient’s vision with the final spectacle prescription in place.
111688 Right Eye Rx The spectacle prescription for the right eye
111689 Left Eye Rx The spectacle prescription for the left eye
111690 Macular Grid Thickness and Volume Report A macular grid thickness and volume report for a patient. The macular grid is an analytic tool described in PS3.1.
111691 Number of Images Used for Macular Measurements Number of images used for the macular grid measurement.
111692 Number of Samples Used per Image Number of samples used per Image for analysis
111693 Analysis Quality Rating A numeric rating of the quality of the entire analysis with respect to grading and diagnostic purposes. Higher numbers indicate greater quality.
111694 Image Set Quality Rating A numeric rating of the quality of an entire image set with respect to grading and diagnostic purposes. Higher numbers indicate greater quality.
111695 Interfering Tears or Drops Tear film or drops affecting test quality
111696 Visual Fixation Quality During Acquisition The assessment of the centricity and persistence of the visual fixation (direction of gaze) during the acquisition
111697 Visual Fixation Quality Problem The reason why the patient’s visual fixation was not steady or was indeterminate
111698 Ophthalmic Macular Grid Problem The reason why the macular grid measurements may be questionable
111700 Specimen Container Identifier Identifier of container (box, block, microscope slide, etc.) for the specimen under observation
111701 Processing type Type of processing that tissue specimen underwent
111702 Datetime of processing Date and time of processing step
111703 Processing step description Description of the individual step in the tissue processing sequence
111704 Sampling Method Method of sampling used to derive specimen from its parent
111705 Parent Specimen Identifier Identifier of the parent specimen which gave rise to the current specimen
111706 Issuer of Parent Specimen Identifier Assigning authority for parent specimen’s identifier
111707 Parent specimen type Parent specimen type which gave rise to current specimen
111708 Position Frame of Reference Description of coordinate system and origin reference point on parent specimen, or parent specimen container, or image used for localizing the sampling site or location within container or image
111709 Location of sampling site Reference to image of parent specimen localizing the sampling site; may include referenced Presentation State object
111710 Location of sampling site X offset Location of sampling site of specimen (nominal center) relative to the Position Frame of Reference.
111711 Location of sampling site Y offset Location of sampling site of specimen (nominal center) relative to the Position Frame of Reference.
111712 Location of sampling site Z offset Location of sampling site of specimen (nominal center) relative to the Position Frame of Reference.
111718 Location of Specimen Description of specimen location, either in absolute terms or relative to the Position Frame of Reference
111719 Location of Specimen X offset Location of specimen (nominal center) relative to the Position Frame of Reference in the X dimension
111720 Location of Specimen Y offset Location of specimen (nominal center) relative to the Position Frame of Reference in the Y dimension
111721 Location of Specimen Z offset Location of specimen (nominal center) relative to the Position Frame of Reference in the Z dimension
111723 Visual Marking of Specimen Description of visual distinguishing idenitifiers, e.g., ink, or a particular shape of the specimen
111724 Issuer of Specimen Identifier Assigning authority for specimen identifier
111726 Dissection with entire specimen submission Dissection of specimen with submission of all its sections for further processing or examination
111727 Dissection with representative sections submission Dissection of specimen with submission of representative sections for further processing or examination
111729 Specimen storage A workflow step, during which tissue specimens are stored in a climate-controlled environment
111741 Transmission illumination Transmission illumination method for specimen microscopy
111742 Reflection illumination Reflection illumination method for specimen microscopy
111743 Epifluorescence illumination Epifluorescence illumination method for specimen microscopy
111744 Brightfield illumination Brightfield illumination method for specimen microscopy
111745 Darkfield illumination Darkfield illumination method for specimen microscopy
111746 Oblique illumination Oblique illumination method for specimen microscopy
111747 Phase contrast illumination Phase contrast illumination method for specimen microscopy
111748 Differential interference contrast Differential interference contrast method for specimen microscopy
111749 Total internal reflection fluorescence Total internal reflection fluorescence method for specimen microscopy
111750 Ultrasound Contact A method of obtaining ophthalmic axial measurements that uses ultrasound, and that requires applanation of the cornea.
111751 Ultrasound Immersion A method of obtaining ophthalmic axial measurements that uses ultrasound, and that requires immersion of the patient’s eye in fluid as he lies in a supine position.
111752 Optical A method of obtaining ophthalmic axial measurements that uses light.
111753 Manual Keratometry Measurements taken of the corneal curvature using a manual keratometer.
111754 Auto Keratometry Measurements taken of the corneal curvature using an automated keratometer.
111755 Simulated Keratometry Simulated Keratometry measurements derived from corneal topography.
111756 Equivalent K-reading Corneal power measurements using Scheimpflug camera.
111760 Haigis The Haigis IOL calculation formula. Haigis W, Lege B, Miller N, Schneider B. Comparison of immersion ultrasound biometry and partial coherence interferometry for intraocular lens calculation according to Haigis. Graefes Arch Clin Exp Ophthalmol 2000;238:765–73.
111761 Haigis-L The Haigis-L IOL calculation formula. Haigis W. Intraocular lens calculation after refractive surgery for myopia: Haigis-L formula. J Cataract Refract Surg. 2008 Oct;34(10):1658-63.
111762 Holladay 1 The Holladay 1 IOL calculation formula. Holladay JT, Prager TC, Chandler TY, Musgrove KH, Lewis JW, Ruiz RS. A three-part system for refining intraocular lens power calculations. J Cataract Refract Surg. 1988; 14:17-24.
111763 Holladay 2 The Holladay 2 IOL calculation formula.
111764 Hoffer Q The Hoffer Q IOL calculation formula. Hoffer KJ. The Hoffer Q formula: a comparison of theoretic and regression formulas. J Cataract Refract Surg 1993;19:700-12. Errata. J Cataract Refract Surg 1994;20:677 and 2007;33:2-3.
111765 Olsen The Olsen IOL calculation formula. Olsen T. Calculation of intraocular lens power: a review. Acta Ophthalmol. Scand. 2007: 85: 472–485.
111766 SRKII The SRKII IOL calculation formula. Sanders DR, Retzlaff J, Kraff MC. Comparison of the SRK II formula and other second generation formulas. J Cataract Refract Surg. 1988 Mar;14(2):136-41.
111767 SRK-T The SRK-T IOL calculation formula. Retzlaff JA, Sanders DR, Kraff MC. Development of the SRK/T intraocular lens implant power calculation formula. J Cataract Refract Surg 1990;16:333-40. Erratum 1990;16:528.
111768 ACD Constant The “ACD Constant” used in IOL calculation.
111769 Haigis a0 The “Haigis a0” constant used in IOL calculation.
111770 Haigis a1 The “Haigis a1” constant used in IOL calculation.
111771 Haigis a2 The “Haigis a2” constant used in IOL calculation.
111772 Hoffer pACD Constant The “Hoffer pACD Constant” used in IOL calculation.
111773 Surgeon Factor The “Surgeon Factor” constant used in IOL calculation.
111776 Front Of Cornea To Front Of Lens Anterior chamber depth defined as the front of the cornea to the front of the lens.
111777 Back Of Cornea To Front Of Lens Anterior chamber depth defined as the back of the cornea to the front of the lens.
111778 Single or Anterior Lens Refers to the anterior lens when there are two lenses in the eye. The distance, in mm, from the anterior surface of the lens to the posterior surface of the lens.
111779 Posterior Lens Refers to the posterior lens when there are two lenses in the eye. The distance, in mm, from the anterior surface of the lens to the posterior surface of the lens.
111780 Measurement From This Device Value obtained from measurements taken by the device creating this SOP Instance.
111781 External Data Source Value obtained by data transfer from an external source – not from measurements taken by the device providing the value.
111782 Axial Measurements SOP Instance Axial Measurements DICOM SOP Instance.
111783 Refractive Measurements SOP Instance Refractive Measurements DICOM SOP Instance.
111786 Standard Deviation of measurements used Standard Deviation is a simple measure of the variability of a data set.
111787 Signal to Noise Ratio Signal to Noise Ratio of the data samples taken to create a measurement.
111800 Visual Field 24-2 Test Pattern Test pattern, nominally covering an area within 24° of fixation. Consists of 54 test points a minimum of 3° from each meridian and placed 6° apart. The “-2” distinguishes this from another 24° pattern (no longer supported).
111801 Visual Field 10-2 Test Pattern Test pattern, nominally covering an area within 10° of fixation. Consists of 68 test points a minimum of 1° from each meridian and placed 2° apart. The “-2” in this case indicates its point layout to be similar to the 30-2 and 24-2.
111802 Visual Field 30-2 Test Pattern Test pattern consisting of test point locations within 30° of fixation. Consists of 76 test points a minimum of 3° from each meridian and placed 6° apart. The “-2” distinguishes this from another 30° pattern (no longer supported).
111803 Visual Field 60-4 Test Pattern Test pattern consisting of 60 test point locations between 30° and 60° of fixation a minimum of 6° from each meridian and placed 12° apart. The “-4” distinguishes this from a similar 60° pattern having 4 additional points.
111804 Visual Field Macula Test Pattern Test pattern consisting of 16 test point locations within 10° of fixation a minimum of 1° from each meridian and placed 2° apart.
111805 Visual Field Central 40 Point Test Pattern Test pattern consisting of 40 test point locations within 30° of fixation that spread out radially from fixation.
111806 Visual Field Central 76 Point Test Pattern Test pattern consisting of 76 test point locations within 30° of fixation a minimum of 3° from each meridian and placed 6° apart.
111807 Visual Field Peripheral 60 Point Test Pattern Test pattern consisting of 60 test point locations between 30° and 60° of fixation a minimum of 6° from each meridian and placed 12° apart.
111808 Visual Field Full Field 81 Point Test Pattern Test pattern consisting of 81 test point locations within 60° of fixation that spread out radially from fixation.
111809 Visual Field Full Field 120 Point Test Pattern Test pattern consisting of 120 test point locations within 60° of fixation that spread out radially from fixation, concentrated in the nasal hemisphere.
111810 Visual Field G Test Pattern Test pattern for Glaucoma and general visual field assessment with 59 test locations of which 16 test locations are in the macular area (up to 10° eccentricity) and where the density of test location is reduced with eccentricity. The test can be extended with the inclusion of 14 test locations between 30° and 60° eccentricity, 6 of which are located at the nasal step.
111811 Visual Field M Test Pattern Test pattern for the macular area. Orthogonal test pattern with 0.7° spacing within the central 4° of eccentricity and reduced density of test locations between 4 and 10,5° of eccentricity. 81 test locations over all. The test can be extended to include the test locations of the Visual Field G Test Pattern between 10,5° and 60°.
111812 Visual Field 07 Test Pattern Full field test pattern with 48 test locations from 0-30° and 82 test locations from 30-70°. Reduced test point density with increased eccentricity. Can be combined with screening and threshold strategies.
111813 Visual Field LVC Test Pattern Low Vision Central. Orthogonal off-center test pattern with 6° spacing. 75 test locations within the central 30°. Corresponds with the 32/30-2 excluding the 2 locations at the blind spot, including a macular test location. The LVC is linked with a staircase threshold strategy starting at 0 dB intensity and applies stimulus area V.
111814 Visual Field Central Test Pattern General test corresponding to the 30-2 but excluding the 2 test locations in the blind spot area, hence with 74 instead of 76 test locations.
111815 Visual Field SITA-Standard Test Strategy Swedish Interactive Thresholding Algorithm (SITA). Strategy gains testing efficiency through use of visual field and information theory models. In: Bengtsson B, Olsson J, Heijl A, Rootzen H.  A new generation of algorithms for computerized threshold perimetry, SITA.  Acta Ophthalmologica Scandinavica, 1997, 75: 368-375.
111816 Visual Field SITA-SWAP Test Strategy Adaptation of SITA testing methods to Blue-Yellow testing.
111817 Visual Field SITA-Fast Test Strategy Similar to SITA-Standard but with less strict criteria for closing test points. Intended for patients who must be tested in the shortest possible time. In: Bengtsson B, Hejl A.  SITA Fast, a new rapid perimetric threshold test.  Description of methods and evaluation in patients with manifest and suspect glaucoma.  Acta Ophthalmologica Scandinavica, 1998, 76: 431-437.
111818 Visual Field Full Threshold Test Strategy Threshold test algorithm that determines a patient’s sensitivity at each test point in the threshold test pattern by adjusting intensity by 4 dB steps until the patient changes their response, and then adjusts the intensity in the opposite direction by 2 dB steps until the patient changes their response again. The last stimulus seen by the patient is recognized as the threshold for that point. The starting values are determined by first thresholding a “primary” point in each quadrant then using the results of each primary point to determine the starting values for neighboring points.
111819 Visual Field FastPac Test Strategy Similar to the Full Threshold algorithm except that it steps by 3 dB and only crosses the threshold only once. In: Flanagan JG, Wild JM, Trope GE.  Evaluation of FASTPAC, a new strategy for threshold estimation with the Humphrey Field Analyzer, in a glaucomatous population.  Ophthalmology, 1993, 100: 949-954.
111820 Visual Field Full From Prior Test Strategy Identical to Full Threshold except that starting values are determined by the results of a previous test performed using the same test pattern and the Full Threshold test strategy.
111821 Visual Field Optima Test Strategy Similar to FastPac except that the steps are pseudo-dynamic (differ based on the intensity of the last presentation).
111822 Visual Field Two-Zone Test Strategy Suprathreshold testing strategy, in which each point is initially tested using stimulus that is 6 dB brighter than the expected hill of vision. If the patient does not respond, the stimulus is presented a second time at the same brightness. If the patient sees either presentation, the point is marked as “seen”; otherwise it is marked as “not seen”.
111823 Visual Field Three-Zone Test Strategy An extension of the two-zone strategy in which test points where the second stimulus is not seen are presented with a third stimulus at maximum brightness.
111824 Visual Field Quantify-Defects Test Strategy An extension of the two-zone strategy, in which test points where the second stimulus is not seen receive threshold testing to quantify the depth of any detected scotomoas.
111825 Visual Field TOP Test Strategy Tendency Oriented Perimetry. Fast thresholding algorithm. Test strategy makes use of the interaction between neighboring test locations to reduce the test time compared to normal full threshold strategy by 60-80%. In: Morales J, Weitzman ML, Gonzalez de la Rosa M.  Comparison between Tendency-Oriented Perimetry (TOP) and octopus threshold perimetry.  Ophthalmology, 2000, 107: 134-142.
111826 Visual Field Dynamic Test Strategy Dynamic strategy is a fast thresholding strategy reducing test duration by adapting the dB step sizes according to the frequency-of-seeing curve of the threshold. Reduction of test time compared to normal full threshold strategy 30-50%.
111827 Visual Field Normal Test Strategy Traditional full threshold staircase strategy. Initial intensities are presented, based on anchor point sensitivities in each quadrant and based on already known neighboring sensitivities. In a first run, thresholds are changed in 4dB steps until the first response reversal. Then the threshold is changed in 2 dB steps until the second response reversal. The threshold is calculated as the average between the last seen and last not-seen stimulus, supposed to correspond with the 50% point in the frequency-of-seeing curve.
111828 Visual Field 1-LT Test Strategy One level screening test: Each test location is tested with a single intensity. The result is shown as seen or not-seen. The intensity can either be a 0 dB stimulus or a predefined intensity.
111829 Visual Field 2-LT Test Strategy Two level screening test: Each test location is initially tested 6 dB brighter than the age corrected normal value.
111830 Visual Field LVS Test Strategy Low Vision Strategy is a full threshold normal strategy with the exception that it starts at 0 dB intensity and applies stimulus area V.
111831 Visual Field GATE Test Strategy German Adaptive Threshold Estimation is a fast strategy based on a modified 4-2 staircase algorithm, using prior visual fields to calculate the starting intensity. In: Chiefer U, Pascual JP, Edmunds B, Feudner E, Hoffmann EM, Johnson CA, Lagreze WA, Pfeiffer N, Sample PA, Staubach F, Weleber RG, Vonthein R, Krapp E, Paetzold J.  Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies.  Investigative Ophthalmology and Visual Science, 2009, 51: 488-494.
111832 Visual Field GATEi Test Strategy Similar to GATE. The i stands for initial. If there was no prior visual field test to calculate the starting values, an anchor point method is used to define the local start values.
111833 Visual Field 2LT-Dynamic Test Strategy A test started as two level screening test. In the course of the test, the threshold of relative defects and/or normal test locations has been quantified using the dynamic threshold strategy.
111834 Visual Field 2LT-Normal Test Strategy A test started as two level screening test. In the course of the test, the threshold of relative defects and/or normal test locations has been quantified using the normal full threshold strategy.
111835 Visual Field Fast Threshold Test Strategy Takes neighbourhood test point results into account and offers stimuli with an adapted value to save time.
111836 Visual Field CLIP Test Strategy Continuous Luminance Incremental Perimetry which measures at first the individual reaction time of the patient and threshold values in every quadrant. The starting value for the main test is slightly below in individual threshold.
111837 Visual Field CLASS Strategy A supra threshold screening strategy. The starting stimuli intensities depend on the classification of the patient’s visual hill by measuring the central (fovea) or peripheral (15° meridian) threshold. The result of each dot slightly underestimates the sensitivity value (within 5 dB).
111838 Age corrected Mode for determining the starting luminance for screening test points – the starting luminance s is chosen based on the age of the patient.
111839 Threshold related Mode for determining the starting luminance for screening test points – the starting luminance is chosen based on the results of thresholding a set of “primary” test points (one in each quadrant).
111840 Single luminance Mode for determining the starting luminance for screening test points – in this case, all starting luminance is set to the same value.
111841 Foveal sensitivity related Mode for determining the starting luminance for screening test points – the starting luminance is chosen based on the result of the foveal threshold value.
111842 Related to non macular sensitivity Mode for determining the starting luminance for screening test points – the starting luminance is chosen based on the result of four threshold values measured near the 15° meridian (one in each quadrant).
111843 Automated Optical Real time evaluation of the camera image to recognize blinks and fixation losses with influence on the test procedure. Blinks that interfere with stimuli presentation cause the automated repetition of such stimulus presentations. Fixation losses can be used to delay the stimulus presentation until correct fixation is regained.
111844 Blind Spot Monitoring A method of monitoring the patient’s fixation by periodically presenting stimulus in a location on the background surface that corresponds to the patient’s blind spot.
111845 Macular Fixation Testing A method of monitoring the patient’s fixation by presenting the stimulus to the patient’s macula.
111846 Observation by Examiner A method of monitoring the patient’s fixation by observation from the examiner of the patient.
111847 Outside normal limits Analysis Results are outside normal limits.
111848 Borderline Analysis Results are borderline.
111849 Abnormally high sensitivity Analysis Results identify abnormally high sensitivity
111850 General reduction in sensitivity Analysis Results identify general reduction in sensitivity.
111851 Borderline and general reduction in sensitivity Analysis Results identify Borderline and general reduction in sensitivity.
111852 Visual Field Index Index of a patient’s remaining visual field normalized for both age and generalized defect.
111853 Visual Field Loss Due to Diffuse Defect Estimate of the portion of a patient’s visual field loss that is diffuse (i.e. spread evenly across all portions of the visual field).
111854 Visual Field Loss Due to Local Defect Estimate of the portion of a patient’s visual field loss that is local (i.e. not spread evenly across all portions of the visual field).
111855 Glaucoma Hemifield Test Analysis An analysis of asymmetry between zones of the superior and inferior visual field. It is designed to be specific for defects due to glaucoma.
111856 Optical Fixation Measurements The data output of an optical fixation monitoring process, consisting of a list of positive and negative numbers indicating the quality of patient fixation over the course of a visual field test. The value 0 represents the initial fixation. Negative numbers indicate a measuring error (i.e. the patient blinked). Positive numbers quantify the degree of eccentricity from initial fixation.
112000 Chest CAD Report A structured report containing the results of computer-aided detection or diagnosis applied to chest imaging and associated clinical information.
112001 Opacity The shadow of an absorber that attenuates the X-Ray beam more effectively than do surrounding absorbers. In a radiograph, any circumscribed area that appears more nearly white (of lesser photometric density) than its surround [Fraser and Pare].
112002 Series Instance UID A unique identifier for a series of DICOM SOP instances.
112003 Associated Chest Component A named anatomic region within the chest cavity.
112004 Abnormal interstitial pattern A collection of opacities detected within the continuum of loose connective tissue throughout the lung, that is not expected in a diagnostically normal radiograph.
112005 Radiographic anatomy A type of anatomy that is expected to be detectable on a radiographic (X-Ray based) image.
112006 Distribution Descriptor Characteristic of the extent of spreading of a finding or feature.
112007 Border definition Characteristic of the clarity of the boundary or edges of a finding or feature.
112008 Site involvement The part(s) of the anatomy affected or encompassed by a finding or feature.
112009 Type of Content Characteristic of the matter or substance within a finding or feature.
112010 Texture Descriptor Characteristic of the surface or consistency of a finding or feature.
112011 Positioner Primary Angle Position of the X-Ray beam about the patient from the RAO to LAO direction where movement from RAO to vertical is positive.
112012 Positioner Secondary Angle Position of the X-Ray beam about the patient from the caudal to cranial direction where movement from caudal to vertical is positive.
112013 Location in Chest The zone, lobe or segment within the chest cavity in which a finding or feature is situated.
112014 Orientation Descriptor Vertical refers to orientation parallel to the superior-inferior (cephalad-caudad) axis of the body, with horizontal being perpendicular to this, and an oblique orientation having projections in both the horizontal and vertical.
112015 Border shape Characteristic of the shape formed by the boundary or edges of a finding or feature.
112015 Border shape Characteristic of the shape formed by the boundary or edges of a finding or feature.
112016 Baseline Category Indicates whether a finding was considered a target lesion, non-target lesion, or non-lesion during evaluation of a baseline series, according to a method such as RECIST.
112016 Baseline Category Indicates whether a finding was considered a target lesion, non-target lesion, or non-lesion during evaluation of a baseline series, according to a method such as RECIST.
112017 Cavity extent as percent of volume The extent of a detected cavity, represented as the percent of the surrounding volume that it occupies.
112017 Cavity extent as percent of volume The extent of a detected cavity, represented as the percent of the surrounding volume that it occupies.
112018 Calcification extent as percent of surface The extent of a detected calcification, represented as the percent of the surrounding surface that it occupies.
112018 Calcification extent as percent of surface The extent of a detected calcification, represented as the percent of the surrounding surface that it occupies.
112019 Calcification extent as percent of volume The extent of a detected calcification, represented as the percent of the surrounding volume that it occupies.
112019 Calcification extent as percent of volume The extent of a detected calcification, represented as the percent of the surrounding volume that it occupies.
112020 Response Evaluation A heading for the reporting of response evaluation for treatment of solid tumors.
112021 Response Evaluation Method The system applied in the reporting of response evaluation for treatment of solid tumors.
112022 RECIST Response Evaluation Criteria In Solid Tumors. See Normative References.
112023 Composite Feature Modifier A term which further specifies the name of an item that is an inferred correlation relating two or more individual findings or features.
112024 Single Image Finding Modifier A term which further specifies the name of an item that was detected on one image.
112025 Size Descriptor A qualitative descriptor for the extent of a finding or feature.
112026 Width Descriptor A qualitative descriptor for the thickness of tubular structures, such as blood vessels.
112027 Opacity Descriptor A characteristic that further describes the nature of an opacity.
112028 Abnormal Distribution of Anatomic Structure The type of adverse affect that a finding or feature is having on the surrounding anatomy.
112029 WHO Response evaluation method as defined in chapter 5, “Reporting of Response” of the WHO Handbook for Reporting Results for Cancer Treatment. See Normative References.
112030 Calcification Descriptor Identification of the morphology of detected calcifications.
112031 Attenuation Coefficient A quantitative numerical statement of the relative attenuation of the X-Ray beam at a specified point; for example, expressed in Hounsfield units [referred to as CT Number in Fraser and Pare].
112032 Threshold Attenuation Coefficient An X-Ray attenuation coefficient that is used as a threshold, for example, in calcium scoring.
112033 Abnormal opacity An opacity that is not expected in a diagnostically normal radiograph.
112034 Calculation Description A textual description of the mathematical method of calculation which resulted in a calculated value.
112035 Performance of Pediatric and Adult Chest Radiography, ACR American College of Radiology. ACR Standard for the Performance of Pediatric and Adult Chest Radiography. In: Standards. Reston, Va: 2001:95-98.
112036 ACR Position Statement American College of Radiology. ACR Position Statement for Quality Control and Improvement, Safety, Infection Control, and Patient Concerns. In: Practice Guidelines and Technical Standards. Reston, Va: 2001:iv.
112037 Non-lesion Modifier A descriptor for a non-lesion object finding or feature, used to indicate whether the object was detected as being internal or external to the patient’s body.
112038 Osseous Modifier A concept modifier for an Osseous Anatomy, or bone related, finding.
112039 Tracking Identifier A text label used for tracking a finding or feature, potentially across multiple reporting objects, over time. This label shall be unique within the domain in which it is used.
112040 Tracking Unique Identifier A unique identifier used for tracking a finding or feature, potentially across multiple reporting objects, over time.
112041 Target Lesion Complete Response Disappearance of all target lesions.
112042 Target Lesion Partial Response At least a 30% decrease in the sum of the Longest Diameter of target lesions, taking as reference the baseline sum Longest Diameter.
112043 Target Lesion Progressive Disease At least a 20% increase in the sum of the Longest Diameter of target lesions, taking as reference the smallest sum Longest Diameter recorded since the treatment started, or the appearance of one or more new lesions.
112044 Target Lesion Stable Disease Neither sufficient shrinkage to qualify for Partial Response nor sufficient increase to qualify for Progressive Disease, taking as reference the smallest sum Longest Diameter since the treatment started.
112045 Non-Target Lesion Complete Response Disappearance of all non-target lesions and normalization of tumor marker level.
112046 Non-Target Lesion Incomplete Response or Stable Disease Persistence of one or more non-target lesions and/or maintenance of tumor marker level above the normal limits.
112047 Non-Target Lesion Progressive Disease Appearance of one or more new lesions and/or unequivocal progression of existing non-target lesions.
112048 Current Response The current response evaluation for treatment of solid tumors, according to a method such as RECIST.
112049 Best Overall Response Best response recorded from the start of the treatment until disease progression/recurrence, taking as reference for Progressive Disease the smallest measurements recorded since the treatment started, according to a method such as RECIST.
112050 Anatomic Identifier A text identifier of an anatomic feature when a multiplicity of features of that type may be present, such as “Rib 1”, “Rib 2” or thoracic vertibrae “T1” or “T2”.
112051 Measurement of Response A measured or calculated evaluation of response. For example, according to a method such as RECIST, the value would be the calculated sum of the lengths of the longest axes of a set of target lesions.
112052 Bronchovascular Of or relating to a bronchial (lung) specific channel for the conveyance of a body fluid.
112053 Osseous Of, relating to, or composed of bone.
112054 Secondary pulmonary lobule The smallest unit of lung surrounded by connective tissue septa; the unit of lung subtended by any bronchiole that gives off three to five terminal bronchioles [Fraser and Pare].
112055 Agatston scoring method A method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the maximum X-Ray attenuation coefficient and the area of calcium deposits.
112056 Volume scoring method A method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the volume of each calcification, typically expressed in mm3.
112057 Mass scoring method A method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the total mass of calcification, typically expressed in mg.
112058 Calcium score A measure often arrived at through calculation of findings from CT examination, which is a common predictor of significant stenosis of the coronary arteries.
112059 Primary complex The combination of a focus of pneumonia due to a primary infection with granulomas in the draining hilar or mediastinal lymph nodes [Fraser and Pare].
112060 Oligemia General or local decrease in the apparent width of visible pulmonary vessels, suggesting less than normal blood flow (reduced blood flow) [Fraser and Pare].
112061 Abnormal lines (1D) Linear opacity of very fine width, i.e. a nearly one dimensional opacity.
112062 Abnormal lucency Area of abnormal very low X-Ray attenuation, typically lower than aerated lung when occuring in or projecting over lung, or lower than soft tissue when occurring in or projecting over soft tissue.
112063 Abnormal calcifications A calcific opacity within the lung that may be organized, but does not display the trabecular organization of true bone [Fraser and Pare].
112064 Abnormal texture Relatively homogeneous, extended, pattern of abnormal opacity in the lung, typically low in contrast.
112065 Reticulonodular pattern A collection of innumerable small, linear, and nodular opacities that together produce a composite appearance resembling a net with small superimposed nodules. The reticular and nodular elements are dimensionally of similar magnitude [Fraser and Pare].
112066 Beaded septum sign Irregular septal thickening that suggests the appearance of a row of beads; usually a sign of lymphangitic carcinomatosis, but may also occur rarely in sarcoidosis [Fraser and Pare].
112067 Nodular pattern A collection of innumerable, small discrete opacities ranging in diameter from 2-10 mm, generally uniform in size and widespread in distribution, and without marginal spiculation [Fraser and Pare].
112068 Pseudoplaque An irregular band of peripheral pulmonary opacity adjacent to visceral pleura that simulates the appearance of a pleural plaque and is formed by coalescence of small nodules [Fraser and Pare].
112069 Signet-ring sign A ring of opacities (usually representing a dilated, thick-walled bronchus) in association with a smaller, round, soft tissue opacity (the adjacent pulmonary artery) suggesting a “signet ring” [Fraser and Pare].
112070 Air bronchiologram Equivalent of air bronchogram, but in airways assumed to be bronchioles because of peripheral location and diameter [Fraser and Pare].
112071 Air bronchogram Radiographic shadow of an air-containing bronchus; presumed to represent an air-containing segment of the bronchial tree (identity often inferred) [Fraser and Pare].
112072 Air crescent Air in a crescentic shape in a nodule or mass, in which the air separates the outer wall of the lesion from an inner sequestrum, which most commonly is a fungus ball of Aspergillus species [Fraser and Pare].
112073 Halo sign Ground-glass opacity surrounding the circumference of a nodule or mass. May be a sign of invasive aspergillosis or hemorrhage of various causes [Fraser and Pare].
112074 Target Lesion at Baseline Flag denoting that this lesion was identified, at baseline, as a target lesion intended for tracking over time [RECIST].
112075 Non-Target Lesion at Baseline Flag denoting that this lesion was not identified, at baseline, as a target lesion, and was not intended for tracking over time [RECIST].
112076 Non-Lesion at Baseline Flag denoting that this finding was identified, at baseline, as a category other than a lesion, and was not intended for tracking over time [RECIST].
112077 Vasoconstriction Local or general reduction in the caliber of visible pulmonary vessels, presumed to result from decreased flow occasioned by contraction of muscular pulmonary arteries [Fraser and Pare].
112078 Vasodilation Local or general increase in the width of visible pulmonary vessels resulting from increased pulmonary blood flow [Fraser and Pare].
112079 Architectural distortion A manifestation of lung disease in which bronchi, pulmonary vessels, a fissure or fissures, or septa of secondary pulmonary lobules are abnormally displaced [Fraser and Pare].
112080 Mosaic perfusion A patchwork of regions of varied attenuation, interpreted as secondary to regional differences in perfusion [Fraser and Pare].
112081 Pleonemia Increased blood flow to the lungs or a portion thereof, manifested by a general or local increase in the width of visible pulmonary vessels [Fraser and Pare].
112082 Interface The common boundary between the shadows of two juxtaposed structures or tissues of different texture or opacity (edge, border) [Fraser and Pare].
112083 Line A longitudinal opacity no greater than 2 mm in width [Fraser and Pare].
112084 Lucency The shadow of an absorber that attenuates the primary X-Ray beam less effectively than do surrounding absorbers. In a radiograph, any circumscribed area that appears more nearly black (of greater photometric density) than its surround [Fraser and Pare].
112085 Midlung window A midlung region, characterized by the absence of large blood vessels and by a paucity of small blood vessels, that corresponds to the minor fissure and adjacent peripheral lung [Fraser and Pare].
112086 Carina angle The angle formed by the right and left main bronchi at the tracheal bifurcation [Fraser and Pare].
112087 Centrilobular structures The pulmonary artery and its immediate branches in a secondary lobule; HRCT depicts these vessels in certain cases; a.k.a. core structures or lobular core structures [Fraser and Pare].
112088 Anterior junction line A vertically oriented linear or curvilinear opacity approximately 1-2 mm wide, commonly projected on the tracheal air shadow [Fraser and Pare].
112089 Posterior junction line A vertically oriented, linear or curvilinear opacity approximately 2 mm wide, commonly projected on the tracheal air shadow, and usually slightly concave to the right [Fraser and Pare].
112090 Azygoesophageal recess interface A space in the right side of the mediastinum into which the medial edge of the right lower lobe extends [Fraser and Pare].
112091 Paraspinal line A vertically oriented interface usually seen in a frontal chest radiograph to the left of the thoracic vertebral column [Fraser and Pare].
112092 Posterior tracheal stripe A vertically oriented linear opacity ranging in width from 2-5 mm, extending from the thoracic inlet to the bifurcation of the trachea, and visible only on lateral radiographs of the chest [Fraser and Pare].
112093 Right tracheal stripe A vertically oriented linear opacity approximately 2-3 mm wide extending from the thoracic inlet to the right tracheobronchial angle [Fraser and Pare].
112094 Stripe A longitudinal composite opacity measuring 2-5 mm in width; acceptable when limited to anatomic structures within the mediastinum [Fraser and Pare].
112095 Hiatus A gap or passage through an anatomical part or organ; especially : a gap through which another part or organ passes.
112096 Rib Scalene Tubercle A small rounded elevation or eminence on the first rib for the attachment of the scalenus anterior.
112097 Vertebral Intervertebral Notch A groove that serves for the transmission of the vertebral artery.
112098 Subscapular Fossa The concave depression of the anterior surface of the scapula.
112099 Scapular Spine A sloping ridge dividing the dorsal surface of the scapula into the supraspinatous fossa (above), and the infraspinatous fossa (below).
112100 Scapular Supraspinatus Fossa The portion of the dorsal surface of the scapula above the scapular spine.
112101 Scapular Infraspinatus Fossa The portion of the dorsal surface of the scapula below the scapular spine.
112102 Aortic knob The portion of the aortic arch that defines the transition between its ascending and descending limbs.
112103 Arch of the Azygos vein Section of Azygos vein near the fourth thoracic vertebra, where it arches forward over the root of the right lung, and ends in the superior vena cava, just before that vessel pierces the pericardium.
112104 Air-fluid level A local collection of gas and liquid that, when traversed by a horizontal X-Ray beam, creates a shadow characterized by a sharp horizontal interface between gas density above and liquid density below [Fraser and Pare].
112105 Corona radiata A circumferential pattern of fine linear spicules, approximately 5 mm long, extending outward from the margin of a solitary pulmonary nodule through a zone of relative lucency [Fraser and Pare].
112106 Honeycomb pattern A number of closely approximated ring shadows representing air spaces 5-10 mm in diameter with walls 2-3 mm thick that resemble a true honeycomb; implies “end-stage” lung [Fraser and Pare]
112107 Fleischner’s line(s) A straight, curved, or irregular linear opacity that is visible in multiple projections; usually situated in the lower half of the lung; vary markedly in length and width [Fraser and Pare].
112108 Intralobular lines Fine linear opacities present in a lobule when the intralobular interstitium is thickened. When numerous, they may appear as a fine reticular pattern [Fraser and Pare].
112109 Kerley A line Essentially straight linear opacity 2-6 cm in length and 1-3 mm in width, usually in an upper lung zone [Fraser and Pare].
112110 Kerley B line A straight linear opacity 1.5-2 cm in length and 1-2 mm in width, usually at the lung base [Fraser and Pare].
112111 Kerley C lines A group of branching, linear opacities producing the appearing of a fine net, at the lung base [Fraser and Pare].
112112 Parenchymal band Elongated opacity, usually several millimeters wide and up to about 5 cm long, often extending to the pleura, which may be thickened and retracted at the site of contact [Fraser and Pare].
112113 Reticular pattern A collection of innumerable small linear opacities that together produce an appearance resembling a net [Fraser and Pare].
112114 Septal line(s) Usually used in the plural, a generic term for linear opacities of varied distribution produced when the interstitium between pulmonary lobules is thickened [Fraser and Pare].
112115 Subpleural line A thin curvilinear opacity, a few millimeters or less in thickness, usually less than 1 cm from the pleural surface and paralleling the pleura [Fraser and Pare].
112116 Tramline shadow Parallel or slightly convergent linear opacities that suggest the planar projection of tubular structures and that correspond in location and orientation to elements of the bronchial tree [Fraser and Pare].
112117 Tubular shadow Paired, parallel, or slightly convergent linear opacities presumed to represent the walls of a tubular structure seen en face; used if the anatomic nature of a shadow is obscure [Fraser and Pare].
112118 Density The opacity of a radiographic shadow to visible light; film blackening; the term should never be used to mean an “opacity” or “radiopacity” [Fraser and Pare].
112119 Dependent opacity Subpleural increased attenuation in dependent lung. The increased attenuation disappears when the region of lung is nondependent; a.k.a. dependent increased attenuation [Fraser and Pare].
112120 Ground glass opacity Hazy increased attenuation of lung, but with preservation of bronchial and vascular margins; caused by partial filling of air spaces, interstitial thickening, partial collapse of alveoli, normal expiration, or increased capillary blood volume [Fraser and Pare].
112121 Infiltrate Any ill-defined opacity in the lung [Fraser and Pare].
112122 Micronodule Discrete, small, round, focal opacity of at least soft tissue attenuation and with a diameter no greater than 7 mm [Fraser and Pare].
112123 Phantom tumor (pseudotumor) A shadow produced by a local collection of fluid in one of the interlobar fissures, usually elliptic in one radiographic projection and rounded in the other, resembling a tumor [Fraser and Pare].
112124 Shadow Any perceptible discontinuity in film blackening attributed to the attenuation of the X-Ray beam by a specific anatomic absorber or lesion on or within the body of the patient; to be employed only when more specific identification is not possible [Fraser and Pare].
112125 Small irregular opacities Term used to define a reticular pattern specific to pneumoconioses [Fraser and Pare].
112126 Small rounded opacities Term used to define a nodular pattern specific to pneumoconioses [Fraser and Pare].
112127 Tree-in-bud sign Nodular dilation of centrilobular branching structures that resembles a budding tree and represents exudative bronchiolar dilation [Fraser and Pare].
112128 Granular pattern Any extended, finely granular pattern of pulmonary opacity within which normal anatomic details are partly obscured [Fraser and Pare].
112129 Miliary pattern A collection of tiny discrete opacities in the lungs, each measuring 2 mm or less in diameter, generally uniform in size and widespread in distribution [Fraser and Pare].
112130 Mosaic pattern Generalized pattern of relatively well defined areas in the lung having different X-Ray attenuations due to a longstanding underlying pulmonary disease.
112131 Extremely small A qualitative descriptor of a size that is dramatically less than typical.
112132 Very small A qualitative descriptor of a size that is considerably less than typical.
112133 Too small A qualitative descriptor of a size that is so small as to be abnormal versus expected size.
112134 Elliptic Shaped like an ellipse (oval).
112135 Lobulated A border shape that is made up of, provided with, or divided into lobules (small lobes, curved or rounded projections or divisions).
112136 Spiculated Radially orientated border shape.
112137 Sharply defined The border of a shadow (opacity) is sharply defined [Fraser and Pare].
112138 Distinctly defined The border of a shadow (opacity) is distinctly defined [Fraser and Pare].
112139 Well demarcated The border of a shadow (opacity) is well distinct from adjacent structures [Fraser and Pare].
112140 Sharply demarcated The border of a shadow (opacity) is sharply distinct from adjacent structures [Fraser and Pare].
112141 Poorly demarcated The border of a shadow (opacity) is poorly distinct from adjacent structures [Fraser and Pare].
112142 Circumscribed A shadow (opacity) possessing a complete or nearly complete visible border [Fraser and Pare].
112143 Air Inspired atmospheric gas. The word is sometimes used to describe gas within the body regardless of its composition or site [Fraser and Pare].
112144 Soft tissue Material having X-Ray attenuation properties similar to muscle.
112145 Calcium Material having X-Ray attenuation properties similar to calcium, a silver-white bivalent metallic element occurring in plants and animals.
112146 Acinar A pulmonary opacity 4-8 mm in diameter, presumed to represent anatomic acinus, or a collection of opacities in the lung, each measuring 4-8 mm in diameter, and together producing an extended, homogeneous shadow [Fraser and Pare].
112147 Air space The gas-containing portion of the lung parenchyma, including the acini and excluding the interstitium [Fraser and Pare].
112148 Fibronodular Sharply defined, approximately circular opacities occurring singly or in clusters, usually in the upper lobes [Fraser and Pare].
112149 Fluffy A shadow (opacity) that is ill-defined, lacking clear-cut margins [Fraser and Pare].
112150 Linear A shadow resembling a line; any elongated opacity of approximately uniform width [Fraser and Pare].
112151 Profusion The number of small opacities per unit area or zone of lung. In the International Labor Organization (ILO) classification of radiographs of the pneumoconioses, the qualifiers 0 through 3 subdivide the profusion into 4 categories. The profusion categories may be further subdivided by employing a 12-point scale [Fraser and Pare].
112152 Silhouette sign The effacement of an anatomic soft tissue border by either a normal anatomic structure or a pathologic state such as airlessness of adjacent lung or accumulation of fluid in the contiguous pleural space; useful in detecting and localizing an opacity along the axis of the X-Ray beam [Fraser and Pare].
112153 Subpleural Situated or occurring between the pleura and the body wall.
112154 Bat’s wing distribution Spatial arrangement of opacities that bears vague resemblance to the shape of a bat in flight; bilaterally symmetric [Frasere and Pare].
112155 Butterfly distribution Spatial arrangement of opacities that bears vague resemblance to the shape of a butterfly in flight; bilaterally symmetric [Frasere and Pare].
112156 Centrilobular Referring to the region of the bronchioloarteriolar core of a secondary pulmonary lobule [Fraser and Pare].
112157 Coalescent The joining together of a number of opacities into a single opacity [Fraser and Pare].
112158 Lobar Of or relating to a lobe (a curved or rounded projection or division). For example, involving an entire lobe of the lung.
112159 Hyper-acute Extremely or excessively acute, as a qualitative measure of severity.
112160 Homogeneous (uniform opacity) Of uniform opacity or texture throughout [Fraser and Pare].
112161 Inhomogeneous Lack of homogeneity in opacity or texture.
112162 Target Discrete opacity centrally within a larger opacity, as a calcification descriptor.
112163 Fibrocalcific Pertaining to sharply defined, linear, and/or nodular opacities containing calcification(s) [Fraser and Pare].
112164 Flocculent Calcifications made up of loosely aggregated particles, resembling wool.
112165 Difference in border shape A change in the shape formed by the boundary or edges of a finding or feature. Retired. Replaced with (F-0517E, SRT, “Difference in border shape”)
112166 Difference in border definition A change in the clarity of the boundary or edges of a finding or feature. Retired. Replaced with (F-05166, SRT, “Difference in border definition”)
112167 Difference in distribution A change in the extent of spreading of a finding or feature. Retired. Replaced with (F-0516C, SRT, “Difference in distribution”)
112168 Difference in site involvement A change in the part(s) of the anatomy affected or encompassed by a finding or feature. Retired. Replaced with (F-05170, SRT, “Difference in site involvement”)
112169 Difference in Type of Content A change in the matter or substance within a finding or feature. Retired. Replaced with (F-05167, SRT, “Difference in substance”)
112170 Difference in Texture A change in the surface or consistency of a finding or feature. Retired. Replaced with (F-0516A, SRT, “Difference in texture”)
112171 Fiducial mark A location in image space, which may or may not correspond to an anatomical reference, which is often used for registering data sets.
112172 Portacath Connected to an injection chamber placed under the skin in the upper part of the chest. When it is necessary to inject some drug, a specific needle is put in the chamber through the skin and a silicon membrane. The advantage of a portacath is that it may be left in place several months contrarily of "classical" cathethers.
112173 Chest tube A tube inserted into the chest wall from outside the body, for drainage. Sometimes used for collapsed lung. Usually connected to a receptor placed lower than the insertion site.
112174 Central line A tube placed into the subclavian vein to deliver medication directly into the venous system.
112175 Kidney stent A stent is a tube inserted into another tube. Kidney stent is a tube that is inserted into the kidney, ureter, and bladder, to help drain urine. Usually inserted through a scoping device presented through the urethra.
112176 Pancreatic stent A stent is a tube inserted into another tube. Pancreatic stent is inserted through the common bile duct to the pancreatic duct, to drain bile.
112177 Nipple ring A non-lesion object which appears to be a circular band, attached to the body via pierced nipple.
112178 Coin A non-lesion object which appears to be a flat round piece of metal.
112179 Minimum Attenuation Coefficient The least quantity assignable, admissible, or possible; the least of a set of X-Ray attenuation coefficients.
112180 Maximum Attenuation Coefficient The greatest quantity or value attainable or attained; the largest of a set of X-Ray attenuation coefficients.
112181 Mean Attenuation Coefficient The value that is computed by dividing the sum of a set of X-Ray attenuation coefficients by the number of values.
112182 Median Attenuation Coefficient The value in an ordered set of X-Ray attenuation coefficients, below and above which there is an equal number of values.
112183 Standard Deviation of Attenuation Coefficient For a set of X-Ray attenuation coefficients: 1) a measure of the dispersion of a frequency distribution that is the square root of the arithmetic mean of the squares of the deviation of each of the class frequencies from the arithmetic mean of the frequency distribution; 2) a parameter that indicates the way in which a probability function or a probability density function is centered around its mean and that is equal to the square root of the moment in which the deviation from the mean is squared.
112184 Performance of Pediatric and Adult Thoracic CT American College of Radiology. ACR Standard for the Performance of Pediatric and Adult Thoracic Computed Tomography (CT). In: Standards. Reston, Va: 2001:103-107.
112185 Performance of CT for Detection of Pulmonary Embolism in Adults American College of Radiology. ACR Standard for the Performance of Computed Tomography for the Detection of Pulmonary Embolism in Adults. In: Standards. Reston, Va: 2001:109-113.
112186 Performance of High-Resolution CT of the Lungs in Adults American College of Radiology. ACR Standard for the Performance of High-Resolution Computed Tomography (HRCT) of the Lungs in Adults. In: Standards. Reston, Va: 2001:115-118.
112187 Unspecified method of calculation The method of calculation of a measurement or other type of numeric value is not specified.
112191 Breast tissue density The relative density of parenchymal tissue as a proportion of breast volume
112192 Volume of parenchymal tissue The volume of parenchymal tissue
112193 Volume of breast The volume of the breast
112194 Mass of parenchymal tissue The mass of parenchymal tissue
112195 Mass of breast The mass of the breast
112196 Area of Vascular Calcification A measured or calculated area of vascular calcification
112197 Volume of Vascular Calcification A measured or calculated volume of vascular calcification
112198 Percentage of Vascular Calcification A measured or calculated percentage of vascular calcification
112199 Mass of Vascular Calcification A measured or calculated mass of vascular calcification
112200 Average calcification distance in a calcification cluster The average nearest neighbor distance of all individual microcalcifications in a cluster.
112201 Standard deviation distance of calcifications in a cluster The standard deviation of nearest neighbor distance of all individual microcalcifications in a cluster.
112188 Two-dimensional method The calcuation method was performed in two-dimensional space.
112189 Three-dimensional method The calculation method was performed in three-dimensional space.
112220 Colon CAD Report A structured report containing the results of computer-aided detection or diagnosis applied to colon imaging and associated clinical information.
112222 Colon Overall Assessment Overall interpretation of the colon using C-RADS categorization system.
112224 Image Set Properties Characteristics of a set of images.
112225 Slice Thickness Nominal slice thickness, in mm.
112226 Spacing between slices Distance between contiguous images, measured from the center-to-center of each image.
112227 Frame of Reference UID Uniquely identifies groups of composite instances that have the same coordinate system that conveys spatial and/or temporal information.
112228 Recumbent Patient Position with respect to gravity Patient orientation with respect to downward direction (gravity).
112229 Identifying Segment Distinguishes a part of a segmentation.
112232 Polyp stalk width The diameter of a polyp stalk measured perpendicular to the axis of the stalk.
112233 Distance from anus The length of the path following the centerline of the colon from the anus to the area of interest.
112238 Anatomic non-colon A location in the body that is outside the colon.
112240 C0 - Inadequate Study/Awaiting Prior Comparisons An inadequate study or a study that is awaiting prior comparisons. The study may have inadequate preparation and cannot exclude lesions greater than or equal to ten millimeters owing to presence of fluid or feces. The study may have inadequate insufflation where one or more colonic segments collapsed on both views. Based on “CT Colonography Reporting and Data System: A Consensus Proposal”, Radiology July 2005; 236:3-9.
112241 C1 - Normal Colon or Benign Lesion The study has a normal colon or benign lesion, with the recommendation to continue routine screening. The study has no visible abnormalities of the colon. The study has no polyps greater than six millimeters. The study may have lipoma, inverted diverticulum, or nonneoplastic findings, for example colonic diverticula. Based on “CT Colonography Reporting and Data System: A Consensus Proposal”, Radiology July 2005; 236:3-9.
112242 C2 - Intermediate Polyp or Indeterminate Finding The study has an intermediate polyp or indeterminate finding and surveillance or colonoscopy is recommended. There may be intermediate polyps between six and nine millimeters and there are less than three in number. The study may have an intermediate finding and cannot exclude a polyp that is greater than or equal to six millimeters in a technically adequate exam. Based on “CT Colonography Reporting and Data System: A Consensus Proposal”, Radiology July 2005; 236:3-9.
112243 C3 - Polyp, Possibly Advanced Adenoma The study has a polyp, possibly advanced adenoma, and a follow-up colonoscopy is recommended. The study has a polyp greater than or equal to ten millimeters or the study has three or more polyps that are each between six to nine millimeters. Based on “CT Colonography Reporting and Data System: A Consensus Proposal”, Radiology July 2005; 236:3-9.
112244 C4 - Colonic Mass, Likely Malignant The study has a colonic mass, likely malignant, and surgical consultation is recommended. The lesion compromises bowel lumen and demonstrates extracolonic invasion. Based on “CT Colonography Reporting and Data System: A Consensus Proposal”, Radiology July 2005; 236:3-9.
112248 ACR Guideline, Performance of Adult CT Colonography American College of Radiology Practice Guideline for the Performance of Computed Tomography (CT) Colonography in Adults. In: Practice Guidelines and Technical Standards. Reston, Va: American College of Radiology;2006:371-376.
112249 ACR Standard, CT medical physics performance monitoring American College of Radiology Technical Standard for Diagnostic Medical Physics Performance Monitoring of Computed Tomography (CT) Equipment. In: Practice Guidelines and Technical Standards. Reston, Va: American College of Radiology;2006:945-948.
112300 AP+45 View Orientation Modifier indicates that the view orientation of the imaging plane is rotated +45° along the cranial-caudal axis
112301 AP-45 View Orientation Modifier indicates that the view orientation of the imaging plane is rotated -45° along the cranial-caudal axis.
112302 Anatomical axis of femur The axis following the shaft of the femur
112303 Acetabular Center of Rotation Center of Rotation of the natural Acetabulum
112304 Femur Head Center of Rotation Center of Rotation of the natural femur head
112305 Acetabular Cup Shell Prosthetic component implanted into the acetabulum. Provides hold for the insert that is mounted inside the cup. [pic]
112306 Acetabular Cup Insert Prosthetic pelvic joint component. Inserted into the cup, takes in the femoral head replacement. [pic]
112307 Acetabular Cup Monoblock Prosthetic pelvic joint cup including insert. [pic]
112308 Femoral Head Ball Component Component for Femoral Head Prosthesis where the conic intake for the stem neck can be exchanged. Combined with a Femoral Head Cone Taper Component. [pic]
112309 Femoral Head Cone Taper Component Exchangeable neck intake for composite femoral head prosthesis. Combined with a Femoral Head Ball Component.
112310 Femoral Stem Prosthesis Implanted into the femoral bone to provide force transmission between joint replacement and bone. On the proximal end a conic neck holds the femoral head replacement. [pic]
112311 Femoral Stem Distal Component Distal half of a modular stem prosthesis system. Combined with a Stem Proximal Component. [pic]
112312 Femoral Stem Proximal Component Proximal half of a modular stem prosthesis system. Combined with a Stem Distal Component. [pic]
112313 Femoral Stem Component Stem prosthetic component with a modular insert for an exchangeable neck component. Combined with a Neck Component. [pic]
112314 Neck Component Prosthetic Neck to be combined with a Stem Component. [pic]
112315 Monoblock Stem Prosthetic Stem and Femoral Head in one piece. [pic]
112315 Distal Centralizer Attachment to the distal end of a cemented stem assuring that the stem is in a central position inside the drilled femoral canal before cementation. [pic]
112316 Prosthetic Shaft Augment A proximal attachment to the shaft used to compensate for bone deficiencies or bone loss. [pic]
112317 Femoral Head Resurfacing Component Artificial femur head surface needed for the partial replacement of the femoral head where only the surface is replaced. [pic]
112318 Pinning Fixation using a pin
112319 Sewing Fixation sewing several objects together
112320 Bolting Fixation using a bolt
112321 Wedging Fixation due to forcing an object into a narrow space
112340 Generic 2D Planning Planning by an unspecified 2D method
112341 Generic 3D Planning Planning by an unspecified 3D method
112342 Generic Planning for Hip Replacement Planning of a Hip Replacement, by an unspecified method
112343 Generic Planning for Knee Replacement Planning of Knee Replacement, by an unspecified method
112344 Müller Method Planning for Hip Replacement Planning of Hip Replacement according to the procedure of M. E. Müller [Eggli et. al.1998]
112345 Implantation Plan A Report containing the results of an Implantation Planning Activity
112346 Selected Implant Component A selection of one Implant Component
112347 Component ID Identification ID of an Implant Component
112348 Implant Template An implant template describing the properties (2D/3D geometry and other data) of one Implant Component
112350 Component Connection A connection of two Connected Implantation Plan Components
112351 Mating Feature Set ID ID of a Mating Feature Set in an Implant Component
112352 Mating Feature ID ID of the Mating Feature in a Mating Feature Set in an Implant Component
112353 Spatial Registration The Spatial Registration of one or more Implant Components
112354 Patient Image Patient Images used for an implantation planning activity
112355 Assembly A collection of Component Connections of Implant Components
112356 User Selected Fiducial Fiducials that are selected by the user and may or may not belong to anatomical landmarks
112357 Derived Fiducial Fiducials that represent geometric characteristics, such as center of rotation, and are derived from other fiducials.
112358 Information used for planning All parameters and data that were used for the planning activity
112359 Supporting Information A description of the plan as encapsulated PDF SOP Instance
112360 Implant Component List A list of all Implant Components selected for an implantation
112361 Patient Data Used During Planning Reference to objects containing patient data that is used for planning
112362 Degrees of Freedom Specification A specification of the values from one or more Degrees of Freedom
112363 Degree of Freedom ID ID of one Degree of Freedom
112364 Related Patient Data Not Used During Planning Reference to objects containing patient data that were not used for planning but are somehow related
112365 Related Implantation Reports Implantation Reports that are somehow related e.g. contemporaneous implantations that are independent
112366 Implant Assembly Template Implant Assembly Template
112367 Planning Information for Intraoperative Usage Information that is intended to be used intra-operatively
112368 Implantation Patient Positioning Position of the patient on the operating room table
112369 Fiducial Intent Intended use of the fiducial
112370 Component Type Type of an Implant Component
112371 Manufacturer Implant Template Implant Template released by the Manufacturer
112372 Derived Planning Images Images that are created by a planning application
112373 Other Derived Planning Data Data that is created by a planning application
112374 Connected Implantation Plan Component One Implant Component that is connected to another Implant Component
112375 Planning Method The method used for planning
112376 Degree of Freedom Exact Translational Value Defines the exact value that was planned for translation
112377 Degree of Freedom Minimum Translational Value Defines the minimum value that was planned for translation
112378 Degree of Freedom Maximum Translational Value Defines the maximum value that was planned for translation
112379 Degree of Freedom Exact Rotational Translation Value Defines the exact value that was planned for rotation
112380 Degree of Freedom Minimum Rotational Value Defines the minimum value that was planned for rotation
112381 Degree of Freedom Maximum Rotational Value Defines the maximum value that was planned for rotation
113000 Of Interest Of Interest
113001 Rejected for Quality Reasons Rejected for Quality Reasons
113002 For Referring Provider For Referring Provider
113003 For Surgery For Surgery
113004 For Teaching For Teaching
113005 For Conference For Conference
113006 For Therapy For Therapy
113007 For Patient For Patient
113008 For Peer Review For Peer Review
113009 For Research For Research
113010 Quality Issue Quality Issue
113011 Document Title Modifier Document Title Modifier
113012 Key Object Description Key Object Description
113013 Best In Set
113014 Study
113015 Series
113016 Performed Procedure Step
113017 Stage-View
113018 For Printing For Printing
113020 For Report Attachment Selection of information objects for attachment to the clinical report of the Current Requested Procedure
113026 Double exposure Double exposure
113030 Manifest A list of objects that have been exported out of one organizational domain into another domain. Typically, the first domain has no direct control over what the second domain will do with the objects.
113031 Signed Manifest A signed list of objects that have been exported out of one organizational domain into another domain, referenced securely with either Digital Signatures or MACs. Typically, the first domain has no direct control over what the second domain will do with the objects.
113032 Complete Study Content The list of objects that constitute a study at the time that the list was created.
113033 Signed Complete Study Content The signed list of objects that constitute a study at the time that the list was created, referenced securely with either Digital Signatures or MACs.
113034 Complete Acquisition Content The list of objects that were generated in a single procedure step.
113035 Signed Complete Acquisition Content The signed list of objects that were generated in a single procedure step, referenced securely with either Digital Signatures or MACs.
113036 Group of Frames for Display A list of frames or single-frame or entire multi-frame instances that together constitute a set for some purpose, such as might be displayed together in the same viewport, as distinct from another set that might be displayed in a separate viewport.
113037 Rejected for Patient Safety Reasons List of objects whose use is potentially harmful to the patient. For example, an improperly labeled image could lead to dangerous surgical decisions.
113040 Lossy Compression Lossy compression has been applied to an image.
113041 Apparent Diffusion Coefficient The image is derived by calculation of the apparent diffusion coefficient.
113042 Pixel by pixel addition The image is derived by the pixel by pixel addition of two images.
113043 Diffusion weighted The image is derived by calculation of the diffusion weighting.
113044 Diffusion Anisotropy The image is derived by calculation of the diffusion anisotropy.
113045 Diffusion Attenuated The image is derived by calculation of the diffusion attenuation.
113046 Pixel by pixel division The image is derived by the pixel by pixel division of two images.
113047 Pixel by pixel mask The image is derived by the pixel by pixel masking of one image by another.
113048 Pixel by pixel Maximum The image is derived by calculating the pixel by pixel maximum of two or more images.
113049 Pixel by pixel mean The image is derived by calculating the pixel by pixel mean of two or more images.
113050 Metabolite Maps from spectroscopy data The image is derived by calculating from spectroscopy data pixel values localized in two dimensional space based on the concentration of specific metabolites (i.e, at specific frequencies).
113051 Pixel by pixel Minimum The image is derived by calculating the pixel by pixel minimum of two or more images.
113052 Mean Transit Time The image is derived by calculating mean transit time values.
113053 Pixel by pixel multiplication The image is derived by the pixel by pixel multiplication of two images.
113054 Negative Enhancement Integral The image is derived by calculating negative enhancement integral values.
113055 Regional Cerebral Blood Flow The image is derived by calculating regional cerebral blood flow values.
113056 Regional Cerebral Blood Volume The image is derived by calculating regional cerebral blood volume values.
113057 R-Coefficient Map The image is derived by calculating R-Coefficient map values
113058 Proton Density map The image is derived by calculating proton density values.
113059 Signal Change Map The image is derived by calculating signal change values.
113060 Signal to Noise Map The image is derived by calculating the signal to noise ratio.
113061 Standard Deviation The image is derived by calculating the standard deviation of two or more images.
113062 Pixel by pixel subtraction The image is derived by the pixel by pixel subtraction of two images.
113063 T1 Map The image is derived by calculating T1 values.
113064 T2* Map The image is derived by calculating T2* values.
113065 T2 Map The image is derived by calculating T2 values.
113066 Time Course of Signal The image is derived by calculating values based on the time course of signal.
113067 Temperature encoded The image is derived by calculating values based on temperature encoding.
113068 Student’s T-Test The image is derived by calculating the value of the Student’s T-Test statistic from multiple image samples.
113069 Time To Peak map The image is derived by calculating values based on the time to peak.
113070 Velocity encoded The image is derived by calculating values based on velocity encoded (e.g., phase contrast).
113071 Z-Score Map The image is derived by calculating the value of the Z-Score statistic from multiple image samples.
113072 Multiplanar reformatting The image is derived by reformatting in a flat plane other than that originally acquired.
113073 Curved multiplanar reformatting The image is derived by reformatting in a curve plane other than that originally acquired.
113074 Volume rendering The image is derived by volume rendering of acquired data.
113075 Surface rendering The image is derived by surface rendering of acquired data.
113076 Segmentation The image is derived by segmentation (classification into tissue types) of acquired data.
113077 Volume editing The image is derived by selectively editing acquired data (removing values from the volume), such as in order to remove obscuring structures or noise.
113078 Maximum intensity projection The image is derived by maximum intensity projection of acquired data.
113079 Minimum intensity projection The image is derived by minimum intensity projection of acquired data.
113080 Glutamate and glutamine For single-proton MR spectroscopy, the resonance peak corresponding to glutamate and glutamine.
113081 Choline/Creatine Ratio For single-proton MR spectroscopy, the ratio between the Choline and Creatine resonance peaks.
113082 N-acetylaspartate /Creatine Ratio For single-proton MR spectroscopy, the ratio between the N-acetylaspartate and Creatine resonance peaks.
113083 N-acetylaspartate /Choline Ratio For single-proton MR spectroscopy, the ratio between the N-acetylaspartate and Choline resonance peaks.
113085 Spatial resampling The image is derived by spatial resampling of acquired data.
113086 Edge enhancement The image is derived by edge enhancement.
113087 Smoothing The image is derived by smoothing.
113088 Gaussian blur The image is derived by Gaussian blurring.
113089 Unsharp mask The image is derived by unsharp masking.
113090 Image stitching The image is derived by stitching two or more images together.
113091 Spatially-related frames extracted from the volume Spatially-related frames in this image are representative frames from the referenced 3D volume dataset
113092 Temporally-related frames extracted from the set of volumes Temporally-related frames in this image are representative frames from the referenced 3D volume dataset
113093 Polar to Rectangular Scan Conversion Conversion of a polar coordinate image to rectangular (Cartesian) coordinate image.
113094 Creatine and Choline For single-proton MR spectroscopy, the resonance peak corresponding to creatine and choline.
113095 Lipid and Lactate For single-proton MR spectroscopy, the resonance peak corresponding to lipid and lactate.
113096 Creatine+Choline/ Citrate Ratio For single-proton MR spectroscopy, the ratio between the Choline and Creatine resonance peak and the Citrate resonance peak.
113097 Multi-energy proportional weighting Image pixels created through proportional weighting of multiple acquisitions at distinct X-Ray energies.
113100 Basic Application Confidentiality Profile De-identification using a profile defined in PS 3.15 that requires removing all information related to the identity and demographic characteristics of the patient, any responsible parties or family members, any personnel involved in the procedure, the organizations involved in ordering or performing the procedure, additional information that could be used to match instances if given access to the originals, such as UIDs, dates and times, and private attributes, when that information is present in the non-Pixel Data Attributes, including graphics or overlays
113101 Clean Pixel Data Option Additional de-identification according to an option defined in PS 3.15 that requires any information burned in to the Pixel Data corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed.
113102 Clean Recognizable Visual Features Option Additional de-identification according to an option defined in PS 3.15 that requires that sufficient removal or distortion of the Pixel Data shall be applied to prevent recognition of an individual from the instances themselves or a reconstruction of a set of instances.
113103 Clean Graphics Option Additional de-identification according to an option defined in PS 3.15 that requires that any information encoded in graphics, text annotations or overlays corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed.
113104 Clean Structured Content Option Additional de-identification according to an option defined in PS 3.15 that requires that any information encoded in SR Content Items or Acquisition Context Sequence Items corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed.
113105 Clean Descriptors Option Additional de-identification according to an option defined in PS 3.15 that requires that any information that is embedded in text or string Attributes corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed.
113106 Retain Longitudinal Temporal Information With Full Dates Option Retention of information that would otherwise be removed during de-identification according to an option defined in PS 3.15 that requires that any dates and times be retained,
113107 Retain Longitudinal Temporal Information With Modified Dates Option Retention of information that would otherwise be removed during de-identification according to an option defined in PS 3.15 that requires that any dates and times be modified in a manner that preserves temporal relationships. E.g., Study Date and Time.
113108 Retain Patient Characteristics Option Retention of information that would otherwise be removed during de-identification according to an option defined in PS 3.15 that requires that any physical characteristics of the patient, which are descriptive rather than identifying information per se, be retained. E.g., Patient’s Age, Sex, Size (height) and Weight.
113109 Retain Device Identity Option Retention of information that would otherwise be removed during de-identification according to an option defined in PS 3.15 that requires that any information that identifies a device be retained. E.g., Device Serial Number.
113110 Retain UIDs Option Retention of information that would otherwise be removed during de-identification according to an option defined in PS 3.15 that requires that UIDs be retained. E.g., SOP Instance UID.
113111 Retain Safe Private Option Retention of information that would otherwise be removed during de-identification according to an option defined in PS 3.15 that requires that private attributes that are known not to contain identity information be retained. E.g., private SUV scale factor.
113601 Small: < 32.0 cm lateral thickness Small body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image.
113602 Medium: 32.038.0 cm lateral thickness Medium body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image.
113603 Large: > 38.0 cm lateral thickness Large body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image.
113611 Stationary Acquisition Acquisition where the X-Ray source does not move in relation to the patient
113612 Stepping Acquisition Acquisition where the X-Ray source moves laterally in relation to the patient
113613 Rotational Acquisition Acquisition where the X-Ray source moves angularly in relation to the patient
113620 Plane A Primary plane of a Biplane acquisition equipment
113621 Plane B Secondary plane of a Biplane acquisition equipment
113622 Single Plane Single plane acquisition equipment
113630 Continuous Continuous X-Ray radiation is applied during an irradiation event
113631 Pulsed Pulsed X-Ray radiation is applied during an irradiation event
113650 Strip filter Filter with uniform thickness
113651 Wedge filter Filter with variation in thickness from one edge to the opposite edge
113652 Butterfly filter Filter with two triangular sections
113661 Outline of lobulations A polyline defining the outline of a lobulated finding
113662 Inner limits of fuzzy margin A polyline defining the inner limits of a finding with fuzzy margin
113663 Outer limits of fuzzy margin A polyline defining the outer limits of a finding with fuzzy margin
113664 Outline of spiculations A polyline defining the outline of the spiculations of a finding
113665 Linear spiculation A polyline segment graphically indicating the location and direction of a spiculation of a finding
113666 Pixelated spiculations A collection of points indicating the pixel locations of the spiculations of a finding
113669 Orthogonal location arc Connected line segments indicating the center of location of a finding on an orthogonal view
113670 Orthogonal location arc inner margin Connected line segments indicating the inner margin of the location of a finding on an orthogonal view
113671 Orthogonal location arc outer margin Connected line segments indicating the outer location of a finding on an orthogonal view
113681 Phantom An artificial subject of an imaging study.
113682 ACR Accreditation Phantom - CT A phantom acceptable for the ACR Computed Tomography Accreditation program
113683 ACR Accreditation Phantom - MR A phantom acceptable for the ACR Magnetic Resonance Imaging Accreditation program
113684 ACR Accreditation Phantom - Mammography A phantom acceptable for the ACR Mammography Accreditation program
113685 ACR Accreditation Phantom – Stereotactic Breast Biopsy A phantom acceptable for the ACR Stereotactic Breast Biopsy Accreditation program
113686 ACR Accreditation Phantom - ECT A phantom acceptable for the ACR SPECT Accreditation program (but not for PET)
113687 ACR Accreditation Phantom - PET A phantom acceptable for the ACR PET Accreditation program (but not for SPECT)
113688 ACR Accreditation Phantom – ECT/PET A SPECT phantom with a PET faceplate acceptable for both the ACR SPECT and PET Accreditation programs
113689 ACR Accreditation Phantom – PET Faceplate A PET faceplate (made to fit an existing flangeless or flanged ECT phantom) acceptable for the ACR PET Accreditation program
113690 IEC Head Dosimetry Phantom A phantom used for CTDI measurement in head modes according to IEC 60601-2-44, Ed.2.1 (Head 16 cm diameter Polymethyl methacrylate PMMA)
113691 IEC Body Dosimetry Phantom A phantom used for CTDI measurement in body modes according to IEC 60601-2-44, Ed.2.1 (Body 32cm diameter Polymethyl methacrylate PMMA)
113692 NEMA XR21-2000 Phantom A phantom in accordance with NEMA standard XR-21-2000
113701 X-Ray Radiation Dose Report X-Ray Radiation Dose Report
113702 Accumulated X-Ray Dose Data X-Ray dose data accumulated over multiple irradiation events, e.g., for a study or a performed procedure step
113704 Projection X-Ray Imaging using a point X-Ray source with a diverging beam projected onto a 2 dimensional detector
113705 Scope of Accumulation Entity over which dose accumulation values are integrated
113706 Irradiation Event X-Ray Data X-Ray dose data for a single Irradiation Event
113710 Niobium or Niobium compound Material containing Niobium or a Niobium compound Retired. Replaced with (C-1190E, SRT, “Niobium or Niobium compound”)
113711 Europium or Europium compound Material containing Europium or a Europium compound Retired. Replaced with (C-1190F, SRT, “Europium or Europium compound”)
113721 Irradiation Event Type Denotes the type of irradiation event recorded
113722 Dose Area Product Total Total calculated Dose Area Product (in the scope of the including report)
113723 Calibration Date Last calibration Date for the integrated dose meter or dose calculation
113724 Calibration Responsible Party Individual or organization responsible for calibration
113725 Dose (RP) Total Total Dose related to Reference Point (RP). (in the scope of the including report)
113726 Fluoro Dose Area Product Total Total calculated Dose Area Product applied in Fluoroscopy Modes (in the scope of the including report).
113727 Acquisition Dose Area Product Total Total calculated Dose Area Product applied in Acquisition Modes (in the scope of the including report).
113728 Fluoro Dose (RP) Total Dose applied in Fluoroscopy Modes, related to Reference Point (RP). (in the scope of the including report)
113729 Acquisition Dose (RP) Total Dose applied in Acquisition Modes, related to Reference Point (RP). (in the scope of the including report)
113730 Total Fluoro Time Total accumulated time of Fluoroscopy (in the scope of the including report)
113731 Total Number of Radiographic Frames Accumulated Count of Frames (single or multi-frame) created from irradiation events performed with high dose (acquisition).
113732 Fluoro Mode Mode of application of X-Rays during Fluoroscopy
113733 KVP Applied X-Ray Tube voltage at peak of X-Ray generation, in kilovolts; Mean value if measured over multiple peaks (pulses)
113734 X-Ray Tube Current Mean value of applied Tube Current
113735 Exposure Time Cumulative time the patient has received X-Ray exposure during the irradiation event
113736 Exposure Mean value of X-Ray Current Time product
113737 Distance Source to Reference Point Distance to the Reference Point (RP) defined according to IEC 60601-2-43 or equipment defined.
113738 Dose (RP) Dose applied at the Reference Point (RP).
113739 Positioner Primary End Angle Positioner Primary Angle at the end of an irradiation event. For further definition see (112011,DCM,”Positioner Primary Angle”)
113740 Positioner Secondary End Angle Positioner Secondary Angle at the end of an irradiation event. For further definition see (112012,DCM,”Positioner Secondary Angle”)
113742 Irradiation Duration Clock time from the start of the first irradiation in the irradiation event until the end of the last irradiation in the same irradiation event. For continuous modes this the time the irradiation intensity is above a 50% threshold with respect to the maximum intensity achieved during an irradiation event.
113743 Patient Orientation Orientation of the Patient with respect to Gravity
113744 Patient Orientation Modifier Enhances or modifies the Patient orientation specified in Patient Orientation
113745 Patient Table Relationship Orientation of the Patient with respect to the Head of the Table
113748 Distance Source to Isocenter Distance from the X-Ray Source to the Equipment C-Arm Isocenter.(Center of Rotation).
113750 Distance Source to Detector Measured or calculated distance from the X-Ray source to the detector plane in the center of the beam.
113751 Table Longitudinal Position Table Longitudinal Position with respect to an arbitrary chosen reference by the equipment. Table motion towards LAO is positive assuming that the patient is positioned supine and its head is in normal position.
113752 Table Lateral Position Table Lateral Position with respect to an arbitrary chosen reference by the equipment. Table motion towards CRA is positive assuming that the patient is positioned supine and its head is in normal position.
113753 Table Height Position Table Height Position with respect to an arbitrary chosen reference by the equipment in (mm). Table motion downwards is positive
113754 Table Head Tilt Angle Angle of the head-feet axis of the table in degrees relative to the horizontal plane. Positive values indicate that the head of the table is upwards.
113755 Table Horizontal Rotation Angle Rotation of the table in the horizontal plane (clockwise when looking from above the table).
113756 Table Cradle Tilt Angle Angle of the left-right axis of the table in degrees relative to the horizontal plane. Positive values indicate that the left of the table is upwards.
113757 X-Ray Filter Material X-Ray absorbing material used in the filter.
113758 X-Ray Filter Thickness Minimum The minimum thickness of the X-Ray absorbing material used in the filters.
113763 Calibration Uncertainty Uncertainty of the ‘actual’ value.
113764 Acquisition Plane Identification of Acquisition Plane with Biplane systems.
113766 Focal Spot Size Nominal Size of Focal Spot of X-Ray Tube
113767 Average X-Ray Tube Current Average X-Ray Tube Current averaged over time for pulse or for continuous Fluoroscopy
113768 Number of Pulses Number of pulses applied by X-Ray systems during an irradiation event (acquisition run or pulsed fluoro)
113769 Irradiation Event UID Unique identification of a single irradiation event
113770 Column Angulation Angle of the X-Ray beam in degree relative to an orthogonal axis to the detector plane.
113771 X-Ray Filters Devices used to modify the energy or energy distribution of X-Rays
113772 X-Ray Filter Type Type of filter(s) inserted into the X-Ray beam (e.g. wedges).
113773 X-Ray Filter Thickness Maximum The maximum thickness of the X-Ray absorbing material used in the filters.
113780 Reference Point Definition System provided definition of the Reference Point used for Dose calculations.
113790 Collimated Field Area Collimated field area at image receptor. Area for compatibility with IEC 60601-2-43.
113791 Pulse Rate Pulse rate applied by equipment during Fluoroscopy
113792 Distance Source to Table Plane Measured or calculated distance from the X-Ray source to the table plane in the center of the beam.
113793 Pulse Width (Average) X-Ray pulse width
113794 Dose Measurement Device Calibrated device to perform dose measurements.
113795 Acquired Image Image acquired during a specified event.
113800 DLP to E conversion via MC computation Effective Dose evaluation from the product of Dose Length Product (DLP) and the Effective Dose Conversion Factor (E/DLP in units of mSv/mGy-cm), where the ratio is derived by means of Monte Carlo computations.
113801 CTDIfreeair to E conversion via MC computation Effective Dose evaluation from the product of the Mean CTDIfree air and the ratio E/CTDIfree air (mSv/mGy), where the ratio is derived by means of Monte Carlo computations
113802 DLP to E conversion via measurement Effective Dose evaluation from the product of Dose Length Product (DLP) and the Effective Dose Conversion Factor (E/DLP in units of mSv/mGy-cm), where the ratio is derived by means of dosimetric measurements with an anthropomorphic phantom
113803 CTDIfreeair to E conversion via measurement Effective Dose evaluation from the product of the Mean CTDIfree air and the ratio E/CTDIfree air (mSv/mGy), where the ratio is derived by means of dosimetric measurements with an anthropomorphic phantom
113804 Sequenced Acquisition The CT acquisition was performed by acquiring single or multi detector data while rotating the source about the gantry while the table is not moving. Additional slices are acquired by incrementing the table position and again rotating the source about the gantry while the table is not moving.
113805 Constant Angle Acquisition The CT acquisition was performed by holding the source at a constant angle and moving the table to obtain a projection image (e.g. localizer).
113806 Stationary Acquisition The CT acquisition was performed by holding the table at a constant position and acquiring multiple slices over time at the same location.
113807 Free Acquisition The CT acquisition was performed while rotating the source about the gantry while the table movement is under direct control of a human operator or under the control of an analysis application (e.g. fluoro).
113808 ICRP Pub 60 Reference authority 1990 Recommendations of the International Commission on Radiological Protection (ICRP Publication 60, published as the Annals of the ICRP Vol. 21, No. 1-3, Pergamon Press, 1991)
113809 Start of X-Ray Irradiation Start, DateTime of the first X-Ray Irradiation Event of the accumulation within a Study
113810 End of X-Ray Irradiation End, DateTime of the last X-Ray Irradiation Event of the accumulation within a Study
113811 CT Accumulated Dose Data X-Ray dose accumulated over multiple CT irradiation events, e.g., for a study or a performed procedure step.
113812 Total Number of Irradiation Events Total number of events during the defined scope of accumulation
113813 CT Dose Length Product Total The total dose length product defined scope of accumulation
113814 CT Effective Dose Total The total Effective Dose at the defined scope of accumulation
113815 Patient Model Identification of the reference-patient model used when Effective Dose is evaluated via Monte Carlo calculations or from a Dose Length Product conversion factor based on Monte Carlo calculations
113816 Condition Effective Dose measured References the physical phantom and the type of dosimeter used when measurements are done to establish Effective Dose Conversion Factors (E/DLP) or ratios E/CTDIfree air
113817 Effective Dose Phantom Type Type of Effective Dose phantom used
113818 Dosimeter Type Type of dosimeter used
113819 CT Acquisition General description of the CT Irradiation event
113820 CT Acquisition Type Method of the CT acquisition
113821 X-Ray Filter Aluminum Equivalent Thickness of an equivalent filter in mm in Aluminum
113822 CT Acquisition Parameters General description of the acquisition parameters
113823 Number of X-Ray Sources Number of X-Ray sources
113824 Exposure Time Total time the patient has received X-Ray exposure during the irradiation event
113825 Scanning Length Length of the table travel during the entire tube loading, according to IEC 60601-2-44 NOTE: Scanning Length might be longer than the programmed acquisition length (Length of Reconstructable Volume)
113826 Nominal Single Collimation Width The value of the nominal width referenced to the location of the isocenter along the z axis of a single row of acquired data in mm
113827 Nominal Total Collimation Width The value of the nominal width referenced to the location of the isocenter along the z axis of the total collimation in mm over the area of active X-Ray detection
113828 Pitch Factor For Spiral scanning: Pitch Factor = (Table Feed per Rotation (mm))/(Nominal Total Collimation Width (mm)) For Sequenced scanning: Pitch Factor = (Table Feed per single Sequenced scan (mm))/(Nominal Total Collimation Width (mm))
113829 CT Dose General description of CT dose values
113830 Mean CTDIvol “Mean CTDIvol” refers to the average value of the CTDIvol associated with this acquisition.
113831 CT X-Ray Source Parameters Identification, tube-potential, tube-current, and exposure-time parameters associated with an X-Ray source during an acquisition.
113832 Identification of the X-Ray Source Identifies the particular X-Ray source (in a multi-source CT system) for which the set of X-Ray source parameter values is reported.
113833 Maximum X-Ray Tube Current Maximum X-Ray tube current
113834 Exposure Time per Rotation The exposure time for one rotation of the source around the object in s
113835 CTDIw Phantom Type A label describing the type of phantom used for CTDIW measurement according to IEC 60601-2-44 (Head 16 cm diameter PMMA, Body 32 cm diameter PMMA)
113836 CTDIfreeair Calculation Factor The CTDIfree air Calculation Factor is the CTDIfree air per mAs, expressed in units of mGy/mAs. The CTDIfree air Calculation Factor may be used in one method calculating Dose.
113837 Mean CTDIfreeair The average value of the free-in-air CTDI associated with this acquisition.
113838 DLP Dose Length Product (DLP), expressed in mGy-cm, is an index characterizing the product of the CTDIvol and the length scanned. For Spiral scanning, DLP = CTDIvol ( Scanning Length. For Sequenced scanning, DLP = CTDIvol ( Nominal Total Collimation Width ( Cumulative Exposure Time / Exposure Time per Rotation. For Stationary and Free scanning, DLP = CTDIvol ( Nominal Total Collimation Width.
113839 Effective Dose Effective dose in mSv
113840 Effective Dose Conversion Factor Effective Dose per DLP, reference value for Effective Dose calculation, expressed in mSv/mGycm
113841 ICRP Pub 103 Effective Dose Reference authority 2007 Recommendations of the International Commission on Radiological Protection (ICRP Publication 103, published as the Annals of the ICRP Vol. 37, No. 2-4, Elsevier, 2007)
113842 X-Ray Modulation Type The type of exposure modulation used for the purpose of limiting the dose.
113845 Exposure Index Measure of the detector response to radiation in the relevant image region of an image acquired with a digital x-ray imaging system as defined in IEC 62494-1; see PS 3.3 definition of Exposure Index Macro.
113846 Target Exposure Index The target value used to calculate the Deviation Index as defined in IEC 62494-1; see PS 3.3 definition of Exposure Index Macro.
113847 Deviation Index A scaled representation of the accuracy of the Exposure Index compared to the Target Exposure Index as defined in IEC 62494-1; see PS 3.3 definition of Exposure Index Macro.
113850 Irradiation Authorizing The clinician responsible for determining that the irradiating procedure was ap propriate for the indications
113851 Irradiation Administering The person responsible for the administration of radiation
113852 Irradiation Event An irradiation event is the occurrence of radiation being applied to a patient in a single continuous time-frame between the start (release) and the stop (cease) of the irradiation. Any automatic on-off switching of the irradiation source during the event is not treated as separate events, rather the event includes the time between start and stop of irradiation as triggered by the user. E.g., a pulsed fluoro X-Ray acquisition shall be treated as a single irradiation event.
113853 Irradiation Event UID Unique Identifier of an Irradiation Event
113854 Source of Dose Information Method by which dose-related details of an Irradiation Event were obtained.
113855 Total Acquisition Time Total accumulated acquisition time (in the scope of the including report)
113856 Automated Data Collection Direct recording of data by a relevant system
113857 Manual Entry Recording of data by a human operator, including manual transcription of electronic data
113858 MPPS Content The data is taken from an MPPS SOP Instance
113859 Irradiating Device A device exposing a patient to ionizing radiation.
113860 15cm from Isocenter toward Source 15cm from the isocenter towards the X-Ray source; See IEC 60601-2-43
113861 30cm in Front of Image Input Surface 30cm in front (towards the tube) of the input surface of the image receptor; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d)(7)
113862 1cm above Tabletop 1cm above the patient tabletop or cradle; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d)(7)
113863 30cm above Tabletop 30cm above the patient tabletop of cradle; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d)(7)
113864 15cm from Table Centerline 15cm from the centerline of the X-Ray table and in the direction of the X-Ray source; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d)(7)
113865 Entrance exposure to a 4.2 cm breast thickness Standard breast means a 4.2 centimeter (cm) thick compressed breast consisting of 50 percent glandular and 50 percent adipose tissue. See Department of Health and Human Services, Food and Drug Administration. Mammography quality standards; final rule. Federal Register. Oct. 28, 1997; 68(208):55852–55994. See 900.2(uu)
113866 Copied From Image Attributes The data is copied from information present in the image attributes, e.g., dose attributes such as CTDIvol (0018,9345)
113867 Computed From Image Attributes The data is computed from information present in the image attributes, e.g., by using dosimetry information for the specific irradiating device make and model, applied to technique information such as KVP and mAs
113868 Derived From Human-Readable Reports The data is derived from human-readable reports, e.g., by natural language parsing of text reports, or optical character recognition from reports saved as images by the irradiating device
113870 Person Name The name of a specific person
113871 Person ID An identification number or code for a specific person
113872 Person ID Issuer The organization which issued a Person ID
113873 Organization Name The name of an organization
113874 Person Role in Organization The role played by a person in an organization
113875 Person Role in Procedure The role played by a person in a procedure
113876 Device Role in Procedure The role played by a device in a procedure
113877 Device Name The name used to refer to a device; usually locally unique
113878 Device Manufacturer Manufacturer of a device
113879 Device Model Name Model Name of a device
113880 Device Serial Number Serial Number of a device
113890 All Planes All planes of a multi-plane acquisition equipment
113893 Length of Reconstructable Volume The length from which images may be reconstructed (i.e., excluding any overranging performed in a spiral acquisition that is required for data interpolation). Value is distinct from (1113825, DCM,”Scanning Length”), which is the actual length of the table travel during the entire tube loading, according to IEC 60601-2-44, and includes overranging. Also distinct from any actual Reconstructed Volume, which may depend on the slice thickness chosen for a particular reconstruction.
113895 Top Z Location of Reconstructable Volume The Z location that is the top (highest Z value) of the Reconstructable Volume. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference.
113896 Bottom Z Location of Reconstructable Volume The Z location that is the bottom (lowest Z value) of the Reconstructable Volume. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference.
113897 Top Z Location of Scanning Length The Z location that is the top (highest Z value) of the scanning length. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference.
113898 Bottom Z Location of Scanning Length The Z location that is the bottom (lowest Z value) of the scanning length. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference.
113899 Exposed Range The range along the z axis of the total volume irradiated, per IEC 60601-2-44, Ed. 3, 203.115(b). The start and stop of loading corresponding to the outer edge of the full width half maximum of the free-in-air dose profile for the beam collimation used.
114000 Not a number Measurement not available: Not a number (per IEEE 754)
114001 Negative Infinity Measurement not available: Negative Infinity (per IEEE 754)
114002 Positive Infinity Measurement not available: Positive Infinity (per IEEE 754)
114003 Divide by zero Measurement not available: Divide by zero (per IEEE 754)
114004 Underflow Measurement not available: Underflow (per IEEE 754)
114005 Overflow Measurement not available: Overflow (per IEEE 754)
114006 Measurement failure Measurement not available: Measurement failure
114007 Measurement not attempted Measurement not available: Measurement not attempted
114008 Calculation failure Measurement not available: Calculation failure
114009 Value out of range Measurement not available: Value out of range
114010 Value unknown Measurement not available: Value unknown
114011 Value indeterminate Measurement not available: Value indeterminate
121001 Quotation Mode Type of source for observations quoted from an external source
121002 Quoted Source Reference to external source of quoted observations
121003 Document Documentary source of quoted observations
121004 Verbal Verbal source of quoted observations
121005 Observer Type Type of observer that created the observations
121006 Person Human observer created the observations
121007 Device Automated device created the observations
121008 Person Observer Name Name of human observer that created the observations
121009 Person Observer’s Organization Name Organization or institution with which the human observer is affiliated for the context of the current observation
121010 Person Observer’s Role in the Organization Organizational role of human observer for the context of the current observation
121011 Person Observer’s Role in this Procedure Procedural role of human observer for the context of the current observation
121012 Device Observer UID Unique identifier of automated device that created the observations
121013 Device Observer Name Institution-provided identifier of automated device that created the observations
121014 Device Observer Manufacturer Manufacturer of automated device that created the observations
121015 Device Observer Model Name Manufacturer-provided model name of automated device that created the observations
121016 Device Observer Serial Number Manufacturer-provided serial number of automated device that created the observations
121017 Device Observer Physical Location During Observation Location of automated device that created the observations whilst the observations were being made.
121018 Procedure Study Instance UID Unique identifier for the Study or Requested Procedure
121019 Procedure Study Component UID Unique identifier for the Performed Procedure Step
121020 Placer Number Identifier for the Order (or Service Request) assigned by the order placer system
121021 Filler Number Identifier for the Order (or Service Request) assigned by the order filler system
121022 Accession Number Identifier for the Order (or Service Request) assigned by the department information system
121023 Procedure Code Type of procedure scheduled or performed
121024 Subject Class Type of observation subject
121025 Patient A patient is the subject of observations
121026 Fetus Fetus of patient is the subject of observations
121027 Specimen Specimen is the subject of observations
121028 Subject UID Unique Identifier of patient or fetus who is the subject of observations
121029 Subject Name Name of patient who is the subject of observations
121030 Subject ID Identifier of patient or fetus who is the subject of observations
121031 Subject Birth Date Birth Date of patient who is the subject of observations
121032 Subject Sex Sex of patient who is the subject of observations
121033 Subject Age Age of patient who is the subject of observations
121034 Subject Species Species of patient who is the subject of observations
121035 Subject Breed The breed of the subject
121036 Mother of fetus Name of mother of fetus which is the subject of observations
121037 Fetus number Retired. Replaced with (11951-1,LN, "Fetus ID”).
121038 Number of Fetuses Retired. Replaced with (11878-6,LN, "Number of Fetuses”).
121039 Specimen UID Unique Identifier of specimen which is the subject of observations
121040 Specimen Accession Number Accession Number of specimen which is the subject of observations Retired.
121041 Specimen Identifier Identifier of specimen which is the subject of observations
121042 Specimen Type Coded category of specimen which is the subject of observations Retired. Replaced with (R-00254, SRT, “Specimen Type”)
121043 Slide Identifier Identifier of specimen microscope slide which is the subject of observations Retired. Replaced with (111700, DCM, Specimen Container Identifier)
121044 Slide UID Unique Identifier of specimen microscope slide which is the subject of observations Retired.
121045 Language
121046 Country of Language
121047 Language of Value
121048 Language of Name and Value
121049 Language of Content Item and Descendants
121050 Equivalent Meaning of Concept Name
121051 Equivalent Meaning of Value
121052 Presence of property
121053 Present Retired. Replaced with (G A203, SRT, “Present”)
121054 Absent Retired. Replaced with (R 4089B, SRT, “Absent”)
121055 Path A set of points on an image, that when connected by line segments, provide a polyline from which a linear measurement was inferred
121056 Area outline A set of points on an image, that when connected by line segments, provide a closed polyline that is the border of a defined region from which an area, or two-dimensional measurement, was inferred
121057 Perimeter outline A set of points on an image, that when connected by line segments, provide a closed polyline that is a two-dimensional border of a three-dimensional region’s intersection with, or projection into the image
121058 Procedure reported
121059 Presence Undetermined Presence or absence of a property is undetermined Retired. Replaced with (R 4089B, SRT, “Undetermined”)
121060 History
121062 Request
121064 Current Procedure Descriptions
121065 Procedure Description
121066 Prior Procedure Descriptions
121068 Previous Findings
121069 Previous Finding
121070 Findings
121071 Finding
121072 Impressions
121073 Impression
121074 Recommendations
121075 Recommendation
121076 Conclusions
121077 Conclusion
121078 Addendum
121079 Baseline
121080 Best illustration of finding
121081 Physician
121082 Nurse
121083 Technologist
121084 Radiographer
121085 Intern
121086 Resident
121087 Registrar
121088 Fellow
121089 Attending [Consultant]
121090 Scrub nurse
121091 Surgeon
121092 Sonologist
121093 Sonographer
121094 Performing
121095 Referring
121096 Requesting
121097 Recording
121098 Verifying
121099 Assisting
121100 Circulating
121101 Standby
121102 Other sex Other sex
121103 Undetermined sex Sex of subject undetermined at time of encoding
121104 Ambiguous sex Ambiguous sex
121105 Radiation Physicist Radiation Physicist
121106 Comment Comment
121109 Indications for Procedure Indications for Procedure
121110 Patient Presentation Patient condition at the beginning of a healthcare encounter
121111 Summary Summary of a procedure, including most significant findings
121112 Source of measurement Image or waveform used as source for measurement
121113 Complications Complications from a procedure
121114 Performing Physician Physician who performed a procedure
121115 Discharge Summary Summary of patient condition upon Discharge from a healthcare facility
121116 Proximal Finding Site Proximal Anatomic Location for a differential measurement (e.g., distance or pressure gradient); may be considered subtype of term (G-C0E3, SRT, “Finding Site”)
121117 Distal Finding Site Distal Anatomic Location for a differential measurement (e.g., distance or pressure gradient); may be considered subtype of term (G-C0E3, SRT, “Finding Site”)
121118 Patient Characteristics Patient Characteristics (findings)
121120 Cath Lab Procedure Log Time-stamped record of events that occur during a catheterization procedure
121121 Room identification Room identification
121122 Equipment identification Equipment identification
121123 Patient Status or Event A recorded Patient Status or an event involving a patient
121124 Procedure Action Item ID Identification of a step, action, or phase of a procedure
121125 DateTime of Recording of Log Entry DateTime of Recording of an Entry in an Event Log
121126 Performed Procedure Step SOP Instance UID SOP Instance UID of a DICOM Modality Performed Procedure Step (MPPS) or General Purpose Performed Procedure Step (GPPPS)
121127 Performed Procedure Step SOP Class UID SOP Class UID for a DICOM Modality Performed Procedure Step (MPPS) or General Purpose Performed Procedure Step (GPPPS) Service
121128 Procedure Action Duration Duration of a step, action, or phase of a procedure
121130 Start Procedure Action Item Beginning of a step, action, or phase of a procedure
121131 End Procedure Action Item End of a step, action, or phase of a procedure
121132 Suspend Procedure Action Item Suspension of a step, action, or phase of a procedure
121133 Resume Procedure Action Item Resumption of a step, action, or phase of a procedure
121135 Observation DateTime Qualifier Concept modifier for the DateTime of Recording of an Entry in an Event Log
121136 DateTime Unsynchronized Recorded DateTime had its source in a system clock not synchronized to other recorded DateTimes
121137 DateTime Estimated Recorded DateTime is estimated
121138 Image Acquired Event of the acquisition of an image
121139 Modality Type of data acquisition device
121140 Number of Frames Number of Frames in a multi-frame image
121141 Image Type Descriptor of an Image
121142 Acquisition Duration Duration of the acquisition of an image or a waveform
121143 Waveform Acquired Event of the acquisition of an image
121144 Document Title Document Title
121145 Description of Material Description of Material used in a procedure
121146 Quantity of Material Quantity of Material used in a procedure
121147 Billing Code Billing Code for materials used in a procedure
121148 Unit Serial Identifier Unit or Device Serial Identifier
121149 Lot Identifier Lot Identifier
121150 Device Code Vendor or local coded value identifying a device
121151 Lesion Identifier Identification of a Lesion observed during an imaging procedure
121152 Person administering drug/contrast Person administering drug/contrast
121153 Lesion Risk Assessment of the risk a coronary lesion presents to the health of a patient
121154 Intervention attempt identifier Identifier for an attempted Intervention
121155 Deployment Use of a device to deploy another device
121156 Percutaneous Entry Action Action of a clinical professional at the site of percutaneous access to a patient’s cardiovascular system
121157 Begin Circulatory Support The action or event of beginning circulatory support for a patient
121158 End Circulatory Support The action or event of ending circulatory support for a patient
121160 Oxygen Administration Rate Rate of Oxygen Administration
121161 Begin Oxygen Administration The action or event of beginning administration of oxygen to a patient
121162 End oxygen administration The action or event of ending administration of oxygen to a patient
121163 By ventilator Method of administration of oxygen to a patient by ventilator
121165 Patient Assessment Performed The action or event of assessing the clinical status of a patient
121166 Begin Pacing The action or event of beginning pacing support for a patient
121167 End Pacing The action or event of ending pacing support for a patient
121168 Begin Ventilation The action or event of beginning ventilation support for a patient
121169 End Ventilation The action or event of ending ventilation support for a patient
121171 Tech Note Procedural note originated by a technologist
121172 Nursing Note Procedural note originated by a nurse
121173 Physician Note Procedural note originated by a Physician
121174 Procedure Note General procedural note
121180 Key Images List of references to images considered significant
121181 DICOM Object Catalog List of references to DICOM SOP Instances
121190 Referenced Frames Individual frames selected as a subset of a multi-frame image
121191 Referenced Segment Segment selected as a subset of a segmentation image, specifically the pixels/voxels identified as belonging to the classification of the identified segment
121192 Device Subject A device is the subject of observations
121193 Device Subject Name Name or other identifier of a device that is the subject of observations
121194 Device Subject Manufacturer Manufacturer of a device that is the subject of observations
121195 Device Subject Model Name Model Name of a device that is the subject of observations
121196 Device Subject Serial Number Serial Number of a device that is the subject of observations
121197 Device Subject Physical Location during observation Physical Location of a device that is the subject of observations during those observations
121198 Device Subject UID Unique Identifier of a device that is the subject of observations
121200 Illustration of ROI Illustration of a region of interest
121201 Area Outline Retired. Duplicate of (121056, DCM, “Area Outline”) and not used.
121202 Area of Defined Region Retired. Replaced with (G-A16A, SRT, “Area of defined region”).
121206 Distance A one dimensional, or linear, numeric measurement
121207 Height Vertical measurement value
121208 Inter-Marker Distance Distance between marks on a device of calibrated size (e.g., a ruler)
121210 Path Retired. Duplicate of (121055, DCM, “Path”) and not used.
121211 Path length A one dimensional, or linear, numeric measurement along a polyline
121213 Perimeter Outline Retired. Duplicate of (121057, DCM, “Perimeter Outline”) and not used.
121214 Referenced Segmentation Frame Frame selected from a segmentation image, specifically the pixels/voxels identified as belonging to the classification of the segment encompassing the identified frame
121216 Volume estimated from single 2D region A three-dimensional numeric measurement that is approximate, based on a two-dimensional region in a single image
121217 Volume estimated from three or more non-coplanar 2D regions A three-dimensional numeric measurement that is approximate, based on three or more non-coplanar two-dimensional image regions
121218 Volume estimated from two non-coplanar 2D regions A three-dimensional numeric measurement that is approximate, based on two non-coplanar two-dimensional image regions
121219 Volume of bounding three dimensional region A three-dimensional numeric measurement of the bounding region of a three-dimensional region of interest in an image set
121220 Volume of circumscribed sphere A three-dimensional numeric measurement of the bounding sphere of a three-dimensional region of interest in an image set
121221 Volume of ellipsoid A three-dimensional numeric measurement of an ellipsoid shaped three-dimensional region of interest in an image set
121222 Volume of sphere A three-dimensional numeric measurement of a sphere shaped three-dimensional region of interest in an image set
121230 Path Vertex Coordinates of a point on a defined path
121242 Distance from nipple Indicates the location of the area of interest as measured from the nipple of the breast.
121243 Distance from skin Indicates the location of the area of interest as measured from the most direct skin point of the breast.
121244 Distance from chest wall Indicates the location of the area of interest as measured from the chest wall.
121301 Simultaneous Doppler
121302 Simultaneous Hemodynamic
121303 Simultaneous ECG
121304 Simultaneous Voice Narrative
121305 Simultaneous Respiratory Waveform A waveform representing chest expansion and contraction due to respiratory activity, measured simultaneously with the acquisition of this Image.
121306 Simultaneous Arterial Pulse Waveform Arterial pulse waveform obtained simultaneously with acquisition of a referencing image
121307 Simultaneous Phonocardiographic Waveform Phonocardiographic waveform obtained simultaneously with acquisition of a referencing image
121311 Localizer Image providing an anatomical reference on the patient under examination, for the purpose of defining the location of the ensuing imaging.
121312 Biopsy localizer Image providing an anatomical reference on the patient under examination, for the purpose of planning or documenting a biopsy.
121313 Other partial views Image providing a partial view of the target anatomy, when the target anatomy is too large for a single image.
121314 Other image of biplane pair Image providing a view of the target anatomy in a different imaging plane, typically from a near perpendicular angle
121315 Other image of stereoscopic pair Image providing a view of the target anatomy in a different imaging plane, typically with a small anglular difference
121316 Images related to standalone object Image related to a non-image information object
121317 Spectroscopy Image where signals are identified and separated according to their frequencies, e.g., to identify individual chemicals, or individual nuclei in a chemical compound.
121320 Uncompressed predecessor An image that has not already been lossy compressed that is used as the source for creation of a lossy compressed image
121321 Mask image for image processing operation Image used as the mask for an image processing operation, such as subtraction
121322 Source image for image processing operation Image used as the source for an image processing operation
121324 Source Image Image used as the source for a derived or compressed image
121325 Lossy compressed image Image encoded with a lossy compression transfer syntax
121326 Alternate SOP Class instance SOP Instance encoded with a different SOP Class but otherwise equivalent data
121327 Full fidelity image Full fidelity image, uncompressed or lossless compressed
121328 Alternate Photometric Interpretation image Image encoded with a different photometric interpretation
121329 Source image for montage Image used as a source for a montage (stitched) image
121330 Lossy compressed predecessor An image that has previously been lossy compressed that is used as the source for creation of another lossy compressed image
121331 Equivalent CDA Document HL7 Document Architecture (CDA) Document that contains clinical content equivalent to the referencing Instance
121332 Complete Rendering for Presentation Instance that contains a displayable complete rendering of the referencing Instance
121333 Partial Rendering for Presentation Instance that contains a displayable partial rendering of the referencing Instance
121334 Extended Rendering for Presentation Instance that contains a displayable complete rendering of the referencing Instance, plus additional content such as inline rendering of referenced images
121335 Source Document Document whose content has been wholly or partially transformed to create the referencing document
121338 Anatomic image Image showing structural anatomic features
121339 Functional image Image showing physical or chemical activity
121340 Spectral filtered image Image providing the same view of the target anatomy acquired using only a specific imaging wavelength, frequency or energy
121341 Device localizer Image providing an anatomical reference on the patient under examination, for the purpose of documenting the location of device such as a diagnostic or therapeutic catheter.
121342 Dose Image Image providing a graphic view of the distribution of radiation dose
121346 Acquisition frames corresponding to volume The referenced image is the source of spatially-related frames from which the referencing 3D volume dataset was derived
121347 Volume corresponding to spatially-related acquisition frames 3D Volume containing the spatially-related frames in the referencing instance
121348 Temporal Predecessor Instance acquired prior to the referencing instance in a set of consecutively acquired instances
121349 Temporal Successor Instance acquired subsequent to the referencing instance in a set of consecutively acquired instances
121350 Same acquisition at lower resolution Image of the same target area at lower resolution acquired in the same acquisition process
121351 Same acquisition at higher resolution Image of the same target area at higher resolution acquired in the same acquisition process
121352 Same acquisition at different focal depth Image of the same target area at different focal depth (Z-plane) acquired in the same acquisition process
121353 Same acquisition at different spectral band Image of the same target area at different spectral band acquired in the same acquisition process
121354 Imaged container label Image specifically targeting the container label
121358 For Processing predecessor Source image from which FOR PRESENTATION images were created.
121360 Replaced report The reference is to a predecessor report that has been replaced by the current report
121361 Addended report The reference is to a predecessor report to which the current report provides and addendum
121362 Preliminary report A report that precedes the final report and may contain only limited information; it may be time sensitive, and it is not expected to contain all the reportable findings
121363 Partial report A report that is not complete.
121380 Active Ingredient Undiluted Concentration Concentration of the chemically or physically interesting (active) ingredient of a drug or contrast agent as delivered in product form from the manufacturer, typically in mg/ml.
121381 Contrast/Bolus Ingredient Opaque X-Ray absorption of the active ingredient of a contrast agent ingredient is greater than the absorption of water (tissue).
121382 Quantity administered Number of units of substance (e.g., tablets) administered to a patient
121383 Mass administered Mass of substance administered to a patient
121401 Derivation Method of deriving or calculating a measured value (e.g., mean, or maximum of set)
121402 Normality Assessment of a measurement relative to a normal range of values; may be considered subtype of term (G-C0F2, SRT, “has interpretation”)
121403 Level of Significance Significance of a measurement
121404 Selection Status Status of selection of a measurement for further processing or use
121405 Population description Description of a population of measurements
121406 Reference Authority Bibliographic or clinical reference for a Description of a population of measurements
121407 Normal Range description Description of a normal range of values for a measurement concept
121408 Normal Range Authority Bibliographic or clinical reference for a Description of a normal range of values
121410 User chosen value Observation value selected by user for further processing or use, or as most representative
121411 Most recent value chosen Observation value is the recently obtained, and has been selected for further processing or use
121412 Mean value chosen Observation value is the mean of several measurements, and has been selected for further processing or use
121414 Standard deviation of population Standard deviation of a measurement in a reference population
121415 Percentile Ranking of measurement Percentile Ranking of an observation value with respect a reference population
121416 Z-Score of measurement Z-score of an observation value with respect a reference population, expressed as the dimensionless quantity (x-m)/s, where (x-m) is the deviation of the observation value (x) from the population mean (m), and s is the standard deviation of the population.
121417 2 Sigma deviation of population 2 Sigma deviation of a measurement in a reference population
121420 Equation Formula used to compute a derived measurement
121421 Equation Citation Bibliographic reference to a formula used to compute a derived measurement; reference may be to a specific equation in a journal article
121422 Table of Values Citation Bibliographic reference to a Table of Values used to look up a derived measurement
121423 Method Citation Bibliographic reference to a method used to compute a derived measurement
121424 Table of Values A Table of Values used to look up a derived measurement
121425 Index Factor (divisor or multiplicand) for normalizing a measurement; e.g., body surface area used for normalizing hemodynamic measurements
121427 Estimated Measurement obtained by observer estimation, rather than with a measurement tool or by calculation Retired. Replaced with (R 10260, SRT, “Estimated”)
121428 Calculated Measurement obtained by calculation Retired. Replaced with (R 41D2D, SRT, “Calculated”)
121430 Concern Identified issue about a state or process that has the potential to require intervention or management
121431 DateTime Concern Noted DateTime concern noted (noted by whom is determined by context of use)
121432 DateTime Concern Resolved DateTime the concern was resolved
121433 DateTime Problem Resolved DateTime the problem was resolved
121434 Service Delivery Location Place at which healthcare services may be provided
121435 Service Performer Identification of a healthcare provider who performed a healthcare service; may be either a person or an organization
121436 Medical Device Used Type or identifier of a medical device used on, in, or by a patient
121437 Pharmacologic and exercise stress test Cardiac stress test using pharmacologic and exercise stressors Retired. Replaced by (P2-31011, SRT, "Pharmacologic and exercise stress test”)
121438 Paced stress test Cardiac stress test using an implanted or external cardiac pacing device Retired. Replaced by (P2-3110B, SRT, "Stress test using cardiac pacing”)
121439 Correction of congenital cardiovascular deformity Procedure for correction of congenital cardiovascular deformity Retired. Replaced by (P1-080B4, SRT, “Correction of congenital cardiovascular deformity”)
121701 RT Patient Setup Process of placing patient in the anticipated treatment position, including specification and location of positioning aids, and other treatment delivery accessories
121702 RT Patient Position Acquisition, single plane MV Acquisition of patient positioning information prior to treatment delivery, using single-plane megavoltage imaging
121703 RT Patient Position Acquisition, dual plane MV Acquisition of patient positioning information prior to treatment delivery, using dual-plane megavoltage imaging
121704 RT Patient Position Acquisition, single plane kV Acquisition of patient positioning information prior to treatment delivery, using single-plane kilovoltage imaging
121705 RT Patient Position Acquisition, dual plane kV Acquisition of patient positioning information prior to treatment delivery, using dual-plane kilovoltage imaging
121706 RT Patient Position Acquisition, dual plane kV/MV Acquisition of patient positioning information prior to treatment delivery, using dual-plane combination kilovoltage and megavoltage imaging
121707 RT Patient Position Acquisition, CT kV Acquisition of patient positioning information prior to treatment delivery, using kilovoltage CT imaging
121708 RT Patient Position Acquisition, CT MV Acquisition of patient positioning information prior to treatment delivery, using megavoltage CT imaging
121709 RT Patient Position Acquisition, Optical Acquisition of patient positioning information prior to treatment delivery, using optical imaging
121710 RT Patient Position Acquisition, Ultrasound Acquisition of patient positioning information prior to treatment delivery, using ultrasound imaging
121711 RT Patient Position Acquisition, Spatial Fiducials Acquisition of patient positioning information prior to treatment delivery, using spatial fiducials
121712 RT Patient Position Registration, single plane Registration of intended and actual patient position prior to treatment delivery, using single-plane images
121713 RT Patient Position Registration, dual plane Registration of intended and actual patient position prior to treatment delivery, using dual-plane images
121714 RT Patient Position Registration, 3D CT general Registration of intended and actual patient position prior to treatment delivery, using 3D CT images and an unspecified registration approach
121715 RT Patient Position Registration, 3D CT marker-based Registration of intended and actual patient position prior to treatment delivery, using 3D CT images and a marker-based registration approach
121716 RT Patient Position Registration, 3D CT volume-based Registration of intended and actual patient position prior to treatment delivery, using 3D CT images and a volume-based registration approach
121717 RT Patient Position Registration, 3D on 2D reference Registration of intended and actual patient position prior to treatment delivery, using 3D verification images and 2D reference images
121718 RT Patient Position Registration, 2D on 3D reference Registration of intended and actual patient position prior to treatment delivery, using 2D verification images and 3D reference images
121719 RT Patient Position Registration, Optical Registration of intended and actual patient position prior to treatment delivery, using optical images
121720 RT Patient Position Registration, Ultrasound Registration of intended and actual patient position prior to treatment delivery, using ultrasound images
121721 RT Patient Position Registration, Spatial Fiducials Registration of intended and actual patient position prior to treatment delivery, using spatial fiducials
121722 RT Patient Position Adjustment Adjustment of patient position such that the patient is correctly positioned for treatment.
121723 RT Patient Position In-treatment-session Review Review of patient positioning information in the process of delivering a treatment session
121724 RT Treatment Simulation with Internal Verification Simulated radiotherapy treatment delivery using verification integral to the Treatment Delivery System
121725 RT Treatment Simulation with External Verification Simulated radiotherapy treatment delivery using verification by a external Machine Parameter Verifier
121726 RT Treatment with Internal Verification Radiotherapy treatment delivery using verification integral to the Treatment Delivery System
121727 RT Treatment with External Verification Radiotherapy treatment delivery using verification by a external Machine Parameter Verifier
121728 RT Treatment QA with Internal Verification Quality assurance of a radiotherapy treatment delivery using verification integral to the Treatment Delivery System
121729 RT Treatment QA with External Verification Quality assurance of a radiotherapy treatment delivery using verification by a external Machine Parameter Verifier
121730 RT Machine QA Quality assurance of a Treatment Delivery Device
122001 Patient called to procedure room Patient called to procedure room
122002 Patient admitted to procedure room Patient admitted to procedure room
122003 Patient given pre-procedure instruction Patient given pre-procedure instruction
122004 Patient informed consent given Patient informed consent given
122005 Patient advance directive given Patient advance directive given
122006 Nil Per Os (NPO) status confirmed Nil Per Os (NPO) status confirmed
122007 Patient assisted to table Patient assisted to table
122008 Patient prepped and draped Patient prepped and draped
122009 Patient connected to continuous monitoring Patient connected to continuous monitoring
122010 Patient transferred to holding area Patient transferred to holding area
122011 Patient transferred to surgery Patient transferred to surgery
122012 Patient transferred to CCU Patient transferred to CCU
122020 Patient disoriented Patient disoriented
122021 Patient reports nausea Patient reports nausea
122022 Patient reports discomfort Patient reports discomfort
122023 Patient reports chest pain Patient reports chest pain
122024 Patient reports no pain Patient reports no pain
122025 Patient alert Patient alert
122026 Patient restless Patient restless
122027 Patient sedated Patient sedated
122028 Patient asleep Patient asleep
122029 Patient unresponsive Patient unresponsive
122030 Patient has respiratory difficulty Patient has respiratory difficulty
122031 Patient coughed Patient coughed
122032 Patient disconnected from continuous monitoring Patient disconnected from continuous monitoring
122033 Hemostasis achieved Hemostasis achieved
122034 Hemostasis not achieved – oozing Hemostasis not achieved – oozing
122035 Hemostasis not achieved – actively bleeding Hemostasis not achieved – actively bleeding
122036 Patient given post-procedure instruction Patient given post-procedure instruction
122037 Patient discharged from department Patient discharged from department or laboratory
122038 Patient pronounced dead Patient pronounced dead
122039 Patient transferred to morgue Patient transferred to morgue
122041 Personnel Arrived Identified personnel or staff arrived in procedure room
122042 Personnel Departed Identified personnel or staff departed procedure room
122043 Page Sent To Page sent to identified personnel or staff
122044 Consultation With Consultation with identified personnel or staff
122045 Office called Office of identified personnel or staff was called
122046 Equipment failure Equipment failure Retired. Replaced with (110501, DCM, “Equipment failure”)
122047 Equipment brought to procedure room Equipment brought to procedure room
122048 Equipment ready Equipment ready for procedure
122049 Equipment removed Equipment removed from procedure room
122052 Bioptome Device for obtaining biopsy sample
122053 Valvular Intervention Valvular Intervention
122054 Aortic Intervention Aortic Intervention
122055 Septal Defect Intervention Septal Defect Intervention
122056 Vascular Intervention Vascular Intervention
122057 Myocardial biopsy Myocardial biopsy
122058 Arterial conduit angiography Arterial conduit angiography
122059 Single plane Angiography Single plane Angiography
122060 Bi-plane Angiography Bi-plane Angiography
122061 Percutaneous Coronary Intervention Percutaneous Coronary Intervention
122062 15-Lead ECG 15-Lead electrocardiography Retired, Replaced with (P2-3120E, SRT, “15-Lead ECG”)
122072 Pre-procedure log Log of events occuring prior to the current procedure
122073 Current procedure evidence Analysis or measurements for current procedure (purpose of reference to evidence document)
122075 Prior report for current patient Prior report for current patient
122076 Consumable taken from inventory Identifier of Consumable taken from inventory
122077 Consumable returned to inventory Identifier of Consumable returned to inventory
122078 Remaining consumable disposed Identifier of consumable whose remaining content has been disposed
122079 Consumable unusable Identifier of Consumable determined to be unusable
122081 Drug start Identifier of Drug whose administration has started
122082 Drug end Identifier of Drug whose administration has ended
122083 Drug administered Identifier of Drug administered as part of procedure
122084 Contrast start Identifier of Contrast agent whose administration has started
122085 Contrast end Identifier of Contrast agent whose administration has ended
122086 Contrast administered Identifier of Contrast agent administered
122087 Infusate start Identifier of Infusate whose administration has started
122088 Infusate end Identifier of Infusate whose administration has ended
122089 Device crossed lesion Action of a device traversing a vascular lesion
122090 Intervention Action Action of a clinical professional performed on a patient for therapeutic purpose
122091 Volume administered Volume of Drug, Contrast agent, or Infusate administered
122092 Undiluted dose administered Undiluted dose of Drug, Contrast agent, or Infusate administered
122093 Concentration Concentration of Drug, Contrast agent, or Infusate administered
122094 Rate of administration Rate of Drug, Contrast agent, or Infusate administration
122095 Duration of administration Duration of Drug, Contrast agent, or Infusate administration
122096 Volume unadministered or discarded Volume of Drug, Contrast agent, or Infusate unadministered or discarded
122097 Catheter Curve Numeric parameter of Curvature of Catheter
122098 Transmit Frequency Transmit Frequency
122099 ST change from baseline Measured change of patient electrocardiographic ST level relative to baseline measurement
122101 Aneurysm on cited vessel Anatomic term modifier indicating aneurysm on cited vessel is the subject of the finding
122102 Graft to cited segment, proximal section Anatomic term modifier indicating proximal section of graft to cited vessel is the subject of the finding
122103 Graft to cited segment, mid section Anatomic term modifier indicating mid section of graft to cited vessel is the subject of the finding
122104 Graft to cited segment, distal section Anatomic term modifier indicating distal section of graft to cited vessel is the subject of the finding
122105 DateTime of Intervention DateTime of Intervention
122106 Duration of Intervention Duration of Intervention
122107 Baseline Stenosis Measurement Lesion stenosis measured prior to any interventional procedure Retired. Replaced with (R 101BB, SRT, “Lumen Diameter Stenosis”), post-coordinated with (G-7293, SRT, “Baseline Phase”)
122108 Post-Intervention Stenosis Measurement Lesion stenosis measured after an interventional procedure Retired. Replaced with (R 101BB, SRT, “Lumen Diameter Stenosis”), post-coordinated with (G-7298, SRT, “Post-intervention Phase”)
122109 Baseline TIMI Flow Assessment of perfusion across a coronary lesion measured prior to any interventional procedure
122110 Post-Intervention TIMI Flow Assessment of perfusion across a coronary lesion measured after an interventional procedure
122111 Primary Intervention Device Indication that device is the primary (first and/or most significant) device used for interventional therapy of a particular pathology (e.g., lesion)
122112 Normal Myocardium Normal Myocardium
122113 Scarred Myocardium Scarred Myocardium
122114 Thinning Myocardium Thinning Myocardium
122120 Hemodynamics Report Hemodynamics Report
122121 Atrial pressure measurements Atrial pressure measurements, report section
122122 Ventricular pressure measurements Ventricular pressure measurements, report section
122123 Gradient assessment Gradient assessment, report section
122124 Blood velocity measurements Blood velocity measurements, report section
122125 Blood lab measurements Blood lab measurements, report section
122126 Derived Hemodynamic Measurements Derived Hemodynamic Measurements, report section
122127 Clinical Context Clinical Context, report section
122128 Patient Transferred From Location from which the patient was transferred
122129 PCI during this procedure Indication that the procedure includes a percutaneous coronary intervention
122130 Dose Area Product Radiation dose times area of exposure
122131 Degree of Thrombus Finding of probability and/or severity of thrombus
122132 Severity of Calcification Severity of Calcification, property of lesion
122133 Lesion Morphology Lesion Morphology; form and/or structural properties of lesion
122134 Vessel Morphology Vessel Morphology; form and/or structural properties of vessel
122138 Circulatory Support Technique (device or procedure) of support for patient circulatory system; hemodynamic support
122139 Reason for Exam Reason for Exam
122140 Comparison with Prior Exam Done Indication that the current exam data has been compared with prior exam data
122141 Electrode Placement Electrocardiographic electrode placement technique
122142 Acquisition Device Type Acquisition Device Type
122143 Acquisition Device ID Acquisition Device ID
122144 Quantitative Analysis Quantitative Analysis, report section
122145 Qualitative Analysis Qualitative Analysis, report section
122146 Procedure DateTime The date and time on which a procedure was performed on a patient.
122147 Clinical Interpretation Clinical Interpretation, report section
122148 Lead ID ECG Lead Identifier
122149 Beat Number Beat Number; ordinal of cardiac cycle within an acquisition
122150 Compound Statement Complex coded semantic unit, consisting of several coded components
122151 Trend Trend (temporal progression) of a clinical condition, finding, or disease
122152 Statement Coded semantic unit
122153 Statement Modifier Coded modifier for a semantic unit
122154 Conjunctive Term Conjunctive term between semantic units
122157 Probability Probability
122158 ECG Global Measurements ECG Global Measurements, report section
122159 ECG Lead Measurements ECG Lead Measurements, report section
122160 Derived Area, Non-Valve Derived cross-sectional area of a vessel or anatomic feature, other than a cardiac valve
122161 Pulmonary Flow Rate of blood flow through Pulmonary artery
122162 Systemic Flow Rate of blood flow through the aorta
122163 Discharge DateTime DateTime of patient discharge from hospital admission
122164 Coronary Artery Bypass During This Admission Indication that a Coronary Artery Bypass operation was performed during the current hospital admission
122165 Date of Death Date of Death
122166 Death During This Admission Indication that the patient died during the current hospital admission
122167 Death During Catheterization Indication that the patient died during the current Catheterization procedure
122170 Type of Myocardial Infarction Finding of type of Myocardial Infarction
122171 Coronary lesion >= 50% stenosis Finding of Coronary lesion with greater than 50% stenosis
122172 Acute MI Present Finding of Acute Myocardial Infarction Presence as indication for interventional procedure
122173 ST Elevation Onset DateTime DateTime of first determination of elevated ECG ST segment, as indication of Myocardial Infarction
122175 Number of lesion interventions attempted Number of lesion interventions attempted during current procedure
122176 Number of lesion interventions successful Number of lesion interventions successful during current procedure, where the residual post intervention stenosis is less than or equal to 50% of the arterial luminal diameter, TIMI Flow is 3 and the minimal decrease in stenosis was 20%.
122177 Procedure Result Overall success of interventional procedure
122178 Lesion Intervention Information Lesion Intervention Information, report section
122179 Peri-procedural MI occurred Indication that Myocardial Infarction occurred during current procedure
122180 CK-MB baseline Creatine Kinase–MB value at baseline (start of procedure)
122181 CK-MB peak Creatine Kinase–MB highest value measured during procedure
122182 R-R interval Time interval between ECG R-wave peaks in subsequent cardiac cycles
122183 Blood temperature Blood temperature
122185 Blood Oxygen content Blood Oxygen content
122187 Blood Carbon dioxide saturation Blood Carbon dioxide saturation
122188 Pulmonary Arterial Content (FCpa) Pulmonary Arterial Content (FCpa)
122189 Pulmonary Venous Content (FCpv) Pulmonary Venous Content (FCpv)
122190 Max dp/dt/P Max dp/dt/P
122191 Ventricular End Diastolic pressure Ventricular End Diastolic pressure
122192 Indicator appearance time Elapsed time from injection of an indicator bolus until it is observed at another location
122193 Maximum pressure acceleration Maximum pressure acceleration
122194 Ventricular Systolic blood pressure Ventricular Systolic blood pressure
122195 Pulse Strength Pulse Strength; palpable strength of systolic flow
122196 C wave pressure The secondary peak pressure in the atrium during atrial contraction
122197 Gradient pressure, average Gradient pressure, average
122198 Gradient pressure, peak Gradient pressure, peak
122199 Pressure at dp/dt max Pressure at dp/dt max
122201 Diastolic blood velocity, mean Diastolic blood velocity, mean
122202 Diastolic blood velocity, peak Diastolic blood velocity, peak
122203 Systolic blood velocity, mean Systolic blood velocity, mean
122204 Systolic blood velocity, peak Systolic blood velocity, peak
122205 Blood velocity, mean Blood velocity, mean
122206 Blood velocity, minimum Blood velocity, minimum
122207 Blood velocity, peak Blood velocity, peak
122208 x-descent pressure Venous or atrial pressure minimum during ventricular systole, after A-wave
122209 y-descent pressure Venous or atrial pressure minimum when tricuspid valve opens during diastole, after V-wave
122210 z-point pressure Atrial pressure upon closure of tricuspid and mitral valves
122211 Left Ventricular ejection time Left Ventricular ejection time
122212 Left Ventricular filling time Left Ventricular filling time
122213 Right Ventricular ejection time Right Ventricular ejection time
122214 Right Ventricular filling time Right Ventricular filling time
122215 Total Pulmonary Resistance Total Pulmonary Resistance
122216 Total Vascular Resistance Total Vascular Resistance
122217 Coronary Flow reserve Coronary Flow reserve
122218 Diastolic/Systolic velocity ratio Diastolic/Systolic velocity ratio
122219 Hyperemic ratio Hyperemic ratio
122220 Hemodynamic Resistance Index Hemodynamic Resistance Index
122221 Thorax diameter, sagittal Thorax diameter, sagittal
122222 Procedure Environmental Characteristics Environmental characteristics in the procedure room
122223 Room oxygen concentration Oxygen concentration in the procedure room
122224 Room temperature Temperature in the procedure room
122225 Room Barometric pressure Barometric pressure in the procedure room
122227 Left to Right Flow Left to Right Flow
122228 Right to Left Flow Right to Left Flow
122229 Arteriovenous difference Arteriovenous oxygen content difference
122230 10 Year CHD Risk Framingham Study 10 Year CHD Risk
122231 Comparative Average 10 Year CHD Risk Framingham Study Comparative Average 10 Year CHD Risk
122232 Comparative Low 10 Year CHD Risk Framingham Study Comparative Low 10 Year CHD Risk
122233 LDL Cholesterol Score Sheet for Men Framingham Study LDL Cholesterol Score Sheet for Men
122234 LDL Cholesterol Score Sheet for Women Framingham Study LDL Cholesterol Score Sheet for Women
122235 Total Cholesterol Score Sheet for Men Framingham Study Total Cholesterol Score Sheet for Men
122236 Total Cholesterol Score Sheet for Women Framingham Study Total Cholesterol Score Sheet for Women
122237 Corrected Sinus Node Recovery Time Corrected Sinus Node Recovery Time
122238 Max volume normalized to 50mmHg pulse pressure Max volume normalized to 50mmHg pulse pressure
122239 Oxygen Consumption Oxygen Consumption
122240 BSA = 3.207*WT^(0.7285-0.0188 log (WT))*HT^0.3 Body Surface Area computed from patient height and weight: BSA = 3.207*WT[g]^(0.7285-0.0188 log (WT[g]))*HT[cm]^0.3 [Boyd E, The growth of the surface area of the human body. Minneapolis: University of Minnesota Press, 1935, eq. (36)]
122241 BSA = 0.007184*WT^0.425*HT^0.725 Body Surface Area computed from patient height and weight: BSA = 0.007184*WT[kg]^0.425*HT[cm]^0.725 [Dubois and Dubois, Arch Int Med 1916 17:863-71]
122242 BSA = 0.0235*WT^0.51456*HT^0.42246 Body Surface Area computed from patient height and weight: BSA = 0.0235*WT[kg]^0.51456*HT[cm]^0.42246 [Gehan EA, George SL, ‘Estimation of human body surface area from height and weight’, Cancer Chemother Rep 1970 54:225-35]
122243 BSA = 0.024265*WT^0.5378*HT^0.3964 Body Surface Area computed from patient height and weight: BSA = 0.024265*WT[kg]^0.5378*HT[cm]^0.3964 [Haycock G.B., Schwartz G.J.,Wisotsky D.H. ‘Geometric method for measuring body surface area: A height weight formula validated in infants, children and adults.’ The Journal of Pediatrics 1978 93:1:62-66]
122244 BSA = (HT * WT/36)^0.5 Body Surface Area computed from patient height and weight: BSA = (HT[m] * WT[kg]/36)^0.5 [Mosteller, R.D. ‘Simplified Calculation of Body Surface Area.’ N Engl J Med 1987 Oct 22;317(17):1098]
122245 BSA = 1321+0.3433*WT Body Surface Area computed from patient weight: BSA = 1321+0.3433*WT[kg] (for pediatrics 3-30 kg) [Current, J.D. ‘A Linear Equation For Estimating The Body Surface Area In Infants And Children’, The Internet Journal of Anesthesiology. 1998. 2:2]
122246 BSA = 0.0004688*WT^(0.8168-0.0154*log(WT)) BSA = 0.0004688*(1000*WT)^(0.8168-0.0154*log(1000*WT)) Where (WT is weight in kilogram) Units = m^2 Boyd, Edith. The Growth of the Surface Area of the Human Body (originally published in 1935 by the University of Minnesota Press), Greenwood Press, Westport, Connecticut, 1975, p. 102. Equation (35)
122247 VO2male = BSA (138.1 - 11.49 * loge(age) + 0.378*HRf) Equation for estimated oxygen consumption: VO2male = BSA (138.1 - 11.49 * loge(age) + 0.378*HRf)
122248 VO2female = BSA (138.1 - 17.04 * loge(age) + 0.378*HRf) Equation for estimated oxygen consumption: VO2female = BSA (138.1 - 17.04 * loge(age) + 0.378*HRf)
122249 VO2 = VeSTPD * 10 * (FIO2 - FE02) Equation for estimated oxygen consumption: VO2 = VeSTPD * 10 * (FIO2 - FE02)
122250 VO2 = 152 * BSA Equation for estimated oxygen consumption: VO2 = 152 * BSA
122251 VO2 = 175 * BSA Equation for estimated oxygen consumption: VO2 = 175 * BSA
122252 VO2 = 176 * BSA Equation for estimated oxygen consumption: VO2 = 176 * BSA
122253 Robertson & Reid table Robertson & Reid Table for estimated oxygen consumption
122254 Fleisch table Fleisch table for estimated oxygen consumption
122255 Boothby table Boothby table for estimated oxygen consumption
122256 if (prem age< 3days) P50= 19.9 Estimate of Oxygen partial pressure at 50% saturation for premature infants less than 3 days old: P50= 19.9
122257 if (age < 1day) P50= 21.6 Estimate of Oxygen partial pressure at 50% saturation for infants less than 1 day old: P50= 21.6
122258 if (age < 30day) P50= 24.6 Estimate of Oxygen partial pressure at 50% saturation for infants less than 30 days old: P50= 24.6
122259 if (age < 18y) P50= 27.2 Estimate of Oxygen partial pressure at 50% saturation for patients less than 18 years old: P50= 27.2
122260 if (age < 40y) P50= 27.4 Estimate of Oxygen partial pressure at 50% saturation for patients less than 40 years old: P50= 27.4
122261 if (age > 60y) P50= 29.3 Estimate of Oxygen partial pressure at 50% saturation for patients more than 60 years old: P50= 29.3
122262 Area = Flow / 44.5 * sqrt(Gradient[mmHg]) Cardiac valve area computed from flow and pressure gradient: Area = Flow / 44.5 * sqrt(Gradient[mmHg]) [Gorlin and Gorlin, Am Heart J, 1951]
122263 MVA = Flow / 38.0 * sqrt(Gradient[mmHg]) Mitral valve area computed from flow and pressure gradient: Mitral valve Area = Flow / 38.0 * sqrt(Gradient[mmHg]) [Gorlin and Gorlin, Am Heart J, 1951]
122265 BMI = Wt/Ht^2 Body Mass Index computed from weight and height: BMI = Wt/Ht^2
122266 BSA = 0.007358*WT^0.425*HT^0.725 Body Surface Area computed from patient height and weight: BSA = 0.007358*WT[kg]^0.425* HT[cm]^0.725 (for East Asian adult, aged 15+ years) [Kanai Izumi, Masamitsu Kanai, 'Clinical examination method summary']
122267 BSA = 0.010265*WT^0.423*HT^0.651 Body Surface Area computed from patient height and weight: BSA = 0.010265*WT[kg]^0.423* HT[cm]^0.651 (For East Asian child aged 12-14 years)
122268 BSA = 0.008883*WT^0.444*HT^0.663 Body Surface Area computed from patient height and weight: BSA = 0.008883*WT[kg]^0.444* HT[cm]^0.663 (For East Asian child aged 6-11 years)
122269 BSA = 0.038189*WT^0.423*HT^0.362 Body Surface Area computed from patient height and weight: BSA = 0.038189*WT[kg]^0.423* HT[cm]^0.362 (For East Asian child aged 1-5 years)
122270 BSA = 0.009568*WT^0.473*HT^0.655 Body Surface Area computed from patient height and weight: BSA = 0.009568*WT[kg]^0.473* HT[cm]^0.655 (For East Asian child aged 0-12 months)
122271 Skin Condition Warm Skin Condition Warm
122272 Skin Condition Cool Skin Condition Cool
122273 Skin Condition Cold Skin Condition Cold
122274 Skin Condition Dry Skin Condition Dry
122275 Skin Condition Clammy Skin Condition Clammy
122276 Skin Condition Diaphoretic Skin Condition Diaphoretic
122277 Skin Condition Flush Skin Condition Flush
122278 Skin Condition Mottled Skin Condition Mottled
122279 Skin Condition Pale Skin Condition Pale
122281 Airway unobstructed Airway unobstructed
122282 Airway partially obstructed Airway partially obstructed
122283 Airway severely obstructed Airway severely obstructed
122288 Not Visualized Anatomy could not be visualized for the purpose of evaluation
122291 Quantitative Arteriography Report Quantitative Arteriography Report
122292 Quantitative Ventriculography Report Quantitative Ventriculography Report
122301 Guidewire crossing lesion unsuccessful Guidewire crossing lesion unsuccessful
122302 Guidewire crossing lesion successful Guidewire crossing lesion successful
122303 Angioplasty balloon inflated Angioplasty balloon inflated
122304 Angioplasty balloon deflated Angioplasty balloon deflated
122305 Device deployed Device deployed
122306 Stent re-expanded Stent re-expanded
122307 Object removed Object removed
122308 Radiation applied Radiation applied
122309 Radiation removed Radiation removed
122310 Interventional device placement unsuccessful Interventional device placement unsuccessful
122311 Interventional device placed Interventional device placed
122312 Intervention performed Intervention performed
122313 Interventional device withdrawn Interventional device withdrawn
122319 Catheter Size Catheter Size
122320 Injectate Temperature Injectate Temperature
122321 Injectate Volume Injectate Volume
122322 Calibration Factor Factor by which a measured or calculated value is multiplied to obtain the estimated real-world value.
122325 IVUS Report Intravascular Ultrasound Report
122330 EEM Diameter External Elastic Membrane (EEM) diameter measured through the center point of the vessel. Center point of the vessel is defined as the center of gravity of the EEM area. The EEM is a discrete interface at the border between the media and the adventitia.
122331 Plaque Plus Media Thickness The distance from intimal leading edge to the external elastic membrane along any line passing through the luminal center, which is defined as the center of gravity of the lumen area.
122332 Lumen Perimeter Planimetered perimeter of the lumen.
122333 EEM Cross-Sectional Area Vessel area measured at the External Elastic Membrane (EEM), a discrete interface at the border between the media and the adventitia.
122334 Plaque plus Media Cross-Sectional Area Area within the EEM occupied by atheroma, regardless of lumen compromise. Plaque plus Media Area = EEM cross-sectional area - vessel lumen cross-sectional area
122335 In-Stent Neointimal Cross-Sectional Area Measurement of in-stent restenosis. In-Stent Intimal Area = Stent cross-sectional area – vessel lumen cross-sectional area
122336 Vascular Volume measurement length Longitudinal extent of the Vascular Volume Measurement. This is the distance from the distal edge to the proximal edge of the Volume measurement.
122337 Relative position Longitudinal distance from the closest edge of a fiducial feature or reference location to the start of the vascular measurement. This value will be a positive if the measurement is distal to the fiducial feature or reference location, or negative if the measurement is proximal to the fiducial feature or reference location.
122339 Stent Volume Obstruction In-Stent Neointimal Volume / Stent Volume
122340 Fiducial feature Reference, normally anatomical, which is used for locating the position of a measurement.
122341 Calcium Length Longitudinal calcium length measurement
122343 Lumen Eccentricity Index Measurement of vessel lumen eccentricity. Lumen Eccentricity Index = (maximum vessel lumen diameter - minimum vessel lumen diameter) / maximum vessel lumen diameter. Lumen diameters are measured through the center point of the lumen, which is defined as the center of gravity of the lumen area.
122344 Plaque plus Media Eccentricity Index Plaque plus Media Eccentricity Index = (maximum Plaque plus media thickness - minimum Plaque plus media thickness) / maximum Plaque plus media thickness
122345 Remodeling Index Measurement of increase or decrease in EEM area that occurs during the development of atherosclerosis. Remodeling Index = Lesion EEM area / reference EEM area
122346 Stent Symmetry Index Measurement of stent circularity. Stent Symmetry Index = (maximum stent diameter - minimum stent diameter) / maximum stent diameter
122347 Stent Expansion Index Measurement of stent area relative to the reference lumen area. Stent Expansion Index = Minimum stent area / reference vessel lumen cross-sectional area
122348 Lumen Shape Index Measurement of vessel lumen eccentricity. Lumen Shape Index = (2( * sqrt(Vessel lumen cross-sectional area / () / Lumen Perimeter) 2 Reference: Tobis & Yock, “Intravascular Ultrasound Imaging”, Chapter 7
122350 Lumen Diameter Ratio Lumen diameter ratio = minimum vessel lumen diameter / maximum vessel lumen diameter, measured at the same cross section in the vessel. Lumen diameters are measured through the center point of the lumen, which is defined as the center of gravity of the lumen area.
122351 Stent Diameter Ratio Stent diameter ratio = Minimum stent diameter / Maximum stent diameter, measured at the same cross section in the vessel. Stent diameters are measured through the center point of the stent, which is defined as the center of gravity of the stent area.
122352 EEM Diameter Ratio EEM diameter ratio = minimum EEM diameter / maximum EEM diameter. Measured at the same cross section in the vessel.
122354 Plaque Burden Fractional area within the External Elastic Membrane (EEM) occupied by atheroma. Plaque Burden = (EEM area - vessel lumen cross-sectional area) / EEM area
122355 Arc of Calcium Angular measurement of a Calcium deposit with the apex located at the center of the lumen, which is defined as the center of gravity of the lumen area.
122356 Soft plaque Plaque characterized by low density or echogenicity.
122357 In-Stent Neointima Abnormal thickening of the intima within the stented segment.
122360 True Lumen Lumen surrounded by all three layers of the vessel-intima, media, and adventitia.
122361 False Lumen A channel, usually parallel to the true lumen, which does not communicate with the true lumen over a portion of its length.
122363 Plaque Rupture Plaque ulceration with a tear detected in a fibrous cap.
122364 Stent Gap Length of gap between two consecutive stents.
122367 T-1 Worst Worst stenosis - the stenosis with the smallest lumen size within a vessel segment.
122368 T-2 Secondary 2nd most severe stenosis within a vessel segment.
122369 T-3 Secondary 3rd most severe stenosis within a vessel segment.
122370 T-4 Secondary 4th most severe stenosis within a vessel segment.
122371 EEM Volume External Elastic Membrane (EEM) volume measured within a specified region. The EEM is a discrete interface at the border between the media and the Adventitia.
122372 Lumen Volume Lumen volume measured within a specified region.
122374 In-Stent Neointimal Volume The amount of plaque between the lumen and stent, within the stent region; In-stent restenosis. In-Stent Neointimal Volume = Stent Volume - Lumen Volume
122375 Native Plaque Volume The amount of plaque between the stent and the EEM, within the stent region.  Native Plaque Volume = EEM Volume - Stent Volume
122376 Total Plaque Volume Total amount of plaque between the EEM and the Lumen, over the entire region that is measured.  Total Plaque Volume = EEM Volume - Lumen Volume.
122380 Proximal Reference Proximal reference segment measurement site. Typically the site with the largest lumen proximal to a stenosis but within the same segment (usually within 10 mm of the stenosis with no major intervening branches).
122381 Distal Reference Distal reference segment measurement site. Typically the site with the largest lumen distal to a stenosis but within the same segment (usually within 10 mm of the stenosis with no major intervening branches).
122382 Site of Lumen Minimum Site of the smallest lumen in a vessel, e.g., due to a stenotic lesion.
122383 Entire Pullback Measurement region that encompasses the entire vessel imaged in a single pullback acquisition
122384 Stented Region Measurement region occupied by the stent
122385 Proximal Stent Margin Region starting at the proximal edge of the Stent and extending several millimeters (usually 5 mm) proximal to the Stent edge.
122386 Distal Stent Margin Region starting at the distal edge of the Stent and extending several millimeters (usually 5 mm) distal to the Stent edge.
122387 Dissection Classification Classification of dissections in a vessel
122388 Intra-stent Dissection Separation of neointimal hyperplasia from stent struts, usually seen only after treatment of in-stent restenosis.
122389 Vulnerable Plaque Plaque with a thin cap fibrous atheroma that is at increased risk of rupture and thrombosis (or re-thrombosis) and rapid stenosis progression.
122390 Eroded Plaque Plaque erosions with no structural defect (beyond endothelial injury) or gap in the plaque.
122391 Relative Stenosis Severity Stenosis severity classifications of multiple lesions in a vessel.
122393 Restenotic Lesion A finding of a previously treated lesion in which stenosis has reoccurred.
122394 Fibro-Lipidic Plaque Loosely packed bundles of collagen fibers with regions of lipid deposition present. Region is cellular and no cholesterol clefts or necrosis are present. Some macrophage infiltration. Increase in extra cellular matrix.
122395 Necrotic-Lipidic Plaque Area within the plaque with very low echogenicity separated from the lumen and surrounded by more echogenic structures (fibrous cap). Highly lipidic necrotic region with remnants of foam cells and dead lymphocytes present. No collagen fibers are visible and mechanical integrity is poor. Cholesterol clefts and micro calcifications are visible.
122398 Intimal Dissection Dissection limited to the intima or atheroma, and not extending to the media.
122399 Medial Dissection Dissection in the arterial Media, extending into the media.
122400 Simultaneously Acquired The referenced information was acquired simultaneously with the information in the object in which the reference occurs.
122401 Same Anatomy Information acquired for the same anatomic region.
122402 Same Indication Information acquired for the same indication (e.g. to elucidate the same diagnostic question).
122403 For Attenuation Correction The referenced information was used to correct the data for differential attenuation through different anatomic tissue.
122404 Reconstructed Value estimated for a vessel in the absence of a stenosis
122405 Algorithm Manufacturer Manufacturer of application used
122406 Left Atrial Ejection Fraction by Angiography Left Atrial Ejection Fraction by Angiography
122407 Left Atrial ED Volume Left Atrial End Diastolic Volume
122408 Left Atrial ES Volume Left Atrial End Systolic Volume
122410 Contour Realignment Contour repositioning of End Diastolic relative to End Systolic contour
122411 Threshold Value The minimum standard deviation to define the hypokinesis and hyperkinesis
122417 Regional Abnormal Wall Motion Report of differentiation of wall motion compared to normal
122421 Calibration Object Object used for Calibration
122422 Calibration Method Method used for Calibration
122423 Calibration Object Size Size of calibration object
122428 Area Length Method Method how long axis is positioned
122429 Volume Method Model for cardiac chamber volume calculation
122430 Reference Method Method to define original diameter of the artery
122431 Regression Slope ED Relation between calculated End Diastolic volume and ventricular End Diastolic volume. The specific meaning is dependent on volume method used.
122432 Regression Offset ED Correction factor for the calculated End Diastolic volume and ventricular End Diastolic volume. The specific meaning is dependent on volume method used.
122433 Regression Slope ES Relation between calculated End Systolic volume and ventricular End Systolic volume. The specific meaning is dependent on volume method used.
122434 Regression Offset ES Correction factor for the calculated End Systolic volume and ventricular End Systolic volume. The specific meaning is dependent on volume method used.
122435 Regression Volume Exponent Exponent of volume in regression formula
122438 Reference Points Container for spatial locations or coordinates used for calculation
122445 Wall Thickness Average thickness of the chamber wall in the current view
122446 Wall Volume Volume of the chamber wall estimated from the current view
122447 Wall Mass Mass of the chamber wall (myocardium)
122448 Wall Stress Peak systolic stress of chamber wall
122449 Centerline Wall Motion Analysis Method to calculate wall motion [example: Sheehan, 1986]
122450 Normalized Chord Length The length between End Diastolic and End Systolic contour perpendicular on the centerline normalized by a method dependent ventricular perimeter length. The centerline is the line equidistant between the End Diastolic and End Systolic contour [example: Sheehan, 1986]
122451 Abnormal Region The report of the boundaries of the abnormal (hyperkinetic, hypokinetic, a-kinetic) regions associated with the territory of the artery [example: Sheehan, 1986]
122452 First Chord of Abnormal Region The chord number specifying the begin of abnormal region [example: Sheehan, 1986]
122453 Last Chord of Abnormal Region The chord number specifying the end of abnormal region [example: Sheehan, 1986]
122459 Territory Region Severity Severity at the regional abnormality extent [example: Sheehan, 1986]
122461 Opposite Region Severity Severity at the opposite regional abnormality extent [example: Sheehan, 1986]
122464 LAD Region in RAO Projection Based on a total number of chords of 100 and RAO project the range of chords belonging to this circumferential extent lies between 5 – 85. [Sheehan, 1986]
122465 RCA Region in ROA Projection Based on a total number of chords of 100 and RAO project the range of chords belonging to this circumferential extent lies between 25 – 85. [Sheehan, 1986]
122466 Single LAD Region in RAO Projection Based on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 10 – 66 (hypokinetic) and 67 – 80 (hyperkinetic). [Sheehan, 1986]
122467 Single RCA Region in RAO Projection Based on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 51 – 80 (hypokinetic) and 10 – 50 (hyperkinetic). [Sheehan, 1986]
122468 Multiple LAD Region in RAO Projection Based on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 10 – 58 (hypokinetic) and 59 –80 (hyperkinetic). [Sheehan, 1986]
122469 Multiple RCA Region in RAO Projection Based on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 59 – 80 (hypokinetic) and 10 – 58 (hyperkinetic). [Sheehan, 1986]
122470 LAD Region in LAO Projection Based on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 50 –100 (hypokinetic) and 20 – 49 (hyperkinetic). [Sheehan, 1986]
122471 RCA Region in LAO Projection Based on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 19 – 67 (hypokinetic) and 68 – 100 (hyperkinetic). [Sheehan, 1986]
122472 CFX Region in LAO Projection Based on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 38 –74 (hypokinetic) and 75 – 100 (hyperkinetic). [Sheehan, 1986]
122473 Circular Method Method based on assumption that the image object is circular.
122474 Densitometric Method Method based on the gray value distribution of the image.
122475 Center of Gravity End Systolic contour realigned to End Diastolic contour based on the center of gravity
122476 Long Axis Based End Systolic contour realigned to End Diastolic contour based on the mid point of the long axis. The long axis end points are defined as the posterior and apex.
122477 No Realignment No Contour Realignment applied
122480 Vessel Lumen Cross-Sectional Area Calculated Vessel Lumen Cross-Sectional Area based on the referenced method
122481 Contour Start Location of the beginning of a contour
122482 Contour End Location of the end of a contour
122485 Sphere Sphere is used as calibration object
122486 Geometric Isocenter Object of interest in isocenter of image and pixel separation is calculated from geometric data
122487 Geometric Non-Isocenter Object of interest not in isocenter of image and pixel separation is calculated from geometric data and out of isocenter distances
122488 Calibration Object Used Object used for calibration (e.g. sphere)
122489 Curve Fitted Reference Application dependent method to calculate the reference diameter based on the multiple diameter values.
122490 Interpolated Local Reference Application dependent method to calculate reference by interpolation, based on the diameter of two or more user defined reference positions.
122491 Mean Local Reference Application dependent method to calculate by averaging the reference, based on the diameter of one or more user defined reference positions.
122493 Radial Based Wall Motion Analysis Method to calculate wall motion based on the lengths of the radials in the predefined regions [Ingels]
122495 Regional Contribution to Ejection Fraction Contribution of Region to global Ejection factor based on radial or landmark based wall motion method
122496 Radial Shortening The reduction of area between End Systolic and End Diastolic based on radial wall motion analysis
122497 Landmark Based Wall Motion Analysis Method to calculate wall motion based on the move of landmarks on the wall [Slager]
122498 Slice Contribution to Ejection Fraction Contribution to the ejection fraction of a specific slice region [Slager]
122499 Frame to Frame Analysis Method to calculate volumes of heart chambers for every image in a range
122501 Area of closed irregular polygon The area is derived by considering a set of coordinates as a closed irregular polygon, accounting for inner angles. The exact method, such as by decomposition into triangles or quadrilaterals, is not specified, since it does not affect the numeric result, apart from the effect of numeric precision during computation of intermediate results.
122502 Area of a closed NURBS The area is derived by using a set of coordinates as control points for a Non Uniform Rational B-Spline (NURBS).
122503 Integration of sum of closed areas on contiguous slices The volume derived by integrating the sum of the areas on adjacent slices across the slice interval; each area is defined by a regular planar shape or by considering a set of coordinates as a closed irregular polygon, accounting for inner angles.
122505 Calibration Procedure used to calibrate measurements or measurement devices
122507 Left Contour Left contour of lumen (direction proximal to distal)
122508 Right Contour Right contour of lumen (direction proximal to distal)
122509 Diameter Graph Ordered set of diameters values derived from contours (direction proximal to distal)
122510 Length Luminal Segment Length Luminal Segment
122511 Graph Increment Increment value along X-axis in Diameter Graph
122516 Site of Maximum Luminal Location of the maximum lumen area in a lesion or vessel.
122517 Densitometric Luminal Cross-sectional Area Graph Ordered set of cross-sectional Vessel Lumen Cross-Sectional Area values derived from contours (direction proximal to distal) based on densitometric method
122528 Position of Proximal Border Position of proximal border of segment relative to the contour start (proximal end of analysis area)
122529 Position of Distal Border Position of distal border of segment relative to the contour start (proximal end of analysis area)
122542 Plaque Area Longitudinal cross sectional area of plaque
122544 Diameter Symmetry Symmetry of stenosis (0 = complete asymmetry, 1 = complete symmetry) [reference PS 3.17 X.2]
122545 Area Symmetry Symmetry of plaque (0 = complete asymmetry, 1 = complete symmetry) [reference PS 3.17 X.2]
122546 Inflow Angle The average slope of the diameter function between the position of the minimum luminal diameter and the position of the proximal border of the segment
122547 Outflow Angle The average slope of the diameter function between the position of the minimum luminal diameter and the position of the distal border of the segment
122548 Stenotic Flow Reserve The relation between coronary pressure and coronary flow
122549 Poiseuille Resistance Poiseuille Resistance at the location of the stenosis
122550 Turbulence Resistance Turbulence Resistance at the location of the stenosis
122551 Pressure Drop at SFR Pressure drop over the stenosis at maximum heart output
122554 Segmentation Method Method for selection of vessel sub-segments
122555 Estimated Normal Flow Estimate of the volume of blood flow in the absence of stenosis
122558 Area Length Kennedy Area Length method defined by Kennedy [Kennedy, 1970]
122559 Area Length Dodge Area Length method defined by Dodge [Dodge, 1960]
122560 Area Length Wynne Area Length method defined by Wynne [Wynne]
122562 Multiple Slices Volume method based on multiple slice
122563 Boak Volume method defined by Boak [Boak]
122564 TS Pyramid Volume method defined by Ferlinz [Ferlinz]
122565 Two Chamber Volume method defined by Graham [Graham]
122566 Parallelepiped Volume method defined by Arcilla [Arcilla]
122572 BSA^1.219 Corrected Body Surface area for indexing the hemodynamic measurements for a pediatric patient
122574 Equidistant method Method for selecting sub-segments that are all of the same length
122575 User selected method Manually selected start and end of sub-segment
122582 Left ventricular posterobasal segment Left ventricular posterobasal segment
122600 Cardiovascular Analysis Report Report of a Cardiovascular Analysis, typically from a CT or MR study
122601 Ventricular Analysis Ventricular Analysis
122602 Myocardial Perfusion Analysis Myocardial Perfusion Analysis
122603 Calcium Scoring Analysis Calcium Scoring Analysis
122604 Flow Quantification Flow Quantification Analysis
122605 Vascular Morphological Analysis Vascular Morphological Analysis
122606 Vascular Functional Analysis Vascular Functional Analysis
122607 Thickening Analysis Analysis of myocardial wall thickening
122608 Absolute Values Of Ventricular Measurements Section Heading for absolute values of ventricular measurements
122609 Normalized Values Of Ventricular Measurements Results of normalizing ventricular measurements
122611 Reference Point Reference Point of a measurement
122612 Central breathing position Central breathing position between inspiration and expiration
122616 Peak Ejection Rate Peak of the ventricular ejection rate
122617 Peak Ejection Time Time of the peak of ventricular ejection
122618 Peak Filling Rate Peak of the fluid filling rate
122619 Peak Filling Time Time interval from a given reference point (e.g. end systole) until time of peak filling
122620 Papillary Muscle Excluded Papillary muscle was excluded from the measurement
122621 Papillary Muscle Included Papillary muscle was included in the measurement
122624 Wall Thickness Ratio end-systolic to end-diastolic The ratio of the end-systolic wall thickness compared to the end-diastolic wall thickness
122627 Curve Fit Method The method to smooth a ventricular volume as a function of time
122628 Baseline Result Correction Baseline correction used in the calculation of the results
122631 Signal Earliest Peak Time The time in a dynamic set of images at which the first peak of the signal is observed for the analysed myocardial wall segments.
122633 Signal Increase Start Time This is the time at which the signal begins to increase.
122634 Signal Time to Peak Time interval between the beginning of the signal increase to the time at which the signal intensity reaches its first maximum in a dynamic set of images.
122635 MR Perfusion Peak Peak of the MR perfusion signal
122636 MR Perfusion Slope Signal intensity as a function of time. It is the change in the signal intensity divided by the change in the time.
122637 MR Perfusion Time Integral MR perfusion time integral from baseline (foot time) to earliest peak
122638 Signal Baseline Start First time point in a dynamic set of images used in the calculation of the baseline signal intensity for each myocardial wall segment.
122639 Signal Baseline End Last time point in a dynamic set of images used in the calculation of the baseline signal intensity for each myocardial wall segment.
122640 Image Interval The time delta between images in a dynamic set of images.
122642 Velocity Encoding Minimum Value The minimum velocity encoded by the phase encoding gradient
122643 Velocity Encoding Maximum Value The maximum velocity encoded by the phase encoding gradient
122645 Net Forward Volume Forward volume-reverse volume
122650 Area Based Method Area Based Method for estimating volume or area
122651 Diameter Based Method Diameter Based Method for estimating volume, area or diameter
122652 Volume Based Method Volume Based Method for estimating volume
122655 NASCET A method of diameter measurements according to NASCET (North American Symptomatic Carotid Endarterectomy Trial)
122656 ECST A method of diameter measurements according to ECST (European Carotid Surgery Trial)
122657 Agatston Score Threshold Agatston Score Threshold
122658 Calcium Mass Threshold Calcium Mass Threshold
122659 Calcium Scoring Calibration Calcium Scoring Calibration
122660 Calcium Volume Calcium Volume
122661 Calcium Mass Calcium Mass
122664 Late Contrast Enhancement Delayed hyperenhancement of a tissue observed in an image acquired after injection of contrast media.
122665 Time interval since injection of contrast media Time interval since injection of contrast media
122666 Time relative to R-wave peak Time relative to R-wave peak
122667 Blood velocity vs. time of cardiac cycle Relationship between blood velocity and time relative to R-wave peak
122668 Time interval since detection of contrast bolus Time interval since detection of contrast bolus
122670 Papillary Muscle Included/Excluded Indicates if the papillary muscle was included or excluded in the measurement
122675 Anterior-Posterior Anterior to Posterior direction
122680 endoleak Persistent flow of blood into the stent-grafting
122683 Stent Fracture Fracture of a stent
122684 Stent Disintegration Disintegration of a stent
122685 Stent Composition Material that a stent consists of
122686 Parent Vessel Finding Finding about the characteristics of the parent vessel of a vessel
122687 Site of Lumen Maximum Site of Maximal lumen diameter of a vessel
122698 X-Concept The physical domain (time, space, etc.) to the horizontal axis of the graphical presentation.
122699 Y-Concept The physical domain (time, space, etc.) to the vertical axis of the graphical presentation.
122700 Indications for Pharmacological Stress Indications for Pharmacological Stress
122701 Procedure time base Reference time for measurement of elapsed time in a procedure
122702 Treadmill speed Treadmill speed
122703 Treadmill gradient Treadmill gradient
122704 Ergometer power Ergometer power
122705 Pharmacological Stress Agent Dose Rate Pharmacological Stress Agent Dose Rate
122706 Rating of Perceived Exertion Rating of Perceived Exertion
122707 Number of Ectopic Beats Number of ectopic beats during a period of collection
122708 Double Product Heart rate times systolic blood pressure
122709 Activity workload Physical activity workload (intensity) measurement
122710 Time since start of stage Elapsed time at stage
122711 Exercise duration after stress agent injection Exercise duration after stress agent injection
122712 Imaging Start Time Imaging Start Time
122713 Attenuation correction method Attenuation correction method
122715 Pharmacological Stress Agent Dose Pharmacological Stress Agent Dose
122716 Maximum Power Output Achieved Maximum power output achieved during course of procedure
122717 Peak activity workload Peak physical activity intensity measurement during course of procedure
122718 Peak Double Product Peak Double Product measurement during course of procedure
122720 OSEM algorithm Ordered subsets expectation maximization reconstruction algorithm
122721 Chang method Chang attenuation correction method
122726 Algorithmic attenuation correction Attenuation correction not based on image-based attenuation maps
122727 NM transmission attenuation correction NM transmission attenuation correction
122728 CT–based attenuation correction CT–based attenuation correction
122729 No Attenuation Correction No attenuation correction
122730 Bazett QTc Algorithm Bazett QT Correction Algorithm; QT/(RR ^ 0.5); Bazett HC. "An analysis of the time-relations of electrocardiograms" Heart 7:353-370 (1920).
122731 Hodges QTc Algorithm Hodges QT Correction Algorithm; QT + 1.75 (heart rate-60); Hodges M, Salerno Q, Erlien D. “Bazett's QT correction reviewed. Evidence that a linear QT correction for heart rate is better.” J Am Coll Cardiol 1:694 (1983)
122732 Fridericia QTc Algorithm Fridericia QT Correction Algorithm; QT/(RR ^ 0.333); Fridericia LS. "The duration of systole in the electrocardiogram of normal subjects and of patients with heart disease" Acta Med Scand 53:469-486 (1920)
122733 Framingham QTc Algorithm Framingham QT Correction Algorithm; QT + 0.154 (1- RR); Sagie A, Larson MG, Goldberg RJ, et al. “An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study).” Am J Cardiol 70:797-801(1992)
122734 Borg RPE Scale Borg Rating of Perceived Exertion Scale, range 6:20
122735 Borg CR10 Scale Borg category ratio scale, open ended range with nominal range 0:10
122739 Overall study quality Overall study quality
122740 Excellent image quality Excellent image quality
122741 Good image quality Good image quality
122742 Poor image quality Poor image quality
122743 Body habitus attentuation Image attenuation due to body physique (overweight)
122744 Breast attenuation Image attenuation due to breast tissue
122745 Diaphragmatic attenuation Image attenuation due to diaphragm
122748 False positive defect finding Finding of a defect (e.g., from automated analysis) is incorrect
122750 Non-diagnostic - low heart rate ECG is non-diagnostic due to low heart rate
122751 Non-diagnostic - resting ST abnormalities ECG is non-diagnostic due to resting ST abnormalities
122752 Non-diagnostic - ventricular pacing or LBBB ECG is non-diagnostic due to ventricular pacing or Left Bundle Branch Block
122755 Strongly positive Strongly positive finding
122756 Strongly positive - ST elevation Strongly positive finding - ST elevation
122757 ST Depression – Horizontal Finding of ST segment depression with no slope
122758 ST Depression – Upsloping Finding of ST segment depression with upslope
122759 ST Depression – Downsloping Finding of ST segment depression with downslope
122760 Stress test score Stress test score
122762 Number of diseased vessel territories Number of diseased vessel territories
122764 Weight exceeds equipment limit Patient weight exceeds equipment limit
122768 Difference in Ejection Fraction Difference in Ejection Fraction
122769 Difference in ED LV Volume Difference in End Diastolic Left Ventricular Volume
122770 Ratio of achieved to predicted maximal oxygen consumption Ratio of achieved to predicted maximal oxygen consumption
122771 Ratio of achieved to predicted functional capacity Ratio of achieved to predicted functional capacity
122772 Aerobic index Workload (Watts) at target heart rate divided by body weight
122773 ST/HR Index ST depression at peak exercise divided by the exercise-induced increase in heart rate [Kligfield P, Ameisen O, Okin PM. “Heart rate adjustment of ST segment depression for improved detection of coronary artery disease.” Circulation 1989;79:245-55.]
122775 Agreement with prior findings Agreement with prior findings
122776 Disagreement with prior findings Disagreement with prior findings
122781 Rest thallium/stress technetium procedure Nuclear Medicine Rest thallium/stress technetium procedure
122782 Rest technetium/stress technetium 1 day procedure Nuclear Medicine Rest technetium/stress technetium 1 day procedure
122783 Rest technetium/stress technetium 2 day procedure Nuclear Medicine Rest technetium/stress technetium 2 day procedure
122784 Stress technetium/rest technetium 1 day procedure Nuclear Medicine Stress technetium/rest technetium 1 day procedure
122785 NM Myocardial Viability procedure Nuclear Medicine Myocardial Viability procedure
122791 PET Myocardial Perfusion, Rest only Positron Emission Tomography Perfusion Imaging procedure, rest only
122792 PET Myocardial Perfusion, Stress only Positron Emission Tomography Perfusion Imaging procedure, stress only
122793 PET Myocardial Perfusion, Rest and Stress Positron Emission Tomography Perfusion Imaging procedure, rest and stress
122795 PET Myocardial Viability, Rest only Positron Emission Tomography Myocardial Viability procedure, rest only
122796 PET Myocardial Viability, Stress only Positron Emission Tomography Myocardial Viability procedure, stress only
122797 PET Myocardial Viability, Rest and Stress Positron Emission Tomography Myocardial Viability procedure, rest and stress
122799 Anginal Equivalent Group of symptoms heralding angina pectoris that does not include chest pain (dyspnea, diaphoresis, profuse vomiting in a diabetic patient, or arm or jaw pain).
123001 Radiopharmaceutical Active ingredient (molecular) used for radioactive tracing
123003 Radiopharmaceutical Start Time Time of radiopharmaceutical administration to the patient for imaging purposes
123004 Radiopharmaceutical Stop Time Ending time of radiopharmaceutical administration to the patient for imaging purposes
123005 Radiopharmaceutical Volume Volume of radiopharmaceutical administered to the patient
123006 Radionuclide Total Dose Total amount of radionuclide administered to the patient at Radiopharmaceutical Start Time
123007 Radiopharmaceutical Specific Activity Activity per unit mass of the radiopharmaceutical at Radiopharmaceutical Start Time
123009 Radionuclide Syringe Counts Pre-injection syringe acquisition count rate
123010 Radionuclide Residual Syringe Counts Syringe acquisition count rate following patient injection
123011 Contrast/Bolus Agent Contrast or bolus agent
123012 Pre-Medication Medication to be administered at the beginning of the Scheduled Procedure Step
123014 Target Region Anatomic Region to be imaged
123015 Imaging Direction Direction of imaging (includes view, transducer orientation, patient orientation, and/or projection)
123016 Imaging Conditions Imaging condition for refinement of protocol (includes secondary posture, instruction, X-Ray / electron beam energy or nuclide, and ultrasound modes), as used in JJ1017 v3.0
123019 Caudal 10 degree distal-cranioproximal oblique Caudal 10 degree distal-cranioproximal oblique radiographic projection, defined per Smallwood et al.
123101 Neighborhood Analysis Surface processing utilizing predefined weighting factors (i.e. kernels) applied to different data values depending on their location relative to other data values within the data domain. Includes Low Pass, High Pass, Gaussian, Laplacian, etc.
123102 Adaptive Filtering Surface processing applied non-uniformly utilizing a priori knowledge of the system and/or relative locations of the data values within the data domain. Example: Neighborhood analysis where weighting factors are modified continuously based on predefined criteria.
123103 Edge Detection Surface processing through the exploitation of discontinuities in the data values within their domain. Includes Gradient filters.
123104 Morphological Operations Surface processing based on the connectivity of values based on the shape or structure of the data values within their domain. Includes erode, dilate, etc.
123105 Histogram Analysis Surface processing applied to the distribution of the data values. Includes thresholding, Bayesian Classification, etc.
123106 Multi-Scale/Resolution Filtering Surface processing accomplished through varying the data domain size. Include deformable models.
123107 Cluster Analysis Surface processing accomplished by combining data values based on their relative location within their domain or value distribution. Includes K- and C-means, Fuzzy Analysis, Watershed, Seed Growing, etc.
123108 Multispectral Processing Surface processing accomplished through the weighted combination of multiple data sets. Includes Principle Component Analysis, linear and non-linear weighed combinations, etc.
123109 Manual Processing Surface processing accomplished through human interaction. Region drawing
123110 Artificial Intelligence Surface processing using Artificial Intelligence techniques, such as Machine Learning, Neural Networks, etc.
123111 Deformable Models Surface processing using Deformable Model techniques, such as Point Distribution Models, Level Sets, Simplex Meshes, etc.
125000 OB-GYN Ultrasound Procedure Report Document Title of OB-GYN procedure report
125001 Fetal Biometry Ratios Report section for assessment of fetal growth using ratios and indexes
125002 Fetal Biometry Report section for assessment of fetal growth
125003 Fetal Long Bones Report section for assessment of fetal growth by long bone measurements
125004 Fetal Cranium Report section for assessment of fetal cranium growth
125005 Biometry Group Biometric assessment of
125006 Biophysical Profile Report section for assessment of biophysical observations that evaluate fetal well-being according to Manning, Antepartum Fetal Evaluation: Development of a Fetal Bbiophysical Profile Score, Am. J Obsetet Gynecol, 1980;136:787.
125007 Measurement Group A grouping of related measurements and calculations that share a common context
125008 Fetus Summary Report section for fetus specific prodedure summary observations
125009 Early Gestation Report section for assessment of early gestation fetus
125010 Identifier A name to differentiate between multiple instances of some item
125011 Pelvis and Uterus Report section for assessment of pelvis and uterus
125012 Growth Percentile rank The rank of a measured growth indicator relative to a normal distribution expressed as a percentage.
125013 Growth Z-score The rank of a measured growth indicator relative to a normal distribution expressed as the dimensionless quantity z = (x-m)/s where (x-m) is the deviation of the value x, from from the distribution mean, m, and s is the standard deviation of the distribution.
125015 Fetus Characteristics Fetus characteristics (findings section title)
125016 Fetal Measurements Fetal Measurements (findings section title)
125021 Frame of Reference Identity There is a defined equivalence between the Frame of Reference of the Registration SOP instance and the Frame of Reference of the referenced images.
125022 Fiducial Alignment The registration is based on fiducials that represent patient or specimen features identified in each data set.
125023 Acquisition Equipment Alignment Registration based on a-priori knowledge of the acquisition geometry. This is not an object registration as in fiducial registration. Rather, it specifies a known spatial relationship.
125024 Image Content-based Alignment Computed registration based on global image information
125025 Visual Alignment Registration by visually guided manipulation.
125030 Inter-Hemispheric Plane A plane fiducial that specifies the location of the plane separating the two hemispheres of the brain.
125031 Right Hemisphere Most Anterior A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the anterior limit of the right brain hemisphere
125032 Right Hemisphere Most Posterior A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the posterior limit of the right brain hemisphere
125033 Right Hemisphere Most Superior A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the superior limit of the right brain hemisphere
125034 Right Hemisphere Most Inferior A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the inferior limit of the Right brain hemisphere
125035 Left Hemisphere Most Anterior A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the anterior limit of the left brain hemisphere
125036 Left Hemisphere Most Posterior A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the posterior limit of the left brain hemisphere
125037 Left Hemisphere Most Superior A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the superior limit of the left brain hemisphere
125038 Left Hemisphere Most Inferior A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the inferior limit of the left brain hemisphere
125100 Vascular Ultrasound Procedure Report Root Document Title for ultrasound vascular evidence reports (worksheets).
125101 Vessel Branch The particular vessel branch, such as the inferior, medial or lateral
125102 Graft Type A descriptor or elaboration of the type of graft
125105 Measurement Orientation A modifier to a 2D distance measurement to describe its orientation. For example, a vascular distance measurement for a vessel plague could have a modifier Transverse or Longitudinal.
125106 Doppler Angle The angle formed between the Doppler beam line and the direction of blood flow within a region of interest in the body defined by the sample volume.
125107 Sample Volume Depth The depth of the center of the Doppler sample volume measured from skin line along the Doppler line.
125195 Pediatric Cardiac Ultrasound Report Pediatric Cardiac Ultrasound Report (document title)
125196 Fetal Cardiac Ultrasound Report Fetal Cardiac Ultrasound Report (document title)
125197 Adult Congenital Cardiac Ultrasound Report Adult Congenital Cardiac Ultrasound Report (document title)
125200 Adult Echocardiography Procedure Report Document title of adult echocardiography procedure (evidence) report.
125201 Illustration of Finding An image that is a pictorial representation of findings. The concept is typically used as a purpose of reference to an image, such as a depiction of myocardium segments depicting wall motion function.
125202 LV Wall Motion Score Index The average of all scored (non-zero) Left Ventricle segment wall motion scores.
125203 Acquisition Protocol A type of clinical acquisition protocol for creating images or image-derived measurements. Acquisition protocols may be specific to a manufacturer’s product.
125204 Area-length biplane Method for calculating left ventricular volume from two orthogonal views containing the true long axis (usually the apical 4 and 2 chamber views). Volume = [( L1/6]*[(4A1)(((L1)]*[(4A2)((( L2)]
125205 Area-Length Single Plane Method for calculating left ventricular volume from a view containing the true long axis (usually the apical 4-chamber view). Volume = [8(A)2]([3(L]
125206 Cube Method (formula) for calculating left ventricle volumes and function derivatives (EF, SV, SI, etc.) that estimates the volume as the cube of diameter.
125207 Method of Disks, Biplane Method of calculating volume based on the summation of disk volumes. The disk axis is parallel to the left ventricular long axis and using a disk diameter averaged from the two chamber and four chamber views.
125208 Method of Disks, Single Plane Method of calculating volume based on the summation of disk volumes. The disk axis is parallel to the left ventricular long axis with disk diameter taken from the four-chamber view.
125209 Teichholz Method (formula) for calculating left ventricle volumes and function derivatives (EF, SV, SI, etc.) Volume = [7.0/(2.4+D)]*D3
125210 Area by Pressure Half-Time Mitral valve area (cm2) by Pressure Half-time = 220 (cm2.ms) / PHT (ms)
125211 Biplane Ellipse Area = (/4 X d1 X d2 d1 = anterior/posterior axis d2 = medial/lateral axis Hagen-Ansert, Sandra L., Textbook of Diagnostic Ultrasound, ed. 3, The C.V.Mosby Co., 1989, p. 73.
125212 Continuity Equation For conduits in series (“in continuity”), volume flow is equal: A1*V1 = A2*V2. where V is the velocity
125213 Continuity Equation by Mean Velocity For conduits in series (“in continuity”), volume flow is equal: A1*V1 = A2*V2. where V is the mean velocity
125214 Continuity Equation by Peak Velocity For conduits in series (“in continuity”), volume flow is equal: A1*V1 = A2*V2. where V is the peak velocity
125215 Continuity Equation by Velocity Time Integral For conduits in series (“in continuity”), volume flow is equal: A1*V1 = A2*V2. where V is the velocity time integral
125216 Proximal Isovelocity Surface Area Utilizes aliasing velocity (by color Doppler) of flow into an orifice (often regurgitant or stenotic) to measure instantaneous flow rate, orifice area, and flow volume. The instantaneous flow rate = (2 π r2 vav ) * (α / π) where vav is the constant velocity known as aliasing velocity at radius r, vp is the peak velocity at the orifice, and α is the angle in radians of the constant velocity surface. Estimated Orifice area = Flow rate / vp, where vp is the peak velocity at the orifice and the flow rate is the PISA peak flow rate. The volume flow is then the product of the orifice area and Velocity Time Integral
125217 Full Bernoulli ΔP = 4*(V12 – V22)
125218 Simplified Bernoulli ΔP = 4*V2
125219 Doppler Volume Flow Volume flow = Conduit CSA * ( Velocity Time Integral )
125220 Planimetry Direct measurement of an area by tracing an irregular perimeter
125221 Left Ventricle Mass by M-mode Mass = 1.04 * [(ST+LVID+PWT)3-LVID3] * 0.8+ 0.6. Mass unit is grams and length in cm.
125222 Left Ventricle Mass by Truncated Ellipse Mass = 1.05 ( ( (b + t)2 X (2/3 (a + t) + d – d3/3(a + t)2 ) – b2 (2/3a + d – d3/3a2) ) a = Semi-major axis from widest minor axis radius to apex. b = Short axis radius calculated from short axis cavity area t = Myocardial thickness calculated from short axis epicardial and cavity areas d = Truncated semi-major axis from widest short axis diameter to plane of mitral annulus. Mass unit is grams and length in cm. Schiller NB et al: Recommendations for quantification of the left ventricle by two-dimensional echocardiography, American Society of Echocardiography 2:364, 1989.
125223 4 Point Segment Finding Scale A four point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989.
125224 5 Point Segment Finding Scale A five point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989.
125225 5 Point Segment Finding Scale With Graded Hypokinesis A five point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology, with severity of hypokinesis graded. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989.
125226 Single Plane Ellipse Method of estimating volume from a planar ellipse. Equivalent to Biplane Ellipse with an assumption that the ellipse in the orthogonal plane has identical major and minor diameters.
125227 Modified Simpson Modified Simpson’s Method of estimating ventricular volume, based on the method of disks with paired apical views. Schiller NB, et al. “Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms”. J Am Soc Echocardiogr. 1989 2(5):358-367. Sep-Oct.
125228 Bullet Method Bullet method of estimating ventricular volume. Volume = 5/6 * L * S L : Left ventricle long axis length S : Left ventricle area, SAX view at level of Mitral Valve.
125230 Power Doppler Color coded ultrasound images of blood flow which depict the amplitude, or power, of Doppler signals. Retired Replaced by (P0-02241, SRT, “Power Doppler”)
125231 3D mode Volumetric ultrasound imaging Retired Replaced by (P0-02242, SRT, “3D mode”)
125233 Start of drug dose administration Onset of administration of dose of a drug
125234 Start of contrast agent administration Onset of contrast agent administration
125235 Destruction of microbubbles Destruction of ultrasonic contrast microbubbles by a high-energy ultrasound pulse
125236 Onset of exercise Instant at which exercise begins
125237 Cessation of exercise Instant at which exercise ends
125238 Onset of stimulation Instant at which stimulation begins
125239 Cessation of stimulation Instant at which stimulation ends
125240 Line scan pattern Ultrasound transducer scan pattern in which information is gathered along a line
125241 Plane scan pattern Ultrasound transducer scan pattern in which information is gathered within a plane
125242 Volume scan pattern Ultrasound transducer scan pattern in which information is gathered within a volume
125251 Non-imaging Doppler ultrasound transducer geometry Ultrasound transducer geometry characterized by a single scan line used for PW or CW Doppler scanning
125252 Linear ultrasound transducer geometry Ultrasonic transducer geometry characterized by parallel lines
125253 Curved linear ultrasound transducer geometry Ultrasonic transducer geometry characterized by radial lines normal to the outside of a curved surface
125254 Sector ultrasound transducer geometry Ultrasonic transducer geometry characterized by lines originating from a common apex
125255 Radial ultrasound transducer geometry Ultrasonic transducer geometry characterized by lines eminating radially from a single point
125256 Ring ultrasound transducer geometry Ultrasonic transducer geometry characterized by a circular ring of transducer elements
125257 Fixed beam direction Ultrasonic steering technique consisting of a single beam normal to the transducer face steered by the orientation of the probe
125258 Mechanical beam steering Ultrasonic steering technique consisting of mechanically directing the beam
125259 Phased beam steering Ultrasonic steering technique consisting of electronically-steered beams
125261 External Transducer Transducer is designed to be placed onto the surface of the subject
125262 Transesophageal Transducer Transducer is designed for insertion into the esophagus
125263 Endovaginal Transducer Transducer is designed for insertion into the vagina
125264 Endorectal Transducer Transducer is designed for insertion into the rectum
125265 Intravascular Transducer Transducer is designed for insertion via a catheter
125270 Left Ventricle Mass by Area Length method to measure the mass of the Left Ventricle via the ASE area-length method at end diastole. LV Mass = 1.05*(5/6*(A1*(L+t) ) - 5/6*(A2*L) ) A1 = Left Ventricle epicardial SAX area at the level of of the papillary muscle tips at end diastole. A2 = Left Ventricle endocardial SAX area cavity area at the level of the papillary muscle tips at end diastole. L = Left Ventricle apical view long axis length at end diastole. t = Myocardial thickness can be computed as : t = sqrt( A1/3.14) – sqrt ( A2/3.14) Reference: 1) Schiller, N.B., et al. “Recommendations for Quantification of the LV by Two-dimensional Echocardiography." J Am Soc Echo, Vol. 2, No. 5: 358-367, Sep-Oct 1989. 2) Reichek, N., et al. "Anatomic Validation of Left Ventricular Mass Estimates from Clinical Two-dimensional Echocardiography: Initial Results." Circulation, Vol. 67, No. 2: 348-52, February 1983.
125271 Left Ventricle Mass by M-mode – adjusted by Height Equation = Left Ventricle Mass by M-mode (in gram) / ( Height (in meter) )^2.7 Reference: Giovanni De Simone, et al. “Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk”. New York, New York and Cincinnati, Ohio.
125272 Left Ventricle Mass by Truncated Ellipse – adjusted by Height Equation = Left Ventricle Mass by Truncated Ellipse / Height^2.7 Reference: Giovanni De Simone, et al. “Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk”. New York, New York and Cincinnati, Ohio.
125273 Left Ventricle Mass by Area Length – adjusted by Height Equation = Left Ventricle Mass by Area Length / Height^2.7 Reference: Giovanni De Simone, et al. “Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk”. New York, New York and Cincinnati, Ohio.
125901 CARDIOsphere CARDIOsphereTM ultrasonic contrast agent produced by POINT Biomedical
125902 Echovist Echovist® ultrasonic contrast agent produced by Schering AG
125903 Imagify ImagifyTM ultrasonic contrast agent produced by Accusphere Inc.
125904 Levovist Levovist® ultrasonic contrast agent produced by Schering AG.
125905 Sonazoid SonazoidTM ultrasonic contrast agent produced by Daiichi Pharmaceutical / General Electric
125906 SonoVue SonoVueTM ultrasonic contrast agent produced by Bracco Diagnostics
125907 Targestar-B TargestarTM-B ultrasonic contrast agent produced by Targeson LLC
125908 Targestar-P TargestarTM-P ultrasonic contrast agent produced by Targeson LLC
113900 Dose Check Alert Details Report section about cumulative dose alerts during an examination.
113901 DLP Alert Value Configured Flag denoting whether a DLP Alert Value was configured.
113902 CTDIvol Alert Value Configured Flag denoting whether a CTDIvol Alert Value was configured.
113903 DLP Alert Value Cumulative Dose Length Product value configured to trigger an alert. See NEMA XR 25-2010 Dose Check Standard.
113904 CTDIvol Alert Value Cumulative CTDIvol value configured to trigger an alert. See NEMA XR 25-2010 Dose Check Standard.
113905 Accumulated DLP Forward Estimate A forward estimate of the accumulated DLP plus the estimated DLP for the next Protocol Element Group. See NEMA XR 25-2010 Dose Check Standard.
113906 Accumulated CTDIvol Forward Estimate A forward estimate at a given location of the accumulated CTDIvol plus the estimated CTDIvol for the next Protocol Element Group. See NEMA XR 25-2010 Dose Check Standard.
113907 Reason for Proceeding Reason provided for proceeding with a procedure that is projected to exceed a configured dose value.
113908 Dose Check Notification Details Report section about dose notifications during a protocol element.
113909 DLP Notification Value Configured Flag denoting whether a DLP Notification Value was configured.
113910 CTDIvol Notification Value Configured Flag denoting whether a CTDIvol Notification Value was configured.
113911 DLP Notification Value Dose Length Product value configured to trigger a notification for a given protocol element.
113912 CTDIvol Notification Value CTDIvol value configured to trigger a notification for a given protocol element.
113913 DLP Forward Estimate A forward estimate of the DLP for the next Protocol Element Group. See NEMA XR 25-2010 Dose Check Standard.
113914 CTDIvol Forward Estimate A forward estimate of the CTDIvol for the next Protocol Element Group. See NEMA XR 25-2010 Dose Check Standard.
ARCHIVE Archive Archive device
AR Autorefraction Autorefraction device
AS Angioscopy Angioscopy device Retired
AU Audio Audio object
BDUS Ultrasound Bone Densitometry Ultrasound Bone Densitometry (modality)
BI Biomagnetic imaging Biomagnetic imaging device
BMD Bone Mineral Densitometry Bone Mineral Densitometry by X-Ray (modality), including dual-energy X-Ray absorptiometry (DXA) and morphometric X-Ray absorptiometry (MXA)
CAD Computer Assisted Detection/Diagnosis Computer Assisted Detection/Diagnosis device
CAPTURE Image Capture Image Capture Device, includes video capture
CD Color flow Doppler Color flow Doppler Retired Replaced by (US, DCM, “Ultrasound”)
CF Cinefluorography Cinefluorography Retired Replaced by (RF, DCM, “Radiofluoroscopy”)
COMP Computation Server Computation Server; includes radiotherapy planning
CP Culposcopy Culposcopy Retired
CR Computed Radiography Computed Radiography device
CS Cystoscopy Cystoscopy Retired
CT Computed Tomography Computed Tomography device
DD Duplex Doppler Duplex Doppler Retired Replaced by (US, DCM, “Ultrasound”)
DF Digital fluoroscopy Digital fluoroscopy Retired Replaced by (RF, DCM, “Radiofluoroscopy”)
DG Diaphanography Diaphanography device
DM Digital microscopy Digital microscopy Retired
DOCD Document Digitizer Equipment Equipment that digitized hardcopy documents and imported them.
DS Digital Subtraction Angiography Digital Subtraction Angiography Retired Replaced by (XA, DCM, “X-Ray Angiography”)
DSS Department System Scheduler Department System Scheduler, workflow manager; includes RIS
DX Digital Radiography Digital Radiography device
EC Echocardiography Echocardiography Retired Replaced by (US, DCM, “Ultrasound”)
ECG Electrocardiography Electrocardiography device
EPS Cardiac Electrophysiology Cardiac Electrophysiology device
ES Endoscopy Endoscopy device
F Female Female sex
FA Fluorescein angiography Fluorescein angiography Retired Replaced by (OP, DCM, “Ophthalmic photography”)
FC Female changed to Male Female sex changed to Male sex
FILMD Film Digitizer Film Digitizer
FP Female Pseudohermaphrodite Female Pseudohermaphrodite
FS Fundoscopy Fundoscopy Retired
GM General Microscopy General Microscopy device
H Hermaphrodite Hermaphrodite
HC Hard Copy Hard Copy
HD Hemodynamic Waveform Hemodynamic Waveform acquisition device
IO Intra-oral Radiography Intra-oral Radiography device
IVUS Intravascular Ultrasound Intravascular Ultrasound device
KER Keratometry Keratometry device
KO Key Object Selection Key Object Selection object
LEN Lensometry Lensometry device
LOG Procedure Logging Procedure Logging device; includes cath lab logging
LP Laparoscopy Laparoscopy Retired
LS Laser surface scan Laser surface scan device
M Male Male sex
MA Magnetic resonance angiography Magnetic resonance angiography Retired Replaced by (MR, DCM, “Magnetic resonance”)
MC Male changed to Female Male sex changed to Female sex
MCD Media Creation Device A device that creates DICOM PS 3.10 interchange media. For example, a CD creator that is managed by the Media Creation Management Service Class.
MEDIM Portable Media Importer Equipment Equipment that retrieved and imported objects from interchange Media.
MG Mammography Mammography device
MP Male Pseudohermaphrodite Male Pseudohermaphrodite
MR Magnetic Resonance Magnetic Resonance device
MS Magnetic resonance spectroscopy Magnetic resonance spectroscopy Retired Replaced by (MR, DCM, “Magnetic resonance”)
NEARLINE Nearline Instances need to be retrieved from relatively slow media such as optical disk or tape
NM Nuclear Medicine Nuclear Medicine device
OAM Ophthalmic Axial Measurements Measurements of the axial length of the eye which are done by various devices
OCT Optical Coherence Tomography Modality device that uses an interferometric, non-invasive optical tomographic technique to image 2D slices and 3D volumes of tissue using visible and near visible frequencies.
OFFLINE Offline Instances need to be retrieved by manual intervention
ONLINE Online Instances are immediately available
OP Ophthalmic photography Ophthalmic photography modality
OPM Ophthalmic Mapping Modality device that measures corneal topography, corneal or retinal thickness, and other similar parameters that are typically displayed as maps.
OPR Ophthalmic Refraction Modality device that measures the refractive characteristics of the eye.
OPT Ophthalmic Tomography Tomography of the eye acquired by a modality that is based on light and optical principles. Tomography based on other principles, such as ultrasound, is excluded.
OPV Ophthalmic Visual Field Modality device that measures visual fields and perform visual perimetry.
OT Other Modality Other Modality device
PR Presentation State Presentation State object
PRINT Hard Copy Print Server Hard Copy Print Server; includes printers with embedded DICOM print server
PT Positron emission tomography Positron emission tomography (PET) device
PX Panoramic X-Ray Panoramic X-Ray device
REG Registration Registration
RF Radiofluoroscopy Radiofluoroscopy device
RG Radiographic imaging Radiographic imaging (conventional film/screen)
RT Radiation Therapy Device Radiation Therapy Device; includes linear accelerator, proton therapy
RTDOSE Radiotherapy Dose Radiotherapy Dose
RTIMAGE Radiotherapy Image Radiotherapy Imaging device; includes portal imaging
RTPLAN Radiotherapy Plan Radiotherapy Plan
RTRECORD Radiotherapy Treatment Record Radiotherapy Treatment Record
RTSTRUCT Radiotherapy Structure Set Radiotherapy Structure Set
SEG Segmentation Segmentation
SM Slide Microscopy Slide Microscopy
SMR Stereometric Relationship Stereometric image pairing modality
SR Structured Report Document Structured Report Document
SRF Subjective Refraction Subjective Refraction device
ST Single-photon emission computed tomography Single-photon emission computed tomography (SPECT) device Retired Replaced by (NM, DCM, “Nuclear Medicine”)
TG Thermography Thermography device
U Unknown Sex Unknown Sex
UNAVAILABLE Unavailable Instances cannot be retrieved.
US Ultrasound Ultrasound device
VA Visual Acuity Visual Acuity device
VF Videofluorography Videofluorography Retired Replaced by (RF, DCM, “Radiofluoroscopy”)
VIDD Video Tape Digitizer Equipment Equipment that digitizes video tape and imports it.
WSD Workstation Workstation
XA X-Ray Angiography X-Ray Angiography device
XC External-camera Photography External-camera Photography device